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ABSTRACT 
Metals are essential to life, yet they can be toxic (or even fatal) for biological 
systems when present in excessive amounts. The major source of metal overload in 
humans is diet; and in some cases, intravenous feeding. Thus the removal of toxic metal 
ions from contaminated clinical products such as total parenteral nutrition (TPN) 
solutions, and drinking and waste water systems is extremely important. The use of 
chelating resins, which are polymeric solids containing covalently immobilized chelating 
compounds, for the selective removal of metal ions from contaminated solutions has been 
conceptualized long ago. Herein, the design and synthesis of metal specific chelating 
compounds and chelating resins will be presented, along with the application of these 
materials to remove toxic metals from aqueous solutions.  
Solution phase hydroxamate based chelating compounds have been synthesized 
for the selective binding of trivalent metals such as iron and aluminum in the presence of 
divalent metals such as calcium. Iron complexation behavior of these solution phase 
chelating compounds has been studied by UV-Vis spectrophotometric methods. These 
hydroxamate chelators have potential applications as chelating agents in the treatment of 
iron and aluminum overload. A set of the strongly binding chelators have been 
immobilized on solid support via various linkages. These solid supported chelators have 
been employed to selectively remove aluminum from contaminated TPN components 
such as a solution of calcium gluconate. Our resins are able to remove more than 90% of 
aluminum from commercial calcium gluconate solutions. This technology of employing 
hydroxamate functionalized resins for the removal of aluminum from calcium gluconate 
solution will be available in hospitals soon and will greatly benefit premature neonates 
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and critically ill patients who receive TPN solutions for life support.  Additionally, 
citramide functionalized chelating resins have been prepared for the removal of trivalent 
metals from contaminated solutions at low pH, and dithiolate based chelating resins were 
prepared for the removal of high priority environmental metal toxins such as lead, 
cadmium, mercury, and arsenic. Overall, this dissertation embodies the design, synthesis, 
and metal binding studies of novel chelators and chelating resins and the applications of 
these resins for the selective removal of metal ions from contaminated solutions. 
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1.1 Metals in biology 
Although biology is generally associated with organic chemistry, inorganic 
elements are also essential to life processes. Metals are ubiquitous in our environment, 
and they play important biological functions in all forms of life.
1
 Not surprisingly, metals 
are essential for humans. Metals play a critical role in protein and nucleic acid 
biochemistry. Proteins associated with metals are called metalloproteins where metals 
function as redox centers, transport oxygen, and utilize their ligand-binding abilities in 
acting as molecular sensors in signal transduction.
2
 Some metalloproteins that catalyze 
biochemical reactions are called metalloenzymes. Though a variety of metals are 
necessary in biological systems, they are usually required only in trace amounts and can 
be toxic, if not fatal, when present in excess.
3
 Many diseases are related to improper 
metal ion concentrations in the body. Some diseases are directly linked to a deficiency of 
certain metals and others are due to their overload. Some examples of diseases related to 
metal deficiency are anemia due to iron deficiency, bone and teeth diseases due to 
calcium deficiency, hyperexcitibility and muscle weakness due to magnesium deficiency, 
among many others. The recent rapid growth of bioinorganic chemistry has helped us to 
understand the role of metals in biological systems in more detail.  
Living organisms utilize some metals in large amounts and other metals in ultra 
trace amounts. Main group metals such as sodium (Na), potassium (K), magnesium (Mg), 
and calcium (Ca) are present in large amounts. Transition metals such as iron (Fe), zinc 
(Zn), and copper (Cu) are present in trace amounts, and manganese (Mn), cobalt (Co), 
chromium (Cr), vanadium (V), nickel (Ni), cadmium (Cd), and a few others are present in 
ultra trace amounts. Transition metals are chiefly concerned with catalyzing reactions 
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either through complex formation with biological ligands or via redox reactions between 
their available oxidation states. Main group elements, on the other hand, function as 
charge carriers in biological systems.
4
 
 
1.2 Metal overload and toxicity 
Recent human activities have dramatically altered the distribution of metals in the 
environment. Due to the recent mining boom and industrialization, metal distribution in 
the environment has greatly increased. Not only the persons working directly in metal 
industry, but also the general public and consumers of metal products are exposed to 
higher levels of metals. Chronic exposure to higher levels of metals can lead to very 
serious toxicological consequences. These effects depend primarily on the type of 
exposure (ingestion, inhalation, or dermal absorption), the form of the metal (elemental, 
salt, vapor, or alloy), the dose, and the length of exposure.
3 
 
The present study focuses on the overload and toxicity of iron (Fe), aluminum 
(Al), and soft heavy metals such as lead (Pb), mercury (Hg), arsenic (As), and cadmium 
(Cd) and ways to remove such metals from biological systems and contaminated 
solutions. Sources and clinical manifestations of overload of these metals are presented 
below. 
 
1.2.1 Iron toxicity 
Iron is essential for all living organisms as it is involved in many biological 
functions such as oxygen transport, electron transport, and photosynthesis. Almost all 
serum iron is bound to the iron binding protein transferrin, resulting in a very low free 
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serum iron concentration of 10
-24
 M. As there is no known specific mechanism for iron 
removal in primate metabolism, iron overload is observed when it is introduced in 
excessive amounts into this closed metabolic loop. In other words, iron toxicity results 
when the concentration of non-heme iron in the blood stream exceeds the transferrin iron-
binding capacity. High iron diet, acute iron ingestion, which can damage intestinal lining 
and result in increased iron uptake, chronic transfusion therapy for disorders such as 
thalassemia, hereditary hemochromatosis, etc. are some of the causes of iron overload.
5
 
Chronic overload leads to peroxidative tissue damage due to the ability of the ferrous ion 
to catalyze the formation of reactive oxygen species (ROS), such as the hydroxyl radical.
6
 
These ROS may react with several endogenous molecules (sugars, lipids, proteins and 
nucleic acids), with subsequent lipid peroxidation, sugar and protein oxidation, as well as 
DNA and RNA damage, thus leading to various pathological situations.
7
 This can lead to 
organ failure, usually liver and heart, and eventually to death. 
 
1.2.2 Aluminum toxicity 
Although aluminum is the third most common element in the earth’s crust, it is 
not essential for plants and animals.
  
In humans, aluminum has no biological function. 
Unlike other trivalent metals, it has a single oxidation state (+3) and cannot undergo 
redox chemistry.
8
 Aluminum becomes toxic when accumulated in organisms. Cumulative 
aluminum toxicity has been overlooked until recently. While aluminum has historically 
been regarded as biologically inert, recent studies suggest toxicity for vulnerable 
individuals such as premature neonates and patients with renal problems. Acute 
aluminum toxicity is almost always limited to patients with insufficient renal 
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functioning.
9
 Aluminum toxicity was first recognized in the 1970s as the cause of 
osteodistrophy and dialysis dementia in patients with renal failure receiving dialysis 
treatment.
10
 Although aluminum toxicity in a healthy human is limited by a combination 
of poor intestinal absorption and effective renal clearance, it still poses a great threat to 
the premature neonates and patients with impaired renal function.
11
  
There are many sources of aluminum. The major source for most humans is diet. 
Underarm antiperspirants, vaccines, antacids, parenteral fluids and inhaled fumes and 
particles from occupational exposure can be significant sources for some people.
12
 
Parenteral nutrition solutions have been shown to be highly contaminated with aluminum 
and are the sources of aluminum overload in premature neonates and in patients receiving 
parenteral nutrition for life support. Aluminum contamination of parenteral fluids and its 
adverse effects will be described later in this chapter. 
Aluminum toxicity has mostly been associated with bone disorders and 
neurological diseases. Aluminum overload causes a metabolic bone disease by binding 
phosphate and inducing phosphorus deficiency. Aluminum can also prevent calcium 
absorption which is vital for bone formation.
13
 Due to the binding of aluminum with 
transferrin (although Al
3+
 cannot displace Fe
3+
 from transferrin), aluminum overload 
causes hypochromic microcytic anemia. Chronic aluminum toxicity is occasionally seen 
in chronic dialysis patients. This is termed as the dialysis encephalopathy syndrome. 
Neurodegenerative diseases like Alzheimer’s disease14 and Parkinson’s dementia15 have 
also been linked to aluminum overdose. Aluminum overdose does have the potential to 
produce some neurobehavioral and neuropathologic changes that are seen or are similar 
to those seen in Alzheimer’s disease.12 
Dawadi, Surendra, 2013, UMSL, p.6 
 
 
 
1.2.3 Heavy metal poisoning 
Heavy metals are commonly defined as those having a specific density of more 
than 5 g/cm
3
 such as Pb, Hg, As, Cd, etc. They are present in ultra trace amounts in the 
body but even trace amounts cause serious problems. Heavy metals are toxic because 
their accumulation causes chronic degenerative changes to the nervous system, liver, and 
kidneys. In some cases, heavy metals also have carcinogenic effects. They exert their 
toxic effects by binding with one or more reactive groups such as -SH, -SS-, -NH2 that 
are essential for normal physiological functions of biomolecules.
16
 The mechanism of 
toxicity of some heavy metals still remains unknown, although enzymatic inhibition, 
impaired antioxidants metabolism, free radical formation, and oxidative stress may play a 
role.
17
 Alissa and Fern
17
 compiled a table which lists the organs affected by heavy metals 
and the toxic effects of four heavy metals, As, Pb, Cd, and Hg. Table 1.1 is adapted from 
Alissa and Fern.
17
 Heavy metal poisoning and the efforts by our group to selectively 
remove heavy metals from environmental waters will be discussed in detail in Chapter 5. 
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Table 1.1 Toxic effects and organs affected by heavy metals
17
 
 
Heavy metal 
 
Most affected organs 
 
 
Chronic health effects 
 
 
 
Arsenic (As) 
 
 Central nervous system 
 Lungs 
 Digestive tract 
 Circulatory system 
 Kidneys 
 
 
 Cancers 
 Peripheral vascular disease 
 Skin lesions 
 Hearing loss 
 Reproductive toxicity 
 Hematologic disorders 
 Neurological diseases 
 Developmental abnormalities    
 neurobehavioral disorders 
 
 
 
 
Lead (Pb) 
 
 Central nervous system 
 Erythropoiesis 
 Kidneys 
 Liver 
 
 
 Cancers 
 Kidney damage 
 Neurological diseases 
 Impaired intellectual ability and 
behavioral problems in children 
 
 
 
 
Cadmium (Cd) 
 
 Liver 
 Bone 
 Lungs 
 
 
 
 Cancers 
 Kidney damage 
 Bronchiolitis, COPD, emphysema, 
fribosis  
 Impaired intellectual ability and 
behavioral problems in children 
 Skeletal damage 
 
 
 
 
 
Mercury (Hg) 
 
 
 Central nervous system 
 Liver 
 Kidneys 
 Lungs 
 
 
 Lung damage 
 Kidney damage 
 Neurological diseases 
 Impaired intellectual ability and 
behavioral problems in children 
 Metallic mercury is an allergen, which 
may cause contact eczema 
 Mercury from amalgam fillings may 
give rise to oral lichen 
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1.3 Chelation therapy of metal overload 
Chelation therapy has been the major treatment method for metal overload and 
toxicity. Chelation therapy employs a chelating agent which complexes with metals and 
allows a swift removal of excess metals from biological systems. The chelating agent 
displaces metal ions from biological ligands such as proteins and converts them into less 
toxic forms which can be easily excreted without further interaction with the body.  
A chelating agent or a chelator is a multi-dentate ligand that binds to more than 
one coordination site of a metal ion. The number of coordination sites occupied by a 
ligand is referred to as denticity. Chelating compounds bind metal ions more tightly than 
monodentate ligands. The heterocyclic ring formed by the binding of at least two 
functional groups of a chelator with a metal ion is called a chelate. As an example, 
catechol 1.1 (Figure 1.1) is a bidentate chelator which forms a five membered chelate 
ring 1.2 when it binds with metals. 
 
 
 
Figure 1.1 Catechol and its chelation with metals 
 
1.3.1 Iron and aluminum chelating agents 
Al
3+
 and Fe
3+
 have ionic radii of 54 pm and 65 pm, respectively. Due to their 
short ionic radius and their high charge, both metals are hard ions. Their interaction with 
ligands is a non-covalent interaction which involves ionic or electrostatic bonds.
10 
Thus, 
they have similar binding properties and preferentially bind to hard, negatively charged 
 1.1  1.2 
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oxygen donor ligands such as carboxylates, catecholates, and hydroxamates. Al
3+ 
is 
however less acidic than Fe
3+
, and therefore, has less affinity towards most hard basic 
donors than Fe
3+
.
18
 The preferred coordination number for both metal ions is 6, producing 
octahedral complexes. All Fe chelators are also Al chelators, although the Fe complexes 
are more stable in most cases. There are no known metal specific chelators between these 
two metals. Iron overload and toxicity has been long known and the development of iron 
chelating agents has been extensively studied, thus, development of aluminum chelators 
is heavily influenced by the known iron chelators. The studies towards the development 
of iron and aluminum chelating agents are presented below.  
The first iron chelating agent introduced to the market was Desferrioxamine 
(DFO) 1.3 (Figure 1.2) which has been in continuous use for more than 40 years. DFO is 
a trihydroxamate siderophore produced by Streptomyces pilosus.
19
 Siderophores are low 
molecular weight, high affinity, iron chelating compounds secreted by microorganisms 
for iron uptake and transport. DFO forms a very strong 1:1 octahedral complex with iron 
and aluminum involving six oxygen atoms of three hydroxamate groups (see Chapter 2 
for detail). The main shortcomings associated with DFO are its lack of oral 
bioavailability and high cost. Other problems such as low efficiency, poor patient 
compliance, and toxic side effects further complicate DFO treatment.
20
 Thus there have 
been a number of studies related to the development of orally active chelators that are 
economically and therapeutically more useful.
21
 Many DFO analogues and variants have 
been developed to address this issue, but most of them turn out to be even more 
impractical than DFO due to their increased molecular weight. Non-hydroxamate based 
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chelators also have been developed over the years in order to address the same problem.
22
 
Effort to develop better therapeutic agents for iron chelation therapy is still ongoing. 
The most important element in such efforts is the need for the development of 
orally active iron chelators. Iron chelators currently in clinical practice, other than DFO, 
are deferiprone 1.4, and deferasirox (Exjade) 1.5 (Figure 1.2). Deferiprone is a member 
of the class of compounds 3-hydroxy-4-pyridinones (3,4-HP). Other members of this 
class of compounds are also investigated as potential iron chelating agents.
7 
The oral, 
three-times-daily agent deferiprone appeared to be a promising advance; however, its use 
has been limited owing to serious adverse events, such as neutropenia and 
agranulocytosis. Deferasirox is a novel, orally active agent that provides 24 hour 
chelation with a once-daily dose.
23
 Other potential Fe chelators are deferrithiocin 1.6, 1-
Phenyl-1-hydroxymethylene bisphosphonic acid 1.7, and kojic acid 1.8 (Figure 1.3), 
among many others.
24
 
 
 
 
Figure 1.2 Structures of iron chelating agents in clinical use
7 
 
 
DFO 1.3 
deferiprone 1.4 
deferasirox 1.5 
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Figure 1.3 Structures of potential iron chelating agents  
 
The first chelating agent introduced into clinical practice for aluminum related 
diseases was DFO 1.1. DFO was initially investigated as an aluminum chelator in 
hemodialysis patients suffering from chronic aluminum intoxication. The choice of DFO 
was based on its previous use in removing Fe from the liver of dialysis patients. It was 
found that DFO can reduce aluminum induced mortality associated with the dialysis 
encephalopathy syndrome, can reduce bone aluminum, and can improve bone 
histomorphometry.
12
 Studies in animals have shown that DFO can increase Al clearance, 
decrease tissue Al concentrations, and reduce measures of Al-induced toxicity in Al-
loaded rats and rabbits. As DFO is not an ideal chelator, particularly for long-term 
treatment of Al accumulation, there has been a concerted effort to identify orally-
effective alternatives. One such alternative is 3,4-hydroxypyridinone (3,4-HP), such as 
deferiprone 1.4 which has been used in aluminum related conditions. Deferiprone has 
aluminum chelation efficacy comparable to that of DFO, and more importantly, it is 
orally active. One shortcoming related to deferiprone, excluding its adverse side effects 
as mentioned earlier, is that it is a bidentate ligand. A three times higher molar dose is 
required for the formation of a 1:3 metal to ligand complex.
12
 Thus, a search for an orally 
effective hexadentate aluminum chelator is also still ongoing. 
 
Kojic acid 1.8 deferrithiocin 1.6 Bis-phosphonic acid 1.7 
Dawadi, Surendra, 2013, UMSL, p.12 
 
 
 
1.3.2 Heavy metal chelating agents 
Ethylenediaminetetraacetic acid (EDTA) 1.13 (Figure 1.4) and its various salts are 
some of the most widely used chelating agents. Unsurprisingly, EDTA has been used for 
the treatment of lead poisoning. EDTA is a hard and strong chelator and binds not only 
heavy metals but also hard metal ions unselectively. Thus, preferred ligands for soft 
metal ions such as Pb
2+
, Hg
2+
, Cd
2+
 and As
3+
 are thiolates. Thiols are soft ligands and 
preferentially coordinate to soft heavy metals. Dimercaprol 1.9 (Figure 1.4), which is also 
known as British anti-Lewisite (BAL), was discovered and used during World War II in 
reversing the effects of the chemical weapon, Lewisite (2-chloroethenyl–
dichloroarsine).
25
 Since then, it has been used clinically as a heavy metal chelating agent. 
Dimercaprol has serious side effects, which led researchers to develop less toxic analogs. 
2,3-dimercaptopropane sulfonate (DMPS) 1.10 is a derivative of dimercaprol and has 
been used as chelating agent in mercury poisoning, although it is not very effective 
against lead.
25
 D-penicillamine 1.11 is a thiol containing amino acid and another example 
of a chelating agent for heavy metal toxicity. Only the D isomer of penicillamine is a 
useful chelating agent, as L-penicillamine is quite toxic. Meso-2,3-dimercaptosuccinic 
acid (DMSA) 1.12 has gained more attention in recent years as a very potent heavy metal 
chelator. 
 
Dawadi, Surendra, 2013, UMSL, p.13 
 
 
 
 
 
Figure 1.4 Structures of heavy metal chelating agents  
 
1.4 Premature neonates and total parenteral nutrition (TPN) solutions 
Nearly fifteen million babies are born prematurily each year around the world. 
This is about 10% of the total births. Most premature neonates do not tolerate oral 
feeding because their gastrointestinal system is not fully developed and require 
intravenous (IV) feeding. IV feeding is accomplished with a total parenteral nutrition 
(TPN) solution, which is prepared from a number of component solutions. These additive 
solutions are categorized into two groups, large-volume parenterals (LVP) and small-
volume parenterals (SVP). LVP’s are usually solutions of electrolytes, carbohydrates, 
proteins and emulsion of lipids, and usually packaged in volumes of 100 ml or more. 
SVP’s are usually bottled in 100 ml or less and include solutions of mineral supplements 
such as calcium gluconate, potassium phosphate, magnesium sulphate, etc. 
 
1.4.1 Aluminum contamination of TPN additives 
Aluminum contamination of TPN solutions has been a well recognized problem 
for many years. Some SVP solutions, especially calcium gluconate and some phosphate 
EDTA 1.13 
dimercaprol 1.9 D-penicillamine 1.11 DMSA 1.12 DMPS 1.10 
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and acetate salts, are substantially contaminated with aluminum. Studies showed that 
three SVP solutions, calcium gluconate, potassium phosphate, and sodium acetate 
contribute greater than 90% of aluminum to the final TPN mixture. Calcium gluconate 
alone accounts for 81% of the aluminum.
26
 This contamination is due to the strong 
binding of ubiquitous aluminum by the gluconate anion during manufacture. Calcium 
gluconate is manufactured by the oxidation of glucose to gluconic acid followed by 
treating with calcium carbonate. The exact source of aluminum contamination in calcium 
gluconate is not known. Aluminum, most probably, comes from raw materials.
27
 It also 
leaches into the solution from glass containers during autoclaving and storage.
27
 
 
1.4.2 Clinical manifestation of aluminum overload in premature neonates 
While aluminum has historically been regarded as biologically inert, recent 
studies suggest toxicity for vulnerable individuals such as premature neonates. Aluminum 
accumulates in the body when the protective gastrointestinal system is bypassed and renal 
function is impaired, both of which apply to premature neonates. Premature neonates who 
receive TPN solution are especially prone to aluminum toxicity as their kidney function 
is immature, and the TPN solution bypasses the protective barrier of the gastrointestinal 
tract. Clinical manifestations of long term exposure to toxic levels of aluminum include 
anemia, impaired bone growth,
28
 and delays in mental development
29
 because most of the 
aluminum gets deposited in the bone, liver, and brain. Neonates who receive TPN 
solution are thus at high risk for impaired neurologic development and metabolic bone 
disease. It is reported that neonates receiving 3 weeks of parenteral therapy have 10 times 
higher aluminum concentration in bone marrow than those receiving limited parenteral 
Dawadi, Surendra, 2013, UMSL, p.15 
 
 
 
therapy.
30
 A study by Bishop and coworkers showed that premature infants who received 
standard TPN had lower neurologic development scores than those who received a 
specially-made aluminum-depleted TPN solution.
31
 Many studies confirm that neonates 
receiving parenteral therapy are at high risk of aluminum overload and toxicity. The US 
Food and Drug Administration (FDA) has recognized aluminum contamination in TPN 
solution and has established an upper limit on the permissible amount of aluminum.
27
 
However, industry has been unable to meet this standard because there is no technology 
available to effectively remove aluminum from the calcium gluconate. 
 
1.4.3 Previous attempts to address the problem 
At present, there are very few options to reduce the aluminum load in TPN 
solutions. Bishop and coworkers
31 
suggested the use of calcium chloride instead of 
calcium gluconate in TPN solutions. Calcium chloride is inherently less contaminated 
with aluminum and in theory can replace calcium gluconate. However, as a chloride salt, 
calcium chloride can predispose children to a greater risk of developing metabolic 
acidosis due to the increased chloride load.
32
  One study in Germany showed a significant 
reduction in the amount of aluminum in calcium gluconate by using plastic containers 
instead of glass containers to store calcium gluconate solution.
26
 This solves the problem 
only if the source of aluminum is glass containers. The United States Food and Drug 
Administration (FDA) recognized the aluminum contamination of TPN additives, 
established the upper limit of aluminum in large-volume parenterals (25 µg/L), and 
requested manufacturers to label the maximum amount of aluminum in small-volume 
parenterals at the product’s date of expiration.27 This only documents estimated 
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aluminum concentration and neither gives exact aluminum concentration nor reduces the 
aluminum in SVPs.
 
The FDA also established a safe level of aluminum exposure in a 
TPN therapy which is less than 5 µg/Kg/day. In one attempt to address the problem, 
Hayes and coworkers
33
 tried to form an Al-DFO complex and irreversibly bind all 
aluminum present in TPN prior to its administration with DFO. This was accomplished 
by determining mean Al concentration in TPN solutions, followed by adding a sufficient 
amount of DFO to chelate any aluminum and iron present. 
 
No real solution of effectively 
removing aluminum from TPN components is available yet. Manufacturers continue to 
work on reducing aluminum content in their products, though it is impractical as yet to 
get to the desired safe level. It is currently impossible to get aluminum levels below 12-
13 µg/Kg/day in a normal mix of TPN without removing essential components.
34
 The 
FDA cautions that it is more important to receive the essential nutrients in TPN as 
prescribed by a physician than to omit any ingredient because of possible aluminum 
toxicity. 
 
1.5 The technology of employing immobilized chelators 
We recently developed a technology to remove aluminum from contaminated 
calcium gluconate solutions without affecting the essential calcium present in the 
solution. We designed and synthesized metal specific chelators and immobilized these 
chelators on a solid support resin.
35
 These chelator functionalized resins, called chelating 
resins, are used to remove toxic metal ions from such contaminated solutions. 
Hydroxamate and citratamide based chelators are employed to extract trivalent metal ions 
Dawadi, Surendra, 2013, UMSL, p.17 
 
 
 
such as aluminum and iron, whereas dithiolate based chelators are used for removing soft 
metals such as lead from contaminated solutions.  
There have been previous examples of chelating resin for similar applications. 
Detailed explanations and literature examples of related chelating resins are provided in 
chapters 3, 4, and 5. 
A chelating resin is made up of three parts, a solid support, a linker, and a 
functional unit involved in the binding. The parts of a chelating resin are shown in Figure 
1.5 as a representative example. A polystyrene resin is a solid support which is extremely 
cost effective and can be purchased with various bead sizes and other resin properties. A 
linker is a group that covalently attaches the functional unit to the solid support. In this 
work, various linkers such as urea, sulfonamide, and secondary amine will be employed. 
The functional unit is usually a multidentate ligand designed to selectively and strongly 
bind the targeted metal ion. The example in Figure 1.5 shows a hydroxamate chelator as a 
functional unit which is immobilized on a polystyrene resin solid support via a urea 
linker. As mentioned earlier, the design of the chelator group is solely dependent on the 
nature of the metal ion to be extracted from aqueous solution. 
 
 
Figure 1.5 Parts of a chelating resin 
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Our hypothesis is that if a metal contaminated solution is passed through a 
cartridge filled with a chelating resin, the toxic metal for which the chelator was designed 
should be selectively removed, and the solution should pass through virtually unchanged 
in terms of the other essential metal ions. In this particular example, as the binding 
affinity of hydroxamates with trivalent metal ions such as aluminum is much higher than 
with divalent metal ions such as calcium, hydroxamate functionalized chelating resin 
should remove aluminum from calcium gluconate solutions. 
Before immobilizing the chelators on solid support, analogous solution phase 
hydroxamate ligands were designed and synthesized. Aluminum and iron binding 
affinities of these ligands were determined using potentiometric and UV-Vis 
spectrophotometric titration methods. These solution phase hydroxamate ligands have 
potential application as chelating agents in iron and aluminum overload conditions. The 
design, synthesis, and trivalent metal binding studies of novel hydroxamate ligands will 
be discussed in chapter 2. Some of the hydroxamate ligands with highest binding affinity 
were immobilized on solid support such as macroporous polystyrene resin via various 
possible linkages. The effect of the linker on binding was studied. The synthesis and 
aluminum extraction from commercial calcium gluconate solution by our hydroxamate 
resins will be discussed in chapter 3. Some applications may require chelating resins be 
able to bind trivalent metals at low pH. As citrate binds trivalent metal ions more strongly 
than hydroxamates in highly acidic solutions, citramide functionalized resins were 
synthesized for such applications. The design, synthesis, and iron chelation of citramide 
functionalized resins will be discussed in chapter 4.  
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1.6 Application of chelating resin in environmental remediation of soft metals 
The current technology of environmental remediation from highly toxic soft 
metals such as Hg, Pb, Cd, and As relies on methods such as reverse osmosis, chemical 
precipitation, ion exchange, and bioremediation. None of these methods are without some 
drawbacks. Thus, effective environmental remediation of heavy metals usually requires a 
combination of these methods. There have been few previous research efforts to design 
and synthesize soft metal specific chelating resins. We propose the immobilization of 
dithiolate ligands such as dimercapto succinic acid (DMSA) on polystyrene resin for the 
preparation of soft metal selective chelating resins. There are numerous applications for 
resins capable of removing hazardous metal ions from water, including treatment of 
runoff and waste water, and the purification of drinking water.  An effective resin would 
allow one to produce large volumes of purified water while concentrating the metals into 
a small volume for recycling or disposal. These chelating resins can be easily transported 
to the site of metal removal. The design, synthesis, and lead chelation studies of dithiolate 
resins will be discussed in chapter 5. 
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CHAPTER 2: Design, synthesis, and trivalent metal chelation properties of novel 
hydroxamate ligands 
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2.1 Specific objectives 
The objectives of this project were: 
1) Design and synthesize novel hydroxamic acid based chelating compounds such as 
tripodal trihydroxamate and dipodal tetrahydroxamate ligands. These hydroxamate 
ligands are designed to have strong affinity towards trivalent metal ions such as Fe
3+
 and 
Al
3+ 
in aqueous solution. Such solution phase chelators have potential application as 
chelating agents in chelation therapy for the treatment of trivalent metal overload. 
2) Study the coordination behavior of these chelators with trivalent metals such as iron 
and aluminum will be studied. 
 
2.2 Background 
A chelator or a chelating compound is a polydentate ligand that binds with metal 
ions to form a stable chelate ring in which a ligand binds to more than one coordination 
sites of the metal ion. The chelating compounds have long been used to bind metal ions 
in the fields of environmental remediation, mining industry, and relatively recently in 
medicine for the treatment of metal poisoning. They also have been used in chemical 
analysis. Ethylenediaminetetraacetic acid (EDTA) has been used extensively in 
complexation titration for the quantitative analysis of metal ions. In recent years, a 
treatment method employing chelating agents to remove toxic metals from biological 
systems, referred to as chelation therapy, has been developed. The major problem 
associated with chelation techniques is the lack of absolute metal specific chelator 
groups. The highest level of selectivity is achieved if the chelators are designed on the 
basis of the hard and soft acids and bases (HSAB) principle. Hard ligands prefer to bind 
hard metal ions and soft polarizable ligand groups prefer to bind soft metals. Trivalent 
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metal ions such as iron and aluminum are hard metal ions, and they prefer to bind with 
hard ligands such as hydroxamates and catecholates. Not surprisingly, hydroxamates and 
catecholates are also the most common binding groups present in natural siderophores. 
Siderophores are low molecular weight high affinity iron chelating compounds 
secreted by microorganisms for iron uptake and transport. Microorganisms synthesize 
and utilize siderophores to sequester iron, which is present in the environment as ferric 
oxide or hydroxide, the predominant and very less soluble state of iron. Over the years, 
several siderophores have been isolated from various microorganisms and characterized. 
Most of these natural siderophores can be classified into two classes, hydroxamate and 
catecholate binding group containing compounds. Desferioxamine-B 2.1 (DFO)
1
 and 
enterobactin 2.2 (Figure 2.1) are respective examples of these two classes of 
siderophores. These compounds form very stable complexes with iron. The stability 
constant, log β, for hydroxamate and catecholate siderophore-Fe3+ complexes are close to 
30 and 49, respectively, indicating very strong binding.
2
 These numbers also suggest that 
the catecholate chelators typically bind iron far more tightly than hydroxamates. The 
major functional difference between hydroxamate and catecholate siderophores is related 
to environmental iron concentration. The hydroxamates are generated by the 
microorganism in a high-iron environment, while the catecholate system is activated 
when iron concentrations are low.
3
 Once the nutritious iron is taken into the cell, 
microorganisms release it from these tight binding siderophores either by the degradation 
of ligands or by the reduction of iron from ferric(III) to ferrous(II). The ferrous ion has 
much lower affinity towards siderophore ligands. 
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Figure 2.1 Two classes of siderophores, hydroxamates (DFO) and catecholates 
(enterobactin)  
 
Siderophores can also be classified into three topological families, linear 2.3, 
tripodal 2.4, and macrocyclic 2.5 (Figure 2.2).
4
 As seen from their structures, DFO and 
enterobactin are linear and tripodal siderophors, respectively. An example of a natural 
macrocyclic siderophore is nocardamine 2.6 (Figure 2.3).
5
 It has a 33 membered 
macrocyclic ring containing three hydroxamate binding groups. It also has three amide 
groups for intramolecular hydrogen bonding, which are responsible for bringing 
hydroxamate groups in right orientation for strong binding. 
 
 
 
Figure 2.2 Three topological families of siderophores 
 
Enterobactin  2.2 DFO 2.1 
linear  2.3 
tripodal  2.4 macrocyclic 2.5 
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Figure 2.3 Macrocyclic siderophore nocardamine 
 
Siderophores are almost always trihydroxamate or tricatecholate compounds. The 
reason for this is both hydroxamate and chatecholate are bidentate ligands and the six 
coordination sites of trivalent metals are fulfilled by three of these chelating groups. 
Hydroxamates and catecholates are both very basic, negative oxygen donors, and have 
high affinity towards highly acidic, hard metal ions such as Fe
3+
 and Al
3+
. Single 
deprotonation of a hydroxamic acid 2.7 turns it into a hydroxamate group, a bidentate 
ligand (Figure 2.4). A hydroxamate group contains two donor oxygen atoms, one binds 
covalently through its negative charge, the other coordinate covalently through its lone 
pair of electrons to form a five membered chelate ring as shown in structure 2.8 (Figure 
2.4).  
 
 
 
Figure 2.4 Trivalent metal coordination of a simple hydroxamic acid 
 
2.7 
2.8 
2.6 
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Several research efforts have been undertaken to synthesize natural and unnatural 
siderophores since the 1980’s, primarily to develop a better chelating agent in the 
chelation therapy of iron overload. Like natural siderophores, artificial siderophores were 
also designed mostly to have hydroxamate and sometimes catecholate binding sites. Early 
efforts in the design, synthesis, and metal chelation properties of natural and synthetic 
hydroxamate siderophores were reported by Bergeron,
3,6
 Raymond,
7
 Martell,
8,21
 
Miller,
9,19
 Neilands,
10
 Shanzer,
11
 and Marshall.
12
 Raymond particularly was more 
interested in catecholate siderophores.  
There are several examples of the design and synthesis of natural and artificial 
DFO-like linear trihydroxamates reported in the literature. These linear trihydroxamates 
are usually unsymmetrical and require many synthetic steps for their preparation. This is 
one of the reasons for DFO being highly expensive which is why it is produced 
commercially by large-scale fermentation of a strain of Streptomyces pilosus.
13
 There are 
also several examples of tripodal trihydroxamate ligands reported in the literature.
15-22
                                                                                                                                              
Rationally designed tripodal chelators consist of three parts: a spacer group, a 
connecting group, and a binding group as seen in cartoon 2.9 (Figure 2.5).
14
 The spacer 
group, sometimes referred to as an anchor, distributes three alkyl chains each bearing a 
binding unit around the central bridgehead atom called the pivotal atom. The nature and 
size of the spacer group are responsible for optimal binding. The connecting group 
determines the nature of the chain and is obtained by the coupling of the spacer group 
with the binding unit. The binding unit is usually a bidentate ligand such as a 
hydroxamate. The spacer unit is sometimes designed to possess a site for further 
functionalization or for immobilization of the chelator on a solid support. 
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Figure 2.5 Parts of a tripodal chelator 
 
Ferrichrome 2.10 (Figure 2.6) is an example of natural tripodal trihydroxamate 
siderophore. It has an 18 member macrocylic ring as spacer group which bears three side 
chains, each having a terminal hydroxamate group. The stability constant log β for the 
ferricrome iron complex is 29.1.
15
  
 
 
 
Figure 2.6 Natural tripodal siderophore ferrichrome 
 
There are several examples of synthetic tripodal trihydroxamate chelators 
designed to bind trivalent metal ions. Most of these synthetic trihydroxamates were 
2.9 
Binding units 
Connecting units 
Spacer unit 
Pivotal atom 
Site for further functionalization 
2.10 
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designed as ferrichrome analogs where various tripodal spacers (anchors) are employed 
instead of the macrocyclic ring. Most of these artificial trihydroxamate ligands were 
designed to maintain the strong iron chelating affinity of natural siderophores. Almost all 
examples of these artificial tripodal trihydroxamates are symmetrical; i.e. they have 
exactly the same side chains each bearing a hydroxamate binding unit. The presence of 
symmetry makes synthesis of these chelators much easier than that of unsymmetrical 
linear siderophores such as DFO. Some of the literature examples of artificial tripodal 
trihydoxamate chelators will be discussed below.  
Masuda and coworkers reported the synthesis of tris(2-aminoethyl)amine (TREN, 
2.11) anchored trihydroxamate ligands 2.12 and 2.13 (Figure 2.7) and their Fe
3+
 
complexes.
15
 The crystal structure of the tris(hydroxamato)Fe
3+
 complex of ligand 2.12 
suggested that multi-intramolecular hydrogen bonding networks formed between amide 
N-H and coordinating N-hydroxy oxygen of hydroxamate group contribute to tight 
binding and stable complex formation when n=1.
15,16
 The complex was less stable for 
ligand 2.13 due to the lack of such intramolecular hydrogen bonding which requires the 
formation of a seven membered ring. The stability constant log β for ligand 2.12 iron 
complex was reported to be 28.7 which is comparable to that of natural siderophore 
ferrichrome 2.10, (29.1).                                                          
 
 
Figure 2.7 TREN and Masuda’s TREN based trihydroxamate ligands 
TREN 2.11 
n = 1, 2.12 
n = 2, 2.13 
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Masuda’s group also reported the synthesis of tris(3-aminopropyl)amine (TRPN, 
2.14) anchored tripodal trihydroxamate ligand 2.15 (Figure 2.8) and its Fe
3+
 complex.
17
  
Previous studies by Raymond and coworkers suggested that the TREN 2.11 has too small 
a backbone for optimal binding, at least in the tricatecholate system of artificial 
enterobactin analogs.
18
 TRPN has one more methylene unit in all of its three alkyl chains 
than in TREN. They concluded that the TRPN based trihydroxamate 2.15 indeed forms 
more stable iron complexes than the TREN based trihydroxamate 2.12. The iron binding 
constant log β for ligand 2.15 was reported to be 30.6 which is almost 2 log units higher 
than that of ligand 2.12 (log β = 28.7). 
 
 
 
Figure 2.8 TRPN and Masuda’s TRPN based trihydroxamate ligand 
 
Masuda’s group recently reported the synthesis of tripodal trihydroxamate 2.16 
where the pivotal atom is a quaternary carbon rather than a tertiary nitrogen (Figure 2.9).
2
 
They prepared iron complex of ligand 2.16 and the stability constant log β was 
determined to be 31.0 which is very close to that of DFO (log β = 30.6) and higher than 
their previous ligands, indicating that 2.16 is strongly bound to Fe
3+
. 
TRPN 2.14 
 2.15 
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Figure 2.9 Masuda’s recent trihydroxamate ligand 
 
Miller and coworkers reported the design and synthesis of trihydroxamate ligands 
2.17, 2.18, and 2.19 (Figure 2.10) anchored through amide bonds to tripodal spacers 
benzenetricarboxylic acid, nitrilotriacetic acid, and tricarballylic acid respectively.
19
  
These trihydroxamate ligands behaved as well as the natural siderophore ferrichrome for 
providing iron nutrition in Escherichia coli RW193, suggesting they are strong iron 
chelators. 
 
                           
 
 
Figure 2.10 Miller’s tripodal trihydroxamate ligands 
 2.17  2.18 
 2.19 
 2.16 
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Spacer groups containing N pivotal atom offers a severe limitation since its 
protonation results in the formation of quaternary ammonium salts which alter the 
optimum electronic and geometric properties of the overall molecules and their metal 
complexes.
14
 Shanzer and coworkers reported the design and synthesis of tripodal 
trihydroxamates as ferrichrome analogs built on 1,1,1-tris(hydroxymethyl)propane 
anchor 2.20 (Figure 2.11) where the pivotal atom is a quaternary carbon.
20
 They studied 
the iron chelation of these hydroxamate ligands and found that the number of atoms 
between pivotal atom and amide carbonyls plays an important role.  Trihydroxamate 2.21 
which has four such atoms has much better iron binding affinity than its shorter 
homologue having only three such atoms.  
 
 
Figure 2.11 1,1,1-tris(hydroxymethyl)propane and Shanzers’s trihydroxamate 
ligand 
 
Martell and coworkers reported the design and synthesis of tripodal 
trihydroxamate ligands based on 1,1,1-tris(hydroxymethyl)ethane anchor 2.22 (Figure 
2.12), and studied the binding properties of these ligands with Fe
3+
 and Ga
3+
.
21
 Ligand 
2.23 which has four atoms between bridgehead carbon and first atom of hydroxamate, 
and ligand 2.24 which has five such atoms, were designed to be homologous. They were 
 2.20 
 2.21 
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designed to study the effect of chain length on binding affinities. Each side chain of these 
ligands possesses ether connecting group rather than amide groups despite the fact that 
amide is the most commonly used connector group between the bridgehead atom and the 
binding site. Compound 2.23 has terminal methylhydroxyamino hydroxamate groups 
whereas compound 2.24 has N-acetyl hydroxamates. Ligand 2.23 was found to have 
higher Fe
3+
 binding constants than 2.24, although surprisingly, Ga
3+
 binding constants are 
in reverse order. 
 
 
 
Figure 2.12 1,1,1-tris(hydroxymethyl)ethane and Martell’s trihydroxamate ligands 
 
Dias and coworkers reported the design and synthesis of trihydroxamate 2.26 
anchored on the tripodal support tris(hydroxymethyl)aminomethane (tris) 2.25 (Figure 
2.8). Ligand 2.26 was designed to contain a terminal primary amine group on the 
bridgehead quarternary carbon. They also attached a fluorescent group on the free amine 
to prepare fluorescent labeled trihydroxamate chelator.
22
 The fluorescent labeled 
siderophore was used to study iron uptake and transport in microorganisms. This 
trihydroxamate showed comparable iron uptake activities as natural siderophore 
ferrichrome in some microorganisms.   
 2.22 
 2.23  2.24 
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Figure 2.13 1,1,1-tris(hydroxymethyl)aminomethane (tris) and Dias’ 
trihydroxamate ligand 
 
These examples showed the availability of various tripodal anchors on which the 
trihydroxamates can be attached. The anchor backbone size plays an important role on 
the stability of metal ligand complex. In the present work, the use of 
hydroxyalkylaminomethanes as a tripodal anchor for the construction of tripodal 
trihydroxamates is described. Hydroxyalkylaminomethanes such as tris 2.25 contain a 
free primary amine group on bridgehead carbon. The presence of the free amine allows 
us to attach these compounds on a solid support for the preparation of chelating resins, 
which will be described separately in Chapter 3. Thus, combining the features of two 
previously mentioned trihydroxamates 2.23 and 2.26, Spilling and coworkers designed 
trihydroxamate ligand 222-THA 2.27 (Figure 2.14). Two other tripodal trihydroxamate 
ligands 2.28 and 2.29 with slightly modified spacer and connecting groups were also 
designed and synthesized. In the present work, we report the design and synthesis of 
these three tripodal trihydroxamate ligands 2.27-2.29. Two symmetrical dipodal 
tetrahydroxamates, which somewhat mimic the linear structure of high affinity 
siderophore DFO, were also designed and synthesized, and will be described later in this 
tris 2.25 
2.26 
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chapter. All of these hydroxamate chelators are designed to have easy, high yielding, and 
cost effective synthetic routes. Iron and aluminum coordination behavior of these 
chelators was studied and will also be described later in this chapter. 
 
2.3 Design and synthesis of novel tripodal trihydroxamate ligands 
2.3.1 Design of trihydroxamate ligands 
 
 
 
Figure 2.14 Trihydroxamate ligands 222-THA, 223-THA, and 333-THA 
 
The original ligand designed was 222-trihydroxamic acid (222-THA) 2.27 (Figure 
2.14).
23
 Tris(hydroxymethyl)aminomethane (tris) 2.25 (Figure 2.13), which contains a 
quaternary carbon as a bridgehead atom, was used as the tripodal base. The number 2 in 
its name refers to the number of methylene groups between the original tris hydroxyl 
oxygen and hydroxamate carbon. It is a C3 symmetrical tripodal ligand with N-terminal 
hydroxamic acids at the end of each arm. Each arm contains an ether connecting group 
instead of commonly used amide groups. The free amine present on the bridgehead 
carbon was protected with a tosyl group for the preparation of solution phase ligands. The 
free amine can also be used to attach these ligands to various solid supports for the 
synthesis of chelating resins. The tosyl group was specifically chosen as the amine 
protecting group because it not only resembles the sulfonamide, a possible linker that will 
223-THA 2.28 333-THA 2.29 222-THA 2.27 
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be employed to make chelating resins, but also the polystyrene resin backbone (see 
chapter 3).  
Unsymmetrical 223 trihydroxamic acid (223-THA) 2.28 was designed to have 
one arm longer than other two arms (one methylene unit added at the position between 
tertiary carbon and ether oxygen). It was assumed that the two shorter arms would first 
form the bis-complex 2.30 with the metal and the third longer arm binds afterwards to 
form the tris-complex 2.31 (Figure 2.15). This process was expected to be easier than in 
222-THA, where all the arms are equal. It was anticipated that the strain on the 
bridgehead carbon is somewhat relieved when one of the arms is slightly longer. 
 
 
 
Figure 2.15 Bis- and tris-complexes of 223-THA with iron 
 
The third trihydroxamate ligand designed was symmetrical 333-trihydroxamic 
acid 2.29 (333-THA), which has one more methylene group in each arm than in 222-
THA. One methylene group is removed from the position between ether oxygen and 
hydroxamate, but two are added between the tertiary carbon and the ether oxygen. It was 
designed to have all three connecting groups longer than in the previous two ligands. 
Bis-complex 2.30 Tris-complex 2.31 
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Commercial availability of the aminitriol 2.43 as a tripodal anchor was also a major 
factor for the selection of this ligand. 
 
2.3.2 Synthesis of 222-THA 
The trihydroxamate 222-THA 2.27 was previously synthesized by Spilling and 
coworkers
24
 (Scheme 2.1). The tris 2.25 was reacted with acrylonitrile in the presence of 
catalytic amount of KOH to obtain the tris-nitrile 2.32.
25
 The low yield of 33% is 
presumably due to the low solubility of the triol in dioxane. The use of other solvents 
such as acetonitrile was recently shown to improve the yield. Reaction of 2.32 in 
refluxing methanolic HCl gave the tris-methyl ester 2.33, which was then reacted with 
tosyl chloride (TsCl) and Et3N in CH2Cl2 to obtain the sulfonamide tris-ester 2.34. The 
ester was converted to the hydroxamic acid 2.27 by reacting with O-trimethylsilyl 
hydroxylamine (NH2OTMS) in MeOH. The ligand 2.27 was solid and purified by 
recrystallization, and its structure was further verified by X-ray crystallography (Figure 
2.16). 
 
 
 
Scheme 2.1 Synthesis of 222-THA 
2.25 2.32 2.33 
2.34 2.27 
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Figure 2.16 Crystal structure of 222-THA 
 
A more efficient and higher yielding synthetic route from 2.25 to 2.33 has been 
developed (Scheme 2.2).
26
 The reaction conditions were optimized and the synthesis was 
scaled up. The tris 2.25 was treated with tert-butyl acrylate in the presence of 5M NaOH 
in DMSO to give the compound tris-tert-butyl ester 2.35 in 75% yield.
27
 Tert-butyl esters 
were converted to methyl esters by treating with concentrated sulfuric acid in dry MeOH 
to produce the compound 2.33 in 76% yield. The overall yield of 57% from 2.25 to 2.33 
(Scheme 2.2) by this route is much better than that of 18% by previous route (Scheme 
2.1). Compound 2.33 was prepared in more than a 20 g scale following this optimized 
synthetic route. 
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Scheme 2.2 A more efficient synthetic route to compound 2.33 
 
2.3.3 Synthesis of 223-THA 
Synthesis of the unsymmetrical tripodal ligand 223-THA 2.28 began from 
acrolein (Scheme 2.3). 3-Nitropropanol 2.36 was prepared from acrolein following the 
published procedure.
28
 Michael addition of sodium nitrite to acrolein in the presence of 
acetic acid led to the formation of 3-nitropropanal, which was then reduced using sodium 
borohydride to give 3-nitro propanol 2.36 in 90% overall yield for the two steps. Base 
catalyzed addition of 2.36 with two equivalents of formaldehyde gave nitrotriol 2.37 in 
84% yield. The nitro group of 2.37 was reduced to an amine by hydrogenation using 
specially generated T-1 Raney nickel as a catalyst
29 
(see experimental section for the 
process of generating T-1 Raney Nickel) and hydrogen at
 
45 psi
30 
to obtain aminotriol 
2.38 in almost quantitative yield. T-1 Raney Nickel is extremely pyrophoric in nature 
because hydrogen gas generated during the reaction of aluminum and base is trapped on 
the highly porous nickel surface. Other hydrogenation conditions such as 10% palladium 
on charcoal with H2, transfer hydrogenation employing ammonium formate and 10% 
palladium on charcoal, or employing ammonium formate and activated zinc were all 
unsuccessful for this reduction. Compound 2.38 was treated with acrylonitrile in the 
presence of a catalytic amount of KOH pellets in dioxane to obtain the tris nitrile 2.39. 
The moderate yield of 49% was again attributed to the low solubility of the triol in 
2.25 2.35 2.33 
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dioxane. Reaction of 2.39 in refluxing methanolic HCl gave the tris-methyl ester 2.40 in 
74% yield, which was then reacted with tosyl chloride and Et3N in CH2Cl2 to obtain the 
sulfonamide tris-ester 2.41 in 75% yield. Compound 2.41 was converted to the 
hydroxamate ligand 2.28 in 88% yield by the reacting with O-trimethylsilyl 
hydroxylamine and KOH in methanol followed by protonation with strong acidic resin 
(amberlyst-15). The crude product was a sticky solid, and 
1
H-NMR suggested that it was 
contaminated with about 5% of carboxylic acid, presumably formed by the hydrolysis of 
hydroxamic acid groups. The product was purified by passing the compound through a 
short column of quaternary amine coated silica ISOLUTE PE-AX 2.42 (Figure 2.17). The 
quaternary amine had acetate as the counter anion. The carboxylic acid being more acidic 
than hydroxamic acid, has a longer retention time on such a column. It should be noted 
that hydroxamic acids cannot be purified by normal phase silica gel chromatography due 
to reaction with silica resulting in decomposition.  
 
 
Scheme 2.3 Synthesis of 223-THA 
2.36 
2.39 2.38 
2.28 2.41 
2.37 
2.40 
acrolein 
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Figure 2.17 Quaternary amine coated silica ISOLUTE PE-AX from Biotage 
 
2.3.4 Synthesis of 333-THA 
Synthesis of the symmetrical tripodal ligand 333-THA started with commercially 
available 4-amino-4-(3-hydroxypropyl)heptane-1,7-diol 2.43 (Scheme 2.4). Selective 
Boc- protection of the amino group of 2.43  in the presence of three hydroxyl groups 
produced compound 2.44 in 68% yield. Rhodium acetate catalyzed alkylation of 
hydroxyl groups with ethyl diazoacetate gave triester 2.45 in 73% yield. Elimination of 
nitrogen gas from ethyl diazoacetate leads to the formation of a rhodium carbenoid 
species that inserts into the oxygen hydrogen bond of the alcohol. Mono- and di-alkylated 
compounds were also isolated, which were combined and treated with more alkylating 
reagents to obtain the trialkylated product 2.45. Other catalysts such as Cu(acac)2 were 
also used for this reaction, but the yield was lower (30%) even though the reaction was 
performed at 40 °C. Boc- deprotection with TFA produced the free amine 2.46 in 73% 
yield. Reprotection of the amine with the tosyl group proceeded smoothly to give the 
sulfonamide triester 2.47 in 91% yield. Reaction of tri-ester with O-trimethylsilyl 
hydroxylamine produced the 333-THA ligand 2.29 in 80% yield. This last reaction was 
performed in the absence of a catalytic amount of KOH unlike previous examples of 
conversion of esters to hydroxamates. The only difference is that 2.47 is an ethyl ester but 
previous examples were methyl esters. 
2.42 
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Scheme 2.4 Synthesis of 333-THA 
 
The trihydroxamate ligand 2.29 is a colorless solid and was purified by 
recrystalization from ethanol/isopropanol mixture (1:1), and its structure was further 
confirmed by X-ray crystallography (Figure 2.18). 
2.43 2.44 2.45 
2.46 2.47 
2.29 
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Figure 2.18 Crystal structure of 333-THA 
 
2.4 Design and synthesis of novel tetrahydroxamate ligands 
2.4.1 Design of tetrahydroxamate ligands 
Two symmetrical dipodal tetrahydroxamate ligands tetrahydroxamate-A 2.49 and 
tetrahydroxamate-B 2.50 were designed (Figure 2.19). Both contain two inner and two 
outer hydroxamate groups. In both tetrahydroxamates, the two inner hydroxamates are 
separated by 9 atoms. In tetrahydroxamate-A, outer and inner hydroxamates are separated 
by 9 carbons, but in tetrahydroxamate-B they are separated by 8 carbon atoms. Previous 
research with a number of terminal dihydroxamic acids showed that optimal binding is 
achieved when two hydroxamates are separated by 8-10 atoms.
31
 The two 
tetrahydroxamate ligands were designed to mimic the structure of high affinity linear 
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siderophore DFO which has 9 atoms between two hydroxamate groups. The availability 
and cost of starting materials with required chain lengths also played an important role in 
the design of these tetrahydroxamate chelators. These two tetrahydroxamates slightly 
differ structurally. In Tetrahydroxamate-A 2.49, outer hydroxamic acids are internal (N-
acyl), but in tetrahydroxamate-B 2.50 they are N-terminal. 
Both tetrahydroxamates are designed to contain a dipodal anchor aminodiol 2.48 
(Figure 2.19). The primary free amine present on the central carbon once again is 
protected with a tosyl group. As mentioned earlier, it can also be used to attach the 
ligands on a solid support for the preparation of chelating resins.  
 
 
 
 
 
 
Figure 2.19 Aminodiol as dipodal base and two tetrahydroxamate ligands 
 
2.4.2 Synthesis of tetrahydroxamate-A 
The convergent synthesis of tetrahydroxamate-A 2.49 involved the synthesis of 
two coupling partners, benzyl protected hydroxylamine 2.57 (scheme 2.6) and di-
carboxylic acid 2.61 (Scheme 2.7). 
Aminodiol 2.48 
 
Tetrahydroxamate-A 2.49 
 
Tetrahydroxamate-B 2.50 
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In the first attempted synthesis of bis-hydroxylamine 2.56, which can be 
converted to the coupling partner 2.57, 1,9-nonanediol was converted to dimesylate
32
 
2.51 by reacting with methanesulfonyl chloride in the presence of triethylamine (Scheme 
2.5). Attempted nucleophilic subtitution of mesyl groups with O-benzyl hydroxylamine 
was unsuccessful, and we were unable to obtain the benzyl protected dihydroxylamine 
2.56. In an another attempt, Finkelstein reaction successfully converted dimesylate 2.51 
into 1,9-diiodononane 2.52 and 1,9-dibromononane 2.53. Both diiodo and dibromo 
nonane failed to react with O-benzyl hydroxylamine to yield the required compound 2.56. 
 
 
 
Scheme 2.5 Attempted synthesis of O-benzylhydroxylamine 
 
In another route (Scheme 2.6), synthesis of hydroxylamine 2.57 began with the 
PCC oxidation of 1,9-nonanediol to form nonanedial 2.54, which was reacted with O-
benzylhydroxylamine hydrochloride and pyridine in refluxing ethanol to produce the 
dioxime 2.55 in 61% yield.
33
 Sodium cyanoborohydride reduction of the dioxime 
2.51 
2.56 
2.51 
2.52 
2.56 
2.53 
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afforded the benzyl protected bis-hydroxylamine 2.56 in 76% yield.
34
 Mono-acetylation
35
 
of one of the hydroxylamine nitrogens using one equivalent of acetic anhydride led to the 
formation of compound 2.57 in 48% yield. The di-acetylated byproduct was also isolated 
along with unreacted hydroxylamine 2.56. 
 
 
Scheme 2.6 Synthesis of O-benzylhydroxylamine 
 
The di-carboxylic acid 2.61 (Scheme 2.7) was prepared by the alkaline hydrolysis 
of ester 2.60, followed by the protonation of the carboxylate salt with a mineral acid. The 
ester 2.60 was prepared following the previously published procedure of Spilling et al.
24
 
The aminodiol was reacted with acrylonitrile in the presence of a catalytic amount of 
KOH to obtain the bis-nitrile 2.58.
36
 Reaction of 2.58 in refluxing methanolic HCl gave 
the bis-methyl ester 2.59, which was then reacted with tosyl chloride and Et3N in CH2Cl2 
to obtain the sulfonamide bis-ester 2.60. 
 
2.57 
2.56 
2.55 
2.54 
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Scheme 2.7 Synthesis of dicarboxylic acid 2.61 
 
The two partners 2.57 and 2.61 were coupled using DCC (Scheme 2.8) to obtain 
the benzyl protected tetrahydroxamate 2.62 in 65% yield. The final deprotection of 
benzyl groups by hydrogenation with H2 over 10% Pd on C afforded the 
tetrahydroxamate-A 2.49 in 91% yield. 
 
 
2.60 
2.58 
2.59 
2.61 
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Scheme 2.8 Coupling of O-benzylhydroxylamine and dicarboxylic acid, and final 
synthesis of tetrahydroxamate-A 
 
2.4.3 Synthesis of tetrahydroxamate-A with free amine 
Tetrahydroxamate-A 2.49 was found to be poorly soluble in water, and it was 
impossible to measure metal binding affinities of this ligand in aqueous solution. Thus, 
we decided to synthesize the ligand 2.63 (Figure 2.20) which has the same 
tetrahydroxamate-A structure except for the presence of unprotected primary amine 
group. The amine is protected with a tosyl group in tetrahydroxamate-A. The hypothesis 
is that the presence of free amine will improve solubility of both the ligand and its 
trivalent metal complex in water.  
 
 
2.61 
2.62 
2.49 
2.57 
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Figure 2.20 Tetrahydroxamate-A (free amine) 
 
Attempted deprotection of tosyl group from the ligand 2.49 using sodium 
amalgam and dibasic sodium phosphate in MeOH was unsuccessful giving only 
decomposition products.
37
 Most tosyl deprotection methods reported in the literature 
employ harsh reaction conditions. In such reaction conditions compound 2.49 may not 
survive. Thus, we decided to protect the amine with a protecting group that can be easily 
removed at the last step of the synthesis. Cbz- seemed to be a good choice because it can 
be deprotected along with benzyl groups by simple hydrogenolysis at the final step of 
synthesis. 
Compound 2.59 was treated with benzyl chloroformate under a Schotten and 
Baumann condition (Scheme 2.9, condition II) to obtain ester 2.63 in 65% yield. 
Condition I which used organic base gave much lower yield. The ester 2.63 was then 
subjected to alkaline hydrolysis followed by protonation with mineral acid to give the di-
carboxylic acid 2.64 in quantitative yield. 
2.63 
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Scheme 2.9 Synthesis of dicarboxylic acid 2.64 
 
The di-carboxylic acid 2.64 was then coupled with hydroxylamine 2.57 using 
DCC to obtain the compound 2.65 in 56% yield, which was then globally deprotected by 
hydrogenolysis with H2 over Pd/C to give the ligand 2.63. 
 
 
Scheme 2.10 Coupling of O-benzylhydroxylamine and dicarboxylic acid, and final 
deprotection 
2.59 2.63 
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2.4.4 Synthesis of tetrahydroxamate-B 
Tetrahydroxamate-B 2.50 was synthesized by coupling di-carboxylic acid 2.61 
used in the synthesis of tetrahydroxamate-A with hydroxylamine 2.69. 
Synthesis of hydroxylamine 2.69 started with monomethyl azelate (Scheme 2.11). 
The aldehyde 2.67 was formed by oxidation of monomethyl azelate following a 
published procedure.
38
 The carboxylic acid group of monomethyl azelate was selectively 
reduced to an alcohol in the presence of an ester group using borane in THF to give the 
alcohol 2.66. The alcohol group of compound 2.66 was oxidized back to aldehyde 2.67, 
which was then reacted with O-benzylhydroxylamine hydrochloride and pyridine in 
refluxing ethanol to produce the oxime 2.68 in 89% yield. Sodium cyanoborohydride 
reduction of the oxime afforded benzyl protected hydroxylamine 2.69 quantitatively. 
 
 
 
Scheme 2.11 Synthesis of O-benzylhydroxylamine 
 
Hydroxylamine 2.69 was then coupled with di-carboxylic acid 2.61 using DCC 
(Scheme 2.12) to produce benzyl protected hydroxamic acid dimethyl ester 2.70 in 60% 
monomethyl azelate 
2.67 
2.68 
2.69 
2.66 
Dawadi, Surendra, 2013, UMSL, p.53 
 
 
 
yield, which was purified by chromatography. The ester groups of 2.70 were then 
converted to the hydroxamic acids by reaction with O-trimethylsilyl hydroxylamine to 
obtain the compound 2.71 in quantitative yield. The benzyl protected hydroxamic acid 
groups of 2.71 were deprotected by hydrogenolysis to obtain the tetrahydoxamate-B 2.50. 
Unlike tetrahydroxamate-A, tetrahydroxamate-B is reasonably soluble in water, 
presumably due to the presence of terminal hydroxamic acid groups.  
 
 
 
Scheme 2.12 Coupling of O-benzylhydroxylamine and dicarboxylic acid and final 
synthesis of tetrahydroxamate-B 
2.50 
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2.69 
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2.5 Iron and aluminum binding properties of hydroxamate ligands 
As DFO, the most commonly used chelating agent in chelation therapy, is 
associated with a number of drawbacks which includes severe side effects, development 
of new chelating agents is utterly important. Thus, iron and aluminum binding affinities 
of novel chelators should be studied to determine their possible use as chelating agents in 
chelation therapy. 
The stability constants of hydroxamate ligands with the trivalent metal ions Al
3+
 
and Fe
3+
 have been determined by potentiometric and UV-Vis spectrophotometric 
titrations, respectively. Iron forms colored complexes with hydroxamates, thus iron 
hydroxamate complexation can be studied by UV-Vis spectrophotometric methods. 
Previous studies
39
 confirmed that there is a strong correlation between the stability 
constants for these two metal ions, which is illustrated by the linear free energy 
relationship (LFER) between log β (Al3+) and log β (Fe3+) (Figure 2.21). The stability 
constant of one metal can be estimated if the constant is known for another metal. The 
studies in the Harris lab and many other studies
40
 suggested that iron complexes are 
almost always stronger than corresponding aluminum complexes. 
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Figure 2.21 Linear free energy relationships for the complexation of Al
3+
 and Fe
3+
 
by hydroxamic acids
39
 
 
There are some advantages of spectrophotometric methods over potentiometric 
methods. The equilibrium system can be studied by spectrophotometric method at low 
pH, where very little complexation has occurred. The more important advantage of the 
spectrophotometric method is the fact that λmax provides information on the number of 
hydroxamate groups coordinated to the metal at a given pH.  
2.5.1 Iron binding properties by UV-Vis spectrophotomeric titration 
The UV-Vis spectrophotometric spectral measurement was used to study the 
complexation behavior of ferric ion with hydroxamate ligands. The origin of the 
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absorption spectra is due to the ligand-to-metal charge-transfer band for the hydroxamate 
groups coordinated to Fe
3+. The λmax for the charge transfer band provides exact 
information of the number of hydroxamate groups bound to Fe
3+
 at a given pH. Previous 
studies reported that mono, bis, and tris(hydroxamate) complexes of Fe
3+
 have λmax 
values of 490, 460 and 430 nm respectively.
39
 Usually, only two of these complexes, 
bis(hydroxamate)Fe
3+
 (111 complex) and tris(hydroxamate)Fe
3+
 complex (110 complex) 
were detected in the working pH range of 0.3 to 7.0. In the 111 complex, two 
hydroxamate groups of trihydroxamate ligand are coordinated to the Fe
3+
, while the third 
group remains protonated and uncoordinated to Fe
3+
. At lower pH, the 111 complex is 
formed as shown in the equation 2.1. The stability constant for the formation of the 111 
complex log β111 is defined in equation 2.2. 
                                                                                          
                                                                                     Equation 2.1 
 
                          
      
              
                               Equation 2.2 
 
At higher pH, the 110 complex is formed as shown in equation 2.3 and the 
stability constant for the formation of the 110 complex log β110 is defined in equation 2.4. 
                                                                       
                                                                                    Equation 2.3 
 
                           
    
          
                                    Equation 2.4 
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a) Complexation of Fe
3+
 by 222-THA 2.27 
 
Figure 2.22 pH titration spectra of a 1:2 ratio of Fe
3+
 with 222-THA
39
 
 
The complexation of Fe
3+
 with 222-THA was previously studied.
39
 pH titration 
spectra of solutions of 1:2 concentration ratios of Fe
3+
 and 223-THA were recorded over 
the pH range 0.3 to 7.0 (Figure 2.22). At pH 3.2, bis(hydroxamato)Fe
3+
 complex 2.72 
(Figure 2.23) was fully formed with λmax = 460 nm and ϵ = 2,024 M
-1
cm
-1
. At higher pH, 
the tris(hydroxamato)Fe
3+
 complex 2.73 started to form which precipitated significantly 
above pH 5.2. The program Hypspec was used to calculate the followings: λmax = 430 nm 
and ϵ = 2,515 M-1cm-1. The spectral data were fitted into a data analysis program 
SPECFIT, and stability constants were calculated. The log β111 and log β110 were 
determined to be 30.83 and 26.72 respectively. 
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Figure 2.23 Bis- and tris-complexes of 222-THA with iron 
 
b) Complexation of Fe
3+
 by 223-THA 2.28 
UV-Vis spectra of solutions of Fe
3+
 and 223-THA were recorded over the pH 
range 0.3 to 6.7. A detailed set of spectra collected between pH 0.3 and 1.5 is shown in 
Figure 2.24. A metal to ligand ratio of 1:1.5 was used. At lower pH, the λmax is at 463 nm. 
This absorbance band increases with increasing pH and maximizes at pH 2.3. At pH 2.3, 
the bis(hydroxamato)Fe
3+
 complex (111 complex) is completely formed, with a molar 
extinction coefficient of ϵ = 2,005 M-1 cm-1. The presence of an isosbestic point at 369 
nm indicates that there is a simple equilibrium between free iron and the 111 complex. 
The absorption spectra in the Figure 2.24 were used to calculate the stability constant of 
the 111 complex by fitting the data in program Hypspec. The log β111 was calculated to 
be 30.20. 
Bis(hydroxamate)Fe
3+
 complex 2.72 
 
Tris(hydroxamate)Fe
3+
 complex 2.73 
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Figure 2.24 UV-Vis spectral changes of Fe
3+
223-THA at low pH conditions: (a) 0.3, 
(b) 0.5, (c) 0.7, (d) 0.9, (e) 1.1, (f) 1.5. Conditions:  [Fe
3+
] = 100 µM, [223-THA] = 150 
µM, ionic strength = 0.1 M KCl 
 
Another detailed set of spectra were collected at pH values between 2.3 and 6.7 
and shown in Figure 2.25. A metal to ligand ratio of 1:2 was used in this 
spectrophotometric titration. When the pH of a solution of Fe
3+
 and 223-THA is 
increased from 2.3 to 6.7 the absorbance band shifts to 430 nm. These changes are 
consistent with the formation of a tris(hydroxamate) complex (110 complex) which has a 
λmax at around 430 nm. The formation of precipitate above pH 4.1 also suggested that the 
110 complex is not very soluble in water. The presence of an isosbestic point at 457 nm 
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indicates that there is a simple equilibrium between the 111 and 110 complexes before 
the precipitation starts. There is no change in the absorption when the pH was increased 
from 5.1 to 6.7 which indicated that the 110 complex was fully formed at pH 5.1. Once 
again, the spectral data for this transition between pH 2.4 to 4.2 were fitted in the 
program Hypspec and the stability constant for 110 complex was determined. The log 
β110 was calculated to be 25.89. 
 
Figure 2.25 UV-vis spectral changes of Fe
3+
223-THA at various pH conditions: (a) 
1.9 (b) 2.4, (c) 3.3, (d) 3.9, (e) 4.2, (f) 5.1, (g) 6.7. Conditions:  [Fe
3+
] = 100 µM, [223-
THA] = 200 µM, ionic strength = 0.1 M KCl 
 
0 
0.05 
0.1 
0.15 
0.2 
0.25 
0.3 
300 350 400 450 500 550 600 
A
b
s 
Wavelength (nm) 
b 
d 
λmax 430 nm 457 nm 
λmax 463 nm 
a 
c 
e 
f 
g 
Dawadi, Surendra, 2013, UMSL, p.61 
 
 
 
c) Complexation of Fe
3+
 by 333-THA 2.29 
 
Figure 2.26 UV-Vis spectral changes of Fe
3+
333-THA at various pH conditions: (a) 
0.8, (b) 1.2, (c) 1.4, (d) 1.6, (e) 1.8, (f) 2.0, (g) 2.2, (h) 2.4, (i) 3.1, (j) 3.3. Conditions:  
[Fe
3+
] = 100 µM, [333-THA] = 200 µM, ionic strength = 0.1 M KCl 
 
UV-Vis spectra for solutions of Fe
3+
 and 333-THA were recorded over the pH 
range 0.3 to 4.0. A metal to ligand ratio of 1:2 was used in the spectrophotometric 
titration. A detailed set of spectra collected between pH 0.8 and 3.3 is shown in Figure 
2.26. At lower pH, the λmax is at 462 nm. This absorbance band increases with increasing 
pH and maximizes at pH 2.4. At pH 2.4, the bis(hydroxamato)Fe
3+
  complex (111 
complex) is completely formed, with a molar extinction coefficient of ϵ = 1,930 M-1 cm-1. 
The absorption spectra in the figure up to pH 2.0 were used to calculate the stability 
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constant of 111 complex by fitting the data in Hypspec. The log β111 was calculated to be 
27.71. 
When the pH of a solution of Fe
3+
 and 333-THA is increased from 2.4 to 4.0, the 
absorbance band shifts toward lower wavelength, but the absorbance also decreases. The 
absence of an isosbestic point indicates that 111 and 110 complexes are not the only 
species present. Additionally, considerable precipitation occurred in the titration mixture 
above pH 3.0. The precipitate was filtered, washed with water, dried, and the IR spectrum 
was obtained. The IR spectrum clearly showed that the precipitate was indeed a metal 
ligand complex, by comparing this IR with the IR of a Fe(OH)3 precipitate. This result 
suggests that the tris(hydroxamato)Fe
3+
 complex of 333-THA is highly insoluble in water 
and crashes out as soon as it is formed. Thus, we are unable to calculate the stability 
constant for the 110 complex. 
 
d) Complexation of Fe
3+
 by tetrahydroxamate-A (free amine) 2.63 
UV-Visible spectra of solutions of Fe
3+
 and tetrahydroxamate-A free amine were 
recorded over the pH range 0.3 to 2.3 (Figure 2.27).  A metal to ligand ratio of 1:1.5 was 
used in the spectrophotometric titration. At lower pH, the λmax is at 464 nm. This 
absorbance band increases with increasing pH and maximizes at pH 1.1. At pH 1.1, the 
bis(hydroxamate) complex (111 complex) is completely formed, with a molar extinction 
coefficient of ε = 2,200 M-1 cm-1. When the pH of a solution of Fe3+ and ligand 2.63 is 
increased from 1.1 to 2.3, the absorbance band shifts to 431 nm and the molar 
absorptivity increases to 2,525 M
-1
cm
-1
. These changes are consistent with the formation 
of a tris(hydroxamate) complex (110 complex). The presence of an isosbestic point at 469 
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nm indicates that there is a simple equilibrium between the 111 and 110 complexes. 
There is no change in the absorption when the pH was increased from 2.3 to 2.5 which 
indicated that the 110 complex was fully formed at pH 2.3. The log β111 and log β110 were 
calculated to be 31.44 and 27.38. 
 
Figure 2.27 UV-Vis spectral changes of Fe
3+
Tetrahydroxamate-A (free amine) at 
various pH conditions: (a) 0.3, (b) 0.5, (c) 0.7, (d) 0.9, (e) 1.0, (f) 1.1, (g) 1.4, (h) 1.6, 
(i) 1.9, (j) 2.3. Conditions:  [Fe
3+
] = 100 µM, [Tetrahydroxamate-A (free amine)] = 
150 µM, ionic strength = 0.1 M KCl 
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e) Complexation of Fe
3+
 by tetrahydroxamate-B 2.50  
UV-Vis spectra of solutions of Fe
3+
 and tetrahydroxamate-B were recorded over 
the pH range 0.3 to 2.0 which is shown in Figure 2.28.  A metal to ligand ratio of 1:1.2 
was used in this titration. At the pH range of 0.3 to 1.5, the λmax is at 463 nm. This 
absorbance band increases with increasing pH and maximizes at pH 1.5. At that pH, the 
bis(hydroxamate) complex (111 complex) is completely formed, with a molar extinction 
coefficient of ϵ = 1,938 M-1 cm-1. The log β111 was calculated to be 32.70. When the pH 
of a solution of Fe
3+
 and tetrahydroxamate-B is increased from 1.5, the precipitation 
occurs. Thus, we are unable to calculate the stability constant for 110 complex.  
 
Figure 2.28 UV-Vis spectral changes of Fe
3+
tetrahydroxamate-B at various pH 
values: (a) 0.3, (b) 0.6, (c) 0.8, (d) 1.0, (e) 1.2, (f) 1.5 (g) 1.7, (h) 2.0. Conditions:  
[Fe
3+
] = 50 µM, [Tetrahydroxamate-B] = 60 µM, ionic strength = 0.1 M KCl 
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2.5.2 Aluminum binding properties by potentiometric titration method 
Ligand protonation constants and aluminum binding constants of three 
trihydroxamic acids 222-THA 2.27, 223-THA 2.28, and 333-THA 2.29 are determined 
by a potentiometric titration method. These studies also suggested that the trihydroxamate 
ligands form an bis(hydroxamate)Al
3+
 complex (111 complex) at low pH, almost in the 
same pH range of formation for the bis(hydroxamate)Fe
3+
 complex. At higher pH, 
tris(hydroxamate)Al
3+
 complex (110 complex) starts to form. Precipitation of 110 
complexes is an issue here too. Data from the potentiometric titration were used to 
calculate aluminum binding constants of trihydroxamates and are listed in the Table 2.1.  
Potentiometric titration studies of tetrahydroxamate ligands were not performed. 
 
2.6 Summary 
After thorough structural investigation of literature examples of natural and 
artificial siderophores, five high affinity trivalent metal chelators are designed and 
synthesized. Three of them were tripodal trihydroxamates, 222-THA 2.27, 223-THA 
2.28, and 333-THA 2.29; and other two were dipodal tetrahydroxamates, 
tetrahydroxamate-A 2.49, and tetrahydroxamate-B 2.50. The structure of 
tetrahydroxamate-A 2.49 was slightly modified to compound 2.63 containing a terminal 
primary amine group for better aqueous solubility. 
Fe
3+
 and Al
3+
 binding affinities of these trihydroxamate and tetrahydroxamate 
ligands were determined by UV-vis spectrophotometric and potentiometric titration 
methods and are listed in table 2.1. Binding affinities of natural siderophore DFO are also 
included for the comparison. 
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Table 2.1 Fe
3+ 
and Al
3+
 binding constants of various hydroxamate ligands 
 222-THA 
2.27 
223-THA 
2.28 
333-THA 
2.29 
Tetrahydroxamate-A 
(free amine) 2.63 
Tetrahydroxamate-B 
2.50 
DFO 
2.1 
Fe
3+
 log 
β111 
30.83 30.20 27.71 31.44 32.17 31.54 
log 
β110 
26.72 25.89 N/A 27.38 28.11 30.60 
Al
3+
 log 
β111 
25.86 25.49 23.35 - - 25.32 
log 
β110 
20.74 20.45 18.44 - - 24.14 
 
The binding constant values in Table 2.1 suggested that the tetrahydroxamate 
ligands are almost as strong as DFO and much stronger than trihydroxamate ligands on 
binding ferric ion. Two tripodal trihydroxamates, 222-THA 2.27 and 223-THA 2.28 
which differ by one methylene unit chain length in one of the arms, have almost equal 
affinities towards Al
3+
 and Fe
3+
 ions. The third trihydroxamate ligand 333-THA 2.29 was 
definitely weaker on binding Al
3+
 ion than other two trihydroxamates. The log β110 
number for Fe
3+
333-THA complex was not available due to the precipitation of 110 
complex during the UV-Vis titration experiment.  
The binding of divalent metal ions Cu
2+
, Ni
2+
, Zn
2+
, Mn
2+
, and Mn
2+
 by one of the 
trihydroxamate ligands, 222-THA 2.27, has also been evaluated by potentiometric 
titration.
39, 41
 The binding constants of 222-THA with these divalent metal ions along 
with Al
3+
 and Fe
3+
 are listed in Table 2.2.
41
 The results indicate that 222-THA is very 
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selective for Al
3+
 and Fe
3+
 over divalent metal ions especially Ca
2+
. This is a very 
important property for the proposed application of these chelators described in Chapter 3. 
However, the ligand has appreciable binding with Cu
2+
. 
 
Table 2.2 Binding constants of the metal complexes of 222-THA 2.27 
  
Fe
3+
 
 
Al
3+
 
 
Cu
2+
 
 
Ni
2+
 
 
Zn
2+
 
 
Mn
2+
 
 
Ca
2+
 
log β111 30.83 25.86 23.61 19.10 19.13 17.06 13.34 
log β110 26.72 20.74 - 10.73 10.13 8.95 3.71 
        
 
2.7 Experimental section 
di-tert-butyl-3,3'-((2-amino-2-((3-(tert-butoxy)-3-oxopropoxy)methyl)propane-1,3-
diyl)bis(oxy))dipropanoate (2.35).  To a suspension of tris 2.25 (12.1 g, 100 mmol) in 
DMSO (20 ml) at 15 
0
C was added 5 M NaOH (2 ml) and the mixture was stirred under 
Argon for 15 minutes. tert- Butyl acrylate (50 ml, 340 mmol) was added drop wise over a 
period of 1 h at the same temperature. When the addition was complete, the reaction 
mixture was allowed to warm to room temperature. The mixture turned into a clear 
solution after about 1 h at room temperature. The reaction mixture was left stirring for an 
additional 15 h. To this mixture was added a phosphate buffer (150 ml, 0.1 M, made by 
dissolving 5 g H3PO4 and 6.5 g NaH2PO4 in 500 ml water, pH ~2), stirred for 5 minutes 
and extracted with EtOAc (2 × 150 ml). The combined EtOAc layers were evaporated to 
get colorless oil (41.3 g, 82%). The product was found to be impure and also contain a 
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little DMSO (
1
H NMR, HPLC). The product was dissolved in EtOAc (150 ml) and the 
buffer (150 ml) was added, shaken and layers were separated. The aqueous layer was 
extracted with EtOAc (150 ml). After the extraction, the aqueous layer was found to be 
acidic with pH ~5. The combined EtOAc layers were evaporated under reduced pressure 
to obtain thick colorless oil (37.7 g, 75%).  The product was analyzed by HPLC and 
1
H 
NMR, and found to be purer and mostly in the form of free amine. The product was again 
dissolved in EtOAc (150 ml) and the buffer (500 ml) was added, shaken and layers were 
separated. The aqueous layer was extracted with EtOAC (2 × 300 ml). After the second 
extraction, pH of the aqueous layer (universal indicator) was found to be about 2. The 
combined EtOAc layers were evaporated under reduced pressure to obtain thick sticky 
colorless oil (37.5 g, 75%) in the form of protonated amine which was used in the next 
step without further purification. The product was previously characterized.
27
 
 
Dimethyl-3,3'-((2-amino-2-((3-methoxy-3-oxopropoxy)methyl)propane-1,3-
diyl)bis(oxy))dipropanoate (2.33). To a solution of tris t- butyl ester (36 g, 71.2 mmol) 
in MeOH (200 ml) was added conc. H2SO4 (9.6 ml, 179.8 mmol, 2.5 eq.) and refluxed at 
63 
0
C for 2h. The mixture of the ester in MeOH was cloudy, but turned to a clear solution 
immediately after the addition of H2SO4. Reaction was monitored by HPLC and found to 
be completed in 2 h. The mixture was allowed to cool down to room temperature and 
10% Na2CO3 (700 ml) was added cautiously with stirring as there was evolution of CO2 
gas. After the complete addition of Na2CO3, the mixture was basic with a pH of ~10 
(universal indicator). It was extracted with EtOAc (3 × 300 ml) and combined EtOAc 
layers were evaporated under reduced pressure to obtain oil as the product which was 
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contaminated with white solid particles (Na2CO3). This mixture was filtered, washed with 
EtOAc and the filtrate was evaporated to obtain light yellow colored oil as the methyl 
ester (20.5 g, 76%). The product was previously characterized.
24 
 
2-(hydroxymethyl)-2-nitrobutane-1,4-diol (2.37).  To a solution of 3-nitropropanol 
2.36 (6.70 g, 63.7 mmol) in H2O (7 mL) were added 37 weight % formaldehyde solution 
in H2O (10 mL, 128 mmol) and solid K2CO3.3/2H2O (21.0 g, 127 mmol) and the mixture 
was stirred at room temperature for 1 h (reaction was exothermic) and then at 30 
0
C for 1 
h. The reaction was monitored by TLC (10% MeOH in CHCl3). 20% aqueous HCl 
solution was added drop wise with stirring until the effervescence of CO2 ceased. The 
resulting mixture was washed with CH2Cl2 (2×30 mL) to remove some impurities and the 
aqueous layer was evaporated under reduced pressure. The residue was triturated with hot 
EtOH (3×50 mL) and the EtOH was filtered and evaporated under reduced pressure to 
yield the product as thick oil (8.85 g, 84%). IR (neat) 3378, 2949, 2888 cm
-1
; 
1
H NMR 
(D2O)  (ppm) 4.05 (ABq,  = 22.2 Hz, J = 12.4 Hz, 4H) 3.73 (t, J = 6.6 Hz, 2H), 2.26 
(t, J = 6.6 Hz, 2H); 
13
C NMR (D2O)  (ppm) 93.9, 62.1, 57.0, 33.3. 
 
Preparation of T-1 Raney Nickel.  In a 250 ml two neck flask, 150 ml of 10% aqueous 
NaOH (15 g in 150 ml solution) solution was heated to 90 
0
C. Nickel/aluminum alloy (10 
g) was added cautiously (reaction is vigorous) in small portions (<1 g at a time) over a 
period of 15 min while stirring the mixture. The temperature was kept between 85 to 90 
0
C during the addition. Heating was then removed and the mixture was stirred for 
additional 50 min at room temperature. The mixture was decanted and the residue was 
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washed with water (5×50 mL) and EtOH (5×15 mL) while always keeping it under the 
solvent because the catalyst is extremely pyrophoric when dry. The catalyst was stored in 
a flask under EtOH in a refrigerator.  
 
2-amino-2-(hydroxymethyl)butane-1,4-diol (2.38).  Freshly prepared T-1 Raney nickel 
(3.6 g) was transferred to a Parr hydrogenation flask as slurry in absolute EtOH (45 mL). 
2-(Hydroxymethyl)-2-nitrobutane-1,4-diol 2.37 (4.80 g, 29.1 mmol) was dissolved in 
absolute EtOH (45 mL) and transferred to the hydrogenation flask. The resulting mixture 
was shaken on a Parr hydrogenator under 45 psi of H2 at room temperature for 20 h. The 
flask was removed from the hydrogenator and flushed with argon for 20 min. The 
catalyst (pyrophoric when dry) was then filtered through a short pad of celite, which was 
never allowed to dry. The celite was washed with EtOH (3 × 30 mL). The EtOH was 
evaporated to give the product as a viscous brown gel (traces of EtOH were always 
present) (3.7 g, 95%) which was used in the next step without further purification. IR 
(neat) 2931, 2875 cm
-1
; 
1
H NMR (D2O)  (ppm) 3.72 (t, J = 7.2 Hz, 2H), 3.47 (s, 4H), 
1.65 (t, J = 7.2 Hz, 2H); 
13
C NMR (D2O)  (ppm) 64.7, 56.9, 54.8, 35.2. 
 
3,3'-((2-amino-2-((2-cyanoethoxy)methyl)butane-1,4 diyl)bis(oxy))dipropanenitrile 
(2.39).  To a stirred solution of 2-amino-2-(hydroxymethyl)butane-1,4-diol 2.38 (3.65 g, 
27.0 mmol) and KOH pellets (0.4 g) in 1,4-dioxane (13 mL) was added acrylonitrile (6.3 
mL, 94 mmol) drop wise over a period of 1 h. Once the addition was complete, the 
mixture was stirred at room temperature for 24 h. The solvent was evaporated under 
reduced pressure to yield thick liquid residue which was dissolved in CH2Cl2 (50 mL) 
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and washed with H2O (50 mL). The aqueous layer was re-extracted with additional 
portions of CH2Cl2 (2×30 mL). The combined CH2Cl2 fractions were dried over Na2SO4 
and evaporated under reduced pressure and the residue was purified by column 
chromatography (SiO2, 5% EtOH in EtOAc) to give the product as a thick brown oil 
(3.89 g, 49%): IR (neat) 3371, 3307, 2873, 2245 cm
-1
; 
1
H NMR (CDCl3)  (ppm) 3.68 (t, 
J = 6.0 Hz, 4H), 3.65 (t, J = 6.1 Hz, 2H), 3.62 (t, J = 6.2 Hz, 2H), 3.41 (ABq,  = 19.5 
Hz, J =  8.7 Hz, 4H), 2.60 (t, J = 6.0 Hz, 4H), 2.59 (t, J = 6.0 Hz, 2H), 1.72 (t, J = 6.1 Hz, 
2H); 
13
C NMR (CDCl3)  (ppm) 118.2 (all three nitrile carbons), 75.1, 67.5, 66.0, 65.8, 
54.7, 34.6, 19.1, 19.0; HRMS (FAB) C14H23N4O3 [M+H]
+
 calcd 295.17703, found 
295.17720. 
 
Dimethyl-3,3'-((2-amino-2-((3-methoxy-3-oxopropoxy)methyl)butane-1,4-
diyl)bis(oxy))dipropanoate (2.40).  Dry HCl gas was bubbled into a solution of the 
trinitrile 2.39 (1.43 g, 4.86 mmol) in MeOH (12 ml) until it was saturated (NH4Cl 
precipitated out). The resulting mixture was heated at reflux for 10 h. Saturated Na2CO3 
was added drop wise while stirring the mixture until CO2 effervescence ceased. The 
solution was extracted with EtOAc (3×30 mL). The combined organic layers were 
washed with brine, dried over Na2SO4 and evaporated to obtain the product as a liquid 
(1.41 g, 74%), which was used in the next step without further purification. IR (neat) 
2951, 2875, 1732 cm
-1
; 
1
H NMR (CDCl3)  (ppm) 3.74- 3.63 (m, 15H), 3.53 (t, J = 6.5 
Hz, 2H), 3.26 (ABq,  = 13.8 Hz, J = 8.9 Hz, 4H), 2.55 (t, J = 6.3 Hz, 6H), 2.03 (br s, 
2H), 1.62 (t, J = 6.4 Hz, 2H); 
13
C NMR (CDCl3)  (ppm) 172.3, 172.2, 75.1, 67.4, 66.8, 
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66.3, 54.7, 51.8, 51.7, 35.1, 35.0, 34.5; HRMS (FAB) C17H32NO9 [M+H]
+
 calcd 
394.20770, found 394.20860. 
 
Dimethyl-3,3'-((2-((3-methoxy-3-oxopropoxy)methyl)-2-(4-
methylphenylsulfonamido)butane-1,4-diyl)bis(oxy))dipropanoate (2.41).  To a stirred 
solution of the amino triester 2.40 (1.40 g, 3.56 mmol) and TsCl (1.60 g, 8.40 mmol) in 
CH2Cl2 (32 mL) was slowly added Et3N (1.0 mL, 7.2 mmol) and the resulting mixture 
was heated at reflux for 20 h. The solvent was evaporated under reduced pressure and the 
residue was dissolved in CH2Cl2 (50 mL), washed with water (2×25 mL), dried over 
Na2SO4 and concentrated under reduced pressure. The crude product was purified by 
column chromatography (SiO2, hexanes/EtOAc gradient) to give the tosyl amide as a 
thick oil (1.42 g, 75%): IR (neat) 3287, 2953, 2876, 1732 cm
-1 
; 
1
H NMR (CDCl3)  
(ppm) 7.73 (d, J = 8.3 Hz, 2H), 7.24 (d, J = 8.3 Hz, 2H), 5.58 (s, 1H), 3.67 (s, 3H), 3.64 
(s, 6H), 3.58 (t, J = 6.3 Hz, 2H), 3.50-3.36 (m, 10H), 2.52 (t, J = 6.3 Hz, 2H), 2.39 (t, J = 
6.3 Hz, 4H), 2.38 (s, 3H), 1.88 (t, J = 6.0 Hz, 2H); 
13
C NMR (CDCl3)  (ppm) 172.1, 
172.0, 142.8, 140.6, 129.3, 126.9, 72.1, 66.9, 66.5, 66.2, 61.6, 51.8, 51.7, 34.8, 34.6, 32.6, 
21.5; HRMS (FAB) C24H38NO11S [M+H]
+
 calcd 548.21655, found 548.21570. 
 
3,3'-((2-(2-(3-(hydroxyamino)-3-oxopropoxy)ethyl)-2-(4-
methylphenylsulfonamido)propane-1,3-diyl)bis(oxy))bis(N-hydroxypropanamide) 
(2.28).  To a solution of the tosylamido triester 2.41 (0.5 g, 0.91 mmol) in dry MeOH (5.5 
mL) was added NH2OTMS (0.67 mL, 5.48 mmol) and the resulting solution was stirred 
at room temperature. The reaction was monitored by TLC (50% EtOAc in hexanes). No 
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reaction was observed after 3 h. KOH (0.3 g) was added and stirring was continued for an 
additional 45 min. Amberlyst-15 (2.6 g, washed with dry MeOH) was added to the 
reaction mixture and stirring was continued for 1 h. The mixture was filtered and the 
filtrate was evaporated under reduced pressure to obtain the ligand 2.28 as a solid (0.44 g, 
88%): IR (neat) 3215, 2876, 1638 cm
-1
; 
1
H NMR (D2O)  (ppm) 7.80 (d, J = 8.2 Hz, 2H), 
7.47 (d, J = 8.2 Hz, 2H), 3.64 (t, J = 6.0 Hz, 2H), 3.48-3.52 (m, 6H), 3.39 (s, 4H), 2.44 (s, 
3H), 2.40 (t, J = 6.0 Hz, 2H), 2.32 (t, J = 5.8 Hz, 4H), 1.85 (t, J = 6.7 Hz, 2H); 
13
C NMR 
(MeOD)  (ppm) 171.0, 170.9, 144.4, 141.9, 123.5, 127.9, 72.5, 67.6, 67.3, 62.5, 54.9, 
34.4, 33.3, 21.5; HRMS (FAB) C21H35N4O11S [M+H]
+
 calcd 551.20227, found 
551.20260. 
 
tert-butyl (1,7-dihydroxy-4-(3-hydroxypropyl)heptan-4-yl)carbamate (2.44). To a 
stirred solution of 4-amino-4-(3-hydroxypropyl)heptane-1,7-diol 2.43 (1.65 g, 8.06 
mmol) in dry MeOH (33 mL) was added (Boc)2O (1.86 g, 8.5 mmol) and the mixture was 
stirred at room temperature for 20 h. The solvent was evaporated under reduced pressure 
and the residue was purified by column chromatography (SiO2, CH2Cl2/MeOH gradient) 
to give the product (1.681 g, 68%) which was crystallized from CH2Cl2 as white crystals: 
IR (neat) 3453, 3400, 3307, 3228, 2947, 2872, 1689 cm
-1
; 
1
H NMR (MeOD)  (ppm) 
3.43 (t, J = 6.6 Hz, 6H), 1.57-1.51 (m, 6H), 1.42-1.35 (m, 6H), 1.32 (s, 9H); 
13
C (MeOD) 
 (ppm) 156.5, 79.3, 63.4, 57.9, 32.4, 28.8, 27.5. 
 
Diethyl 2,2'-((4-((tert-butoxycarbonyl)amino)-4-(3-(2-ethoxy-2-
oxoethoxy)propyl)heptane-1,7-diyl)bis(oxy))diacetate (2.45). To a stirred solution of 
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tert-butyl (1,7-dihydroxy-4-(3-hydroxypropyl)heptan-4-yl)carbamate 2.44 (0.6 g, 1.96 
mmol) and Rh2(OAc)4 (0.043 g, 0.098 mmol) in CH2Cl2 (6 mL) was added a solution of 
ethyl diazoacetate (1.05 ml, 9.98 mmol) in CH2Cl2 (50 ml) over a period of 1 h (syringe 
pump) at room temperature. After the addition was complete, the mixture was stirred for 
5 h at room temperature. The solvent was removed under reduced pressure and the crude 
product was purified by column chromatography (SiO2, hexane/EtOAc gradient) to give 
the pure product 2.45 (0.8 g, 73%): IR (neat) 3356, 2952, 2875, 1749, 1729, 1640 cm
-1
; 
1
H NMR (CDCl3)  (ppm) 4.20 (q, J = 7.1 Hz, 6H), 4.05 (s, 6H), 3.49 (t, J = 6.3 Hz, 6H), 
1.63-1.57 (m, 12H), 1.39 (s, 9H), 1.27 (t, J = 7.1 Hz, 9H); 
13
C (CDCl3)  (ppm) 170.6, 
154.3, 78.7, 72.1, 68.5, 60.9, 56.9, 31.8, 28.6, 23.7, 14.4; HRMS (FAB) C27H49NO11Na 
[M+Na]
+
 calcd 586.32037, found 586.31950. 
 
Diethyl 2,2'-((4-amino-4-(3-(2-ethoxy-2-oxoethoxy)propyl)heptane-1,7-
diyl)bis(oxy))diacetate (2.46). Compound 2.45 (1.147 g, 2.03 mmol) was mixed with a 
1:1 mixture of CF3CO2H (2.3 mL, 31 mmol) and CH2Cl2 (2.3 mL) and the resulting 
solution was stirred at room temperature. The reaction was monitored by TLC (50% 
EtOAc in hexane). When the reaction was complete, the solvent was evaporated under 
reduced pressure.  The residue was dissolved in CH2Cl2 (10 mL) and a saturated solution 
of Na2CO3 was added drop wise while cautiously shaking the flask until CO2 evolution 
ceased. The layers were separated and the aqueous layer was extracted twice more with 
CH2Cl2 (2×20 mL). The combined organic layers were dried over Na2SO4 and evaporated 
under reduced pressure to give the crude product, which was purified by column 
chromatography (SiO2, CH2Cl2/MeOH gradient) to give the free amine 2.46 as a colorless 
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oil (0.683 g, 73%): IR (neat) 3436, 2945, 2864, 1744, 1634, cm
-1
; 
1
H NMR (CDCl3)  
(ppm) 4.19 (q, J = 7.1 Hz, 6H), 4.05 (s, 6H), 3.52 (t, J = 5.7 Hz, 6H), 1.65-1.54 (m, 12H), 
1.24 (t, J = 7.1 Hz, 9H); 
13
C (CDCl3)  (ppm) 170.6, 72.1, 68.5, 61.0, 54.7, 35.2, 23.7, 
14.3. 
 
Diethyl 2,2'-((4-(3-(2-ethoxy-2-oxoethoxy)propyl)-4-(4-
methylphenylsulfonamido)heptane-1,7-diyl)bis(oxy))diacetate (2.47). To the stirred 
solution of the free amine 2.46 (0.68 g, 1.46 mmol) and tosyl chloride (0.66 g, 3.5 mmol) 
in CH2Cl2 (13 ml) was added Et3N (0.40 mL, 2.87 mmol) and the mixture was heated at 
reflux for 17 h. The solvent was evaporated under reduced pressure and the residue was 
dissolved in CH2Cl2 (25 ml) and washed with water (2×25 mL). The aqueous layer was 
extracted with CH2Cl2 (2×25 mL) and the combined organic layers was dried over 
Na2SO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography (SiO2, hexane/EtOAc gradient) to give the product as a gummy solid 
(0.826 g, 91%): IR (neat) 3278, 2948, 2877, 1747 cm
-1
; 
1
H NMR (CDCl3)  (ppm) 7.68 
(d, J = 8.2 Hz, 2H), 7.17 (d, J = 8.2 Hz, 2H), 4.10 (q, J = 7.1 Hz, 6H), 3.88 (s, 6H), 3.24 
(t, J = 5.9 Hz, 6H), 2.31 (s, 3H), 1.48-1.38 (m, 12H), 1.18 (t, J = 7.1 Hz, 9H); 
13
C 
(CDCl3)  (ppm) 170.3, 142.6, 140.7, 129.3, 126.7, 72.4, 68.1, 61.9, 61.0, 32.7, 23.2, 
21.3, 14.1; HRMS (FAB) C29H47NO11SNa [M+Na]
+
 calcd 640.27673, found 640.27700. 
 
2,2'-((4-(3-(2-(hydroxyamino)-2-oxoethoxy)propyl)-4-(4-
methylphenylsulfonamido)heptane-1,7-diyl)bis(oxy))bis(N-hydroxyacetamide) 
(2.29). To a solution of the triester 2.47 (0.54 g, 1.46 mmol) in MeOH (6 mL) was added 
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NH2OTMS (1.00 mL, 8.17 mmol) and the mixture was stirred at room temperature for 30 
h. The solvent was evaporated under reduced pressure to give a foamy solid. 
Recrystallization from a 1:1 mixture of EtOH and i-PrOH yielded the product 2.29 as a 
white crystalline solid (0.55 g, 80%): IR (neat) 3256, 2953, 2872, 1642 cm 
-1
; 
1
H NMR 
(D2O)  (ppm) 7.81 (d, J = 8.3 Hz, 2H), 7.44 (d, J = 8.3 Hz, 2H), 3.99 (s, 6 H), 3.35 (t, J 
= 5.9 Hz, 6H), 2.43 (s, 3H), 1.52 (m, 12H); 
13
C (MeOD)  (ppm) 169.2, 144.4, 142.7, 
130.7, 128.0, 72.9, 70.1, 63.0, 33.7, 24.2, 21.5; HRMS (FAB) C23H39N4O11S [M+H]
+
 
calcd 579.23358, found 579.23320.  The structure of 2.29 was further confirmed X-ray 
crystallography. 
 
Nonanedial O,O-dibenzyl dioxime (2.55).  To a solution of nonanedial 2.54 (3.80 g, 
24.3 mmol) and O-benzylhydroxylamine hydrochloride (10.1 g, 63.3 mmol) in EtOH 
(120 mL) was added pyridine (8.6 g, 108.8 mmol) drop wise. The resulting solution was 
heated at reflux for 4 h. The solvent was evaporated under reduced pressure and the 
residue was dissolved in CH2Cl2 (200 mL) and washed with water (3×100 mL). The 
aqueous layer was re-extracted with CH2Cl2 (2×100 mL). The combined organic layers 
were dried over Na2SO4, evaporated under reduced pressure, and the residue was purified 
by column chromatography (SiO2 hexanes) to give the product as a colorless liquid (6.12 
g, 69%) as a 1.5:1 mixture of geometric isomers. IR (neat) 3030, 2925, 2856 cm
-1
; 
1
H 
NMR (CDCl3)  (ppm) 7.46 (t, J = 6.2 Hz, 0.6H), 7.39-7.31 (m, 5H), 6.69 (t, J = 5.4 Hz, 
0.4H), 5.13 (s, 0.8 H), 5.08 (s, 1.2H), 2.39 (app q, 0.8H), 2.20 (app q, 1.2H), 1.48 (m 2H), 
1.32 ( m, 3H); 
13
C NMR (CDCl3)  (ppm) 152.6, 151.7, 138.3, 137.8, 128.5 (×2), 128.3, 
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128.0, 127.9, 127.8, 75.8, 75.6, 29.6, 29.3, 29.1, 29.0, 26.7, 26.2, 25.9; HRMS (FAB) 
C23H31N2O2 [M+H]
+
 calcd 367.23856, found 367.23830.   
One of the isomers was isolated and characterized completely. 
1
H NMR (CDCl3)  (ppm) 
7.39 (t, J = 6.2 Hz, 2H), 7.31-7.24 (m, 10H), 5.00 (s, 4H), 2.13 (app q, 4H), 1.41 (quin, J 
= 6.8 Hz, 4H), 1.25 (m, 6H); 
13
C NMR (CDCl3)  (ppm) 151.7, 137.9, 128.5, 128.4, 
127.9, 75.6, 29.6, 29.1, 29.0, 26.7. 
 
N,N'-(nonane-1,9-diyl)bis(O-benzylhydroxylamine) (2.56).  To a solution of 2.55 (0.11 
g, 0.3 mmol) and NaCNBH3 (0.042 g, 0.66 mmol) in MeOH (2 mL) was added 2N HCl 
in MeOH drop wise until the solution pH was between 3 and 4. The resulting mixture 
was stirred for 3 h at room temperature.  The solvent was evaporated under reduced 
pressure and the solid residue was dissolved in water (2 mL) and 6 N KOH solution was 
added drop wise to adjust the solution pH to >9. The aqueous solution was extracted with 
CH2Cl2 (3×10 ml), and combined organic extracts were washed with brine (20 mL), dried 
over Na2SO4 and evaporated under reduced pressure.  The residue was purified by 
column chromatography (SiO2 hexanes/EtOAc gradient) to give the product as a colorless 
liquid (0.083 g, 76%): IR (neat) 3028, 2924, 2852, 1453, 1363 cm
-1
; 
1
H NMR (CDCl3)  
(ppm) 7.30-7.38 (m, 10H), 4.73 (s, 4H), 2.94 (t, J = 7.0 Hz, 4H), 1.52 (app quin, J =6.7 
Hz, 4H), 1.30 (br s, 10H); 
13
C NMR (CDCl3)  (ppm) 138.2, 128.5 (×2), 127.9, 76.3, 
52.3, 29.6, 27.4, 27.3; HRMS (FAB) C23H34N2O2Na [M+Na]
+
 calcd 393.2518, found 
393.2517. 
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N-(benzyloxy)-N-(9-((benzyloxy)amino)nonyl)acetamide (2.57).  To a solution of 2.56 
(3.0 g, 8.09 mmol) in CH2Cl2 (50 mL) was added a solution of DMAP (0.99 g, 8.10 
mmol), and Ac2O (0.77 mL, 8.14 mmol) in CH2Cl2 (50 mL). Finally, pyridine (1.34 mL, 
16.56 mmol) was added drop wise and the resulting mixture was stirred at room 
temperature for 2 h. The mixture was diluted with CH2Cl2 (30 mL) and washed with 
saturated NaHCO3 (50 mL). The organic layer was dried over Na2SO4 and evaporated 
under reduced pressure and the solid residue was purified by column chromatography 
(SiO2, hexanes/EtOAc gradient) to give a colorless liquid (1.6 g, 48%): IR (neat) 3031, 
2927, 2854, 1660 cm
-1
; 
1
H NMR (CDCl3)  (ppm) 7.31-7.39 (m, 10H), 5.56 (br s, 1H), 
4.82 (s, 2H), 4.71 (s, 2H), 3.63 (t, J = 6.9 Hz, 2H), 2.93 (t, J = 7.1 Hz, 2H), 2.10 (s, 3H), 
1.64 (m, 2H), 1.50 (m, 2H), 1.29 (br s, 10H); 
13
C NMR (CDCl3)  (ppm) 154.2, 138.2, 
134.7, 129.3, 129.0, 128.9, 128.5 (×2), 127.9, 76.4, 76.3, 52.3, 29.6, 29.4, 27.5, 27.3, 
27.0, 26.9, 20.7; HRMS (FAB) C25H37N2O3 [M+H]
+
 calcd 413.28040, found 413.2776. 
 
3,3'-((2-methyl-2-(4-methylphenylsulfonamido)propane-1,3-
diyl)bis(oxy))dipropanoic acid (2.61).  To a solution of bis-ester (2.60) (3.00 g, 6.96 
mmol) in aqueous THF (1:1, 30 ml) at 0 
o
C, was added LiOH.H2O (1.17 g, 27.9 mmol) 
and the resulting mixture was stirred for 1 h. After 1 h, the flask was allowed to warm to 
room temperature while stirring was continued. When all starting material was consumed 
(TLC 1:1 EtOAc/hexanes), the reaction was quenched with 2N HCl and the solution pH 
was adjusted to 1. The mixture was filtered (to remove LiCl) and extracted with CH2Cl2 
(3×50 mL).  The combined organic extracts were washed with brine, dried over Na2SO4 
and evaporated under reduced pressure to give the di-acid as a white powder (2.67 g, 
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95%) which was used in the next step without further purification. IR (neat) 3300, 3051, 
2925, 2875, 1697 cm 
-1
; 
1
H NMR (D2O)  (ppm) 7.84 (d, J = 8.3 Hz, 2H), 7.45 (d, J = 8.3 
Hz, 2H), 3.60-3.53 (m, 4H), 3.37 (ABq,  = 22.8 Hz, J = 10 Hz, 4H), 2.53 (t, J = 6.0 
Hz, 4H), 2.44 (s, 3H), 1.14 (s, 3H); 
13
C NMR (MeOD)  (ppm) 175.6, 144.3, 142.5, 
130.5, 128.0, 74.8, 68.0, 60.1, 35.7, 21.5, 19.4; HRMS (FAB) C17H26NO8S [M+H]
+
 calcd 
404.13790, found 404.13880. 
 
3,3'-((2-methyl-2-(4-methylphenylsulfonamido)propane-1,3-diyl)bis(oxy))bis(N-
(benzyloxy)-N-(9-(N-(benzyloxy)acetamido)nonyl)propanamide) (2.62).  To a 
solution of 2.57 (0.40 g, 0.97 mmol) and DMAP (0.16 g, 1.31 mmol) in CH2Cl2 (10 mL) 
and pyridine (0.11 mL, 1.4 mmol), was added a solution of 2.61 (0.18 g, 0.45 mmol) and 
HOBt (0.14 g, 1.03 mmol) in CH2Cl2 (10 mL) and the mixture was cooled to 0 
o
C. DCC 
(0.2 g, 0.97 mmol) was added and the mixture was stirred for 1 h at 0 
o
C. It was allowed 
to warm to room temperature and was stirred for an additional 15 h. The solvent was 
evaporated under reduced pressure and the residue was purified by column 
chromatography (SiO2, hexanes/EtOAc gradient) to give the product as a thick colorless 
oil (0.342 g, 65%): IR (neat) 3033, 2930, 2856, 1650, 1601 cm
-1
; 
1
H NMR (CDCl3)  
(ppm) 7.75 (d, J = 8.2 Hz, 2H), 7.45-7.33 (m, 20H), 7.17 (d, J = 8.2 Hz, 2H), 5.74 (s, 
1H), 4.78 (s, 4H), 4.76 (s, 4H), 3.63-3.59 (m, 12H), 3.30 (ABq,  = 52.5 Hz, J = 9.2 Hz, 
4H), 2.66-2.55 (m, 4H), 2.25 (s, 3H), 2.04 (s, 6H), 1.58 (m, 8H), 1.23 (br s, 20H), 1.08 (s, 
3H); 
13
C NMR (CDCl3)  (ppm) 172.2, 172.0, 142.4, 140.8, 134.4, 134.3, 129.9, 129.3, 
129.2, 129.0, 128.7, 128.6, 128.5, 127.0, 126.7, 126.2, 77.6, 76.2, 76.0, 73.7, 66.7, 58.6, 
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45.2, 32.5, 29.2, 29.0, 26.7, 26.5, 21.3, 20.4, 18.1; HRMS (FAB) C67H94N5O12S [M+H]
+
 
calcd 1192.66199, found 1192.66110. 
 
3,3'-((2-methyl-2-(4-methylphenylsulfonamido)propane-1,3-diyl)bis(oxy))bis(N-
hydroxy-N-(9-(N-hydroxyacetamido)nonyl)propanamide) (2.49).  To a solution of 
2.62 (0.34 g, 0.28 mmol) in MeOH (11 mL) was added 10% Pd/C (0.074 g). The flask 
was then evacuated and flushed with H2 from two balloons and the mixture was stirred 
under H2 at room temperature until the starting material was consumed (TLC, 70% 
EtOAc in hexanes). The reaction flask was purged with Ar and the mixture was filtered. 
The filtrate was evaporated under reduced pressure to give the product as a foamy solid 
(0.22 g, 91%): IR (neat) 3360, 3060, 2928, 2857, 1611 cm
-1
; 
1
H NMR (MeOD)  (ppm) 
7.68 (d, J = 8.2 Hz, 2H), 7.23 (d, J = 8.2 Hz, 2H), 3.52-3.46 (m, 12H), 3.27-3.17 (m, 4H 
overlapping with MeOH peak), 2.58 (t, J = 6.0 Hz, 4H), 2.31 (s, 3H), 1.99 (s, 6H), 1.51 
(br s, 8H), 1.21 (br s, 20H), 1.00 (s, 3H); 
13
C NMR (MeOD)  (ppm) 173.6, 173.5, 144.2, 
142.6, 130.5, 128.0, 75.0, 68.0, 60.1, 48.9, 33.9, 30.6, 30.4, 27.8, 21.6, 20.3, 19.5; HRMS 
(FAB) C39H70N5O12S [M+H]
+
 calcd 832.4742, found 832.4725. 
 
Dimethyl-3,3'-((2-(((benzyloxy)carbonyl)amino)-2-methylpropane-1,3-
diyl)bis(oxy))dipropanoate (2.63).  To a stirred solution of 2.59 (2.0 g, 7.2 mmol) in 
THF (57 mL) was added 10% aqueous Na2CO3 (57.0 mL, 53.7 mmol). After 15 minutes 
at room temperature CbzCl (1.13 mL, 7.93 mmol) was added and stirring was continued 
for an additional 5 h. The layers were separated and the aq. layer was extracted with 
EtOAc (2×30 mL). The combined organic extracts were washed with water and brine, 
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dried over Na2SO4 and evaporated under reduced pressure.  The residue was purified by 
column chromatography (SiO2, hexane/EtOAc gradient) to obtain the product as a 
colorless oil (1.9 g, 65%): IR (neat) 3366, 2951, 2875, 1731 cm
-1
; 
1
H NMR (300 MHz, 
CDCl3)  (ppm) 7.33-7.31 (m, 5H), 5.28 (s, 1H), 5.01 (s, 2H), 3.67 (t, J = 6.2 Hz, 4H), 
3.64 (s, 6H), 3.47 (ABq,  = 42.9 Hz, J = 9.0 Hz, 4H), 2.53 (t, J = 6.2 Hz, 4H), 1.29 (s, 
3H); 
13
C NMR (300 MHz, CDCl3)  (ppm) 172.2, 155.3, 136.8, 128.6, 128.2, 128.1, 
73.1, 66.9, 66.1, 55.8, 51.8, 34.9, 19.8; HRMS (FAB) C20H30NO8 [M+H]
+
 calcd 
412.19714, found 412.19750. 
 
3,3'-((2-(((benzyloxy)carbonyl)amino)-2-methylpropane-1,3-
diyl)bis(oxy))dipropanoic acid (2.64).  To a solution of bis-ester (2.63) (7.40 g, 18.0 
mmol) in 50% aqueous THF (75 mL) was added LiOH (1.68 g, 70.1 mmol) at 0 
0
C and 
the resulting mixture was stirred for 1 h. After 1 h, the flask was allowed to warm to 
room temperature with continued stirring. Once the starting material was consumed (TLC 
analysis, 1:1 EtOAc/hexanes), the reaction was quenched with 2N HCl to adjust the 
solution pH to 2. The mixture was extracted with CH2Cl2 (3×100 mL) and the combined 
extracts were washed with brine, dried over Na2SO4, and evaporated under reduced 
pressure to give the product as a colorless gel (6.8 g, quant) which was used in the next 
step without further purification. IR (neat) 3033, 2939, 2878, 1709 cm 
-1
; 
1
H NMR (300 
MHz, CDCl3)  (ppm) 10.28 (br s, 2H), 7.35-7.29 (m, 5H), 5.34 (br s, 1H), 5.04 (s, 2H), 
3.68 (t, J = 6.2 Hz, 4H), 3.49 (ABq,  = 39.6 Hz, J = 8.9 Hz, 4H), 2.57 (t, J = 6.2 Hz, 
4H), 1.31 (s, 3H); 
13
C NMR (300 MHz, CDCl3)  (ppm) 177.7, 155.4, 136.6, 128.6, 
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128.2, 128.2, 77.3, 72.9, 66.4, 55.7, 34.8, 19.1; HRMS (FAB) C18H26NO8 [M+H]
+
 calcd 
384.1658, found 384.1648. 
 
Benzyl (3,35-diacetyl-13,25-bis(benzyloxy)-19-methyl-14,24-dioxo-1,37-diphenyl-
2,17,21,36-tetraoxa-3,13,25,35-tetraazaheptatriacontan-19-yl)carbamate (2.65).  To a 
solution of 2.57 (1.1 g, 2.66 mmol) and DMAP (0.44 g, 3.60 mmol) in CH2Cl2 (50 mL) 
and pyridine (0.29 mL 3.58 mmol), was added a stirred solution of 2.64 (0.47 g, 1.22 
mmol) and HOBt (0.37 g, 2.71 mmol) in CH2Cl2 (50 mL). The mixture was cooled to 0 
0
C and DCC (0.58 g, 2.81 mmol) was added. The mixture was stirred for 1 h at 0 
0
C, then 
allowed to warm to room temperature and stirred for an additional 15 h. The solvent was 
concentrated under reduced pressure and the solids were removed by filtration (DCC 
urea) and washed with CH2Cl2.  The filtrate was evaporated under reduced pressure and 
the residue was purified by column chromatography (SiO2,
 
EtOAc/hexanes gradient) to 
give the product as a white solid product (0.80 g, 56%): IR (neat) 3029, 2930, 2856, 
1719, 1649 cm
-1
; 
1
H NMR (300 MHz, CDCl3)  (ppm) 7.36-7.25 (m, 5H), 5.49 (s, 1H), 
5.00 (s, 2H), 4.79 (s, 4H), 4.78 (s, 4H), 3.71 (t, J = 6.2 Hz, 4H), 3.60-3.55 (m, 8H), 3.49 
(ABq,  = 45.8 Hz, J = 9.1 Hz, 4H), 2.64 (t, J = 5.9 Hz, 4H), 2.07 (s, 6H), 1.60-1.58 (m, 
8H), 1.32 (s, 3H), 1.24 (s, 20H); 
13
C NMR (300 MHz, CDCl3)  (ppm) 172.4, 172.2, 
155.1, 136.8, 134.5, 129.1 (×2), 128.9, 128.8, 128.7, 128.4, 127.9, 127.8, 77.4, 76.3, 76.2, 
73.2, 67.1, 65.9, 55.7, 45.3, 33.9, 32.7, 29.4, 29.3, 29.2, 29.1, 26.8, 26.7, 26.6, 20.5, 19.0; 
HRMS (FAB) C68H94N5O12 [M+H]
+
 calcd 1172.68994, found 1172.68620. 
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9,9'-((3,3'-((2-amino-2-methylpropane-1,3 
diyl)bis(oxy))bis(propanoyl))bis(hydroxyazanediyl))bis(N-hydroxynonanamide) 
(2.63).  To a solution of 2.65 (0.50 g, 0.43 mmol) in MeOH (16 mL) was added 10% 
Pd/C (0.11 g) under argon. The flask was evacuated and flushed with H2 (balloons) and 
then the mixture was stirred under H2 at room temperature until the starting material was 
consumed (TLC analysis, 70% EtOAc in hexanes). The reaction mixture was then 
flushed with Ar and filtered. The filtrate was evaporated in vacuo to obtain a sticky solid 
as the product (0.29 g, quant): IR (neat) 3133 (broad), 2927, 2854, 1607 cm
-1
; 
1
H NMR 
(300 MHz, MeOD)  (ppm) 3.75 (t, J = 6.1 Hz, 4H), 3.60 (t, J = 7.1 Hz, 4H), 3.58 (t, J = 
7.1 Hz, 4H), 3.41 (ABq,  = 26.4 Hz, J = 9.6 Hz, 4H), 2.76 (t, J = 6.1 Hz, 4H), 2.09 (s, 
6H), 1.61 (m, 8H), 1.32 (m, 20H), 1.15 (s, 3H); 
13
C NMR (300 MHz, MeOD)  (ppm) 
173.5, 173.4, 74.9, 68.3, 56.5, 48.9, 34.8, 33.8, 30.7, 30.4, 27.8, 26.8, 26.2, 20.4 (×2); 
HRMS (FAB) C32H64N5O10 [M+H]
+
 calcd 678.46533, found 678.46620. 
 
Methyl 9-((benzyloxy)imino)nonanoate (2.68).  To a solution of aldehyde 2.67 (3.40 g, 
18.2 mmol) and O-benzylhydroxylamine hydrochloride (3.79 g, 23.7 mmol) in EtOH (73 
mL) was added pyridine (3.75 g, 47.4 mmol) drop wise. The resulting solution was 
heated at reflux for 3 h. The solvent was evaporated under reduced pressure and the 
residue was triturated with EtOAc (5×20 mL). The EtOAc fractions were combined and 
filtered, then evaporated under reduced pressure.  The residue was purified by column 
chromatography (SiO2 hexanes/EtOAc gradient) to give the oxime as a thick colorless 
liquid (4.7 g, 89%) as the mixture of two geometric isomers: IR (neat) 3027, 2929, 2856, 
1736, cm
-1
; 
1
H NMR (CDCl3)  (ppm) 7.44 (t, J = 6.2 Hz, 0.6H), 7.37-7.27 (m, 5H), 6.67 
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(t, J = 5.5 Hz, 0.4H), 5.11 (s, 0.8H), 5.06 (s, 1.2H), 3.67 (s, 3H), 2.37 (m, 0.6H), 2.31 (m, 
2H), 2.17 (m, 1.4H), 1.62 (m, 2H), 1.47 (m, 2H), 1.31 (m, 6H); 
13
C NMR (CDCl3)  
(ppm) 174.4, 152.6, 151.7, 138.3, 137.8, 128.5 (× 2), 128.4, 128.0, 127.9 (× 2), 75.8, 
75.6, 51.6, 34.2, 29.6, 29.3, 29.1, 29.0, 26.7, 26.3, 25.9, 25.0. 
One of the isomers was isolated and characterized, but isomerized soon on standing: 
1
H 
NMR (CDCl3)  (ppm) 7.44 (t, J = 6.2 Hz, 1H), 7.37-7.27 (m, 5H), 5.06 (s, 2H), 3.67 (s, 
3H), 2.30 (t, J = 7.4Hz, 2H), 2.17 (app q, J = 6.4 Hz, 2H), 1.62 (m, 2H), 1.47 (m, 2H), 
1.31 (br s, 6H). 
 
Methyl 9-((benzyloxy)amino)nonanoate (2.69).  To a solution of oxime 2.68 (4.70 g, 
16.1 mmol) and NaCNBH3 (1.12 g, 17.8 mmol) in MeOH (100 mL) was added 2N HCl 
in MeOH drop wise at room temperature until the solution pH (checked by universal 
indicator) was adjusted to 4-3, then the solution was stirred for 3 h at room temperature. 
The solvent was evaporated under reduced pressure to give a solid residue, which was 
dissolved in water (100 mL).  6 N KOH solution was added drop wise to adjust the 
solution pH to >9. The aqueous solution was extracted with CH2Cl2 (3×100 mL). The 
combined organic layers were washed with brine, dried over Na2SO4 and evaporated 
under reduced pressure. The residue was purified by column chromatography (SiO2 2% 
EtOAc in hexanes) to give the hydroxylamine as a colorless liquid (4.6 g, quant): IR 
(neat) 3022, 2928, 2854, 1736 cm
-1
; 
1
H NMR (CDCl3)  (ppm) 7.36-7.27 (m, 5H), 4.71 
(s, 2H), 3.67 (s, 3H), 2.92 (t, J = 7.0 Hz, 2H), 2.30 (t, J = 7.4 Hz, 2H), 1.62 (m, 2H), 1.50 
(m, 2H), 1.30 (br s, 8H); 
13
C NMR (CDCl3)  (ppm) 174.5, 138.1, 128.5, 127.9, 76.3, 
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52.3, 51.6, 34.2, 29.4, 29.3, 29.2, 27.4, 27.2, 25.1; HRMS (FAB) C17H28NO3 [M+H]
+
 
calcd 294.20691, found 294.20750. 
 
Dimethyl-10,22-bis(benzyloxy)-16-methyl-16-(4-methylphenylsulfonamido)-11,21-
dioxo-14,18-dioxa-10,22-diazahentriacontane-1,31-dioate (2.70).  To a solution of 
hydroxylamine 2.69 (0.10 g, 0.34 mmol) and DMAP (0.06 g, 0.49 mmol) in CH2Cl2 (4 
mL) and pyridine (0.04 mL, 0.49 mmol) was added a solution of dicarboxylic acid 2.61 
(0.06 g, 0.15 mmol) and HOBt (0.05 g, 0.37 mmol) in CH2Cl2 (4 mL).  The mixture was 
cooled to 0 
0
C and DCC (0.07 g, 0.34 mmol) was added. The mixture was stirred for 1 h 
at 0 
0
C, then it allowed to warm to room temperature and stirred for an additional 20 h. 
The solvent was evaporated under reduced pressure and the liquid residue was purified 
by column chromatography (SiO2 hexanes/EtoAc gradient) to give a thick colorless oil 
(0.142 g, 60%): IR (neat) 3269, 3028, 2930, 2857, 1734, 1653 cm
-1
; 
1
H NMR (CDCl3)  
(ppm) 7.77 (d, J = 8.2 Hz, 2H), 7.41-7.36 (m, 10H), 7.22 (d, J = 8.2 Hz, 2H), 5.65 (s, 
1H), 4.82 (s, 4H), 3.66-3.63 (m, 14H), 3.34 (ABq,  = 87 Hz, J = 9.2 Hz, 4H), 2.67-2.57 
(m, 4H), 2.38 (s, 3H), 2.28 (t, J = 7.5 Hz, 4H), 1.62-1.57 (m, 8H), 1.28 (m, 16H), 1.09 (s, 
3H); 
13
C NMR (CDCl3)  (ppm) 174.4, 172.5, 142.8, 141.0, 134.6, 129.5, 129.3, 129.1, 
128.9, 127.0, 76.5, 74.0, 76.1, 58.9, 51.6, 45.6, 34.2, 34.8, 29.3, 29.2, 26.8, 25.0, 21.6, 
18.3; HRMS (FAB) C51H76N3O12S [M+H]
+
 calcd 954.51495, found 954.51690. 
 
9,9'-(9-methyl-9-(4-methylphenylsulfonamido)-4,14-dioxo-1,17-diphenyl-2,7,11,16-
tetraoxa-3,15-diazaheptadecane-3,15-diyl)bis(N-hydroxynonanamide) (2.71).  To a 
solution of 2.70 (2.03 g, 2.13 mmol) in dry MeOH (45 mL) was added KOH (0.80 g, 14.3 
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mmol), NH2OTMS (1.22 mL, 9.38 mmol) and the resulting solution was stirred at room 
temperature for 15 h. Amberlyst-15 (6 g, washed with dry MeOH) was added to the 
reaction mixture and stirred for an additional 1 h. The mixture was filtered and the filtrate 
was evaporated under reduced pressure to obtain the white foamy solid product (2.01 g, 
quant.) which was used without further purification in the next step: IR (neat): 3258, 
2927, 2857, 1632, 1454, 1110 cm
-1
; 
1
H NMR (MeOD)  (ppm) 7.63 (d, J = 8.2 Hz, 2H), 
7.15 (d, J = 8.2 Hz, 2H), 4.76 (s, 4H), 3.55 (app t, J = 5.9 Hz, 4H), 3.42 (app t, J = 5.8 
Hz, 4H), 3.23-3.12 (ABq, 4H over laps with MeOD), 2.47 (app t, J = 5.8 Hz, 4H), 2.24 
(s, 3H), 2.13 (t, J = 7.4 Hz, 1.4H), 1.94 (t, J = 7.3 Hz, 2.3H), 1.48 (m, 8H), 1.17 (m, 
16H), 0.95 (s, 3H); 
13
C NMR (MeOD)  174.4, 173.1, 144.2, 142.6, 136.2, 130.7, 130.5, 
130.1, 129.9, 128.0, 77.4, 75.1, 68.0, 60.1, 46.1, 35.0, 33.9, 30.4, 30.3, 30.2, 27.9, 27.7, 
26.8, 26.1, 21.6, 19.6; HRMS (FAB) C49H74N5O12S [M+H]
+
 calcd 956.50543, found 
956.50500. 
 
9,9'-((3,3'-((2-methyl-2-(4-methylphenylsulfonamido)propane-1,3-
diyl)bis(oxy))bis(propanoyl))bis(hydroxyazanediyl))bis(N-hydroxynonanamide) 
(2.50).  To a solution of 2.71 (2.0 g, 2.1 mmol) in MeOH (100 mL) under argon was 
added 10% Pd/C (0.22 g). The flask was then evacuated, flushed with H2 (balloons) and 
the mixture was stirred under H2 at room temperature for 3 h. The reaction mixture was 
filtered and the filtrate was evaporated under reduced pressure to give the product as a 
foamy solid (1.3 g, 81%): IR (neat) 3500-2600 (broad), 2927, 2856, 1613 cm
-1
; 
1
H NMR 
(MeOD)  7.58 (d, J = 8.0 Hz, 2H), 7.14 (d, J = 8.0 Hz, 2H), 3.44-3.36 (m, 8 H), 3.16-
3.09 (m, 4H, overlaps with CD3OD), 2.47 (t, J = 5.7 Hz, 4H), 2.21 (s, 3H), 1.89 (t, J = 7.2 
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Hz, 4H), 1.41 (br. S, 8H), 1.12 (br. S, 16H), 0.89 (s, 3H); 
13
C NMR (MeOD)  173.6, 
173.1, 144.3, 142.5, 130.5, 128.0, 74.9, 68.0, 60.1, 52.1, 34.9, 33.8, 30.3, 30.1, 27.8, 27.7, 
26.8, 26.1, 21.6, 19.4; HRMS (FAB) C35H62N5O12S [M+H]
+
 calcd 776.41150, found 
776.41130. 
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CHAPTER 3: Synthesis of hydroxamate functionalized chelating resins and aluminum 
removal studies 
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3.1 Specific objectives 
The objectives of this project were: 
(1) Immobilization of hydroxamate chelators 222-THA 2.27, 223-THA 2.28, and 
tetrahydroxamate-B 2.50 on a solid support such as polystyrene resin to obtain 
hydroxamate functionalized chelating resins. These resins will be applied to remove 
aluminum from clinical calcium gluconate solutions. 
(2) An exploration of linker strategies for the immobilization of chelators via a terminal 
free amine. The effect of the linker on kinetics of aluminum extraction from calcium 
gluconate solutions will be studied, and variations in aluminum binding affinities with 
alternate linkers will be compared. 
 
3.2 Background  
A chelating resin is a solid polymeric material containing covalently linked 
chelating compounds. Chelating resins bind metal ions by forming coordination 
complexes. Closely related materials, ion exchange resins, bind metals through ionic 
interactions. Chelating resins are designed to have higher binding affinities and greater 
selectivity for a certain metal ion or a group of metal ions, as opposed to ion exchange 
resins which are less selective. This selectivity can be easily understood in terms of the 
well-known principle of hard and soft acid and base (HSAB) theory. Many of the known 
chelating resins, such as chelex 3.1 (Figure 3.1), contain immobilized nonspecific 
ligands. They exhibit high capacity for metal ions but poor selectivity.  Chelex, for 
example, contains iminodiacetic acid as a chelating group and binds most divalent and 
trivalent metal ions. It is selective, however, for divalent metal ions over monovalent 
metal ions. Chelex is regularly used for the complexation of divalent metal ions such as 
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Cu
2+
, Ni
2+
 and Zn
2+
.
1
 The spherical balls drawn as a part of the structure of chelex 3.1 
and all other chelating resins mentioned in this chapter represent the polymeric backbone 
of the solid support. 
 
 
 
Figure 3.1 Structure of Chelex 
 
For some applications, immobilized ligands designed to target specific metals can 
yield superior results. As alkali and alkaline earth metals such as sodium, potassium, 
calcium, and magnesium are present in relatively high concentrations in natural waters, 
the chelating resins should possess the ability to selectively bind heavy metals, transition 
metals or any other toxic metals from such systems for their commercial applications.
2
 In 
this study, we are concerned with the preparation of chelating resins functionalized with 
trivalent metal selective hydroxamate ligands, and their use in the removal of aluminum 
from commercial calcium gluconate solutions.  
There are relatively few literature examples of synthesis and metal binding studies 
of hydroxamate functionalized chelating resins. Usually, there are two methods for the 
synthesis of chelating resins. The first method involves the polymerization of monomers 
already containing a chelating group of interest or, a group which can be easily converted 
to the chelating group. In the second method, a chelating group is separately synthesized 
and then immobilized on a solid support via a chemical reaction between appropriate 
functional groups present in the chelator group and the solid support. Some of the 
3.1 
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relevant examples of hydroxamate based chelating resins and their syntheses are provided 
below.    
Lee and Hong
3
 studied the synthetic methods for hydroxamate chelating resin 3.5 
and its metal binding properties. The synthesis involved the polymerization of ethyl 
acrylate 3.2 crosslinked with divinylbenzene 3.3, which gave ester functionalized resin 
3.4, followed by conversion of ester groups to hydroxamic acids by treatment with 
hydroxylamine in MeOH to obtain resin 3.5 (Scheme 3.1). The poly(hydroxamic acid) 
resin 3.5 showed excellent binding capacities for copper, iron, vanadium, and uranyl ions. 
 
 
 
Scheme 3.1 Lee’s synthesis of hydroxamate chelating resins 
 
Crumbliss and Garrison reported the synthesis of hydroxamate functionalized 
Fe(III) selective chelating resins 3.8, 3.9 (Scheme 3.1), and their iron binding capacity.
2
 
They used the Amberlite IRC-50 ion exchange resin 3.6 (Rohm and Haas) as the solid 
support. The synthesis proceeded by converting the carboxylic acid group of amberlite 
resin 3.6 into acid chloride 3.7 by treatment with thionyl chloride. Resin 3.7 was then 
treated with hydroxylamine hydrochloride or N-methyl hydroxylamine hydrochloride to 
obtain the hydroxamate functionalized resins 3.8 and 3.9, respectively. They reported 
Fe(III) binding capacities of 1.75 and 1.52 mmol Fe/g dry resin for resins 3.8 and 3.9 at 
pH 2.5, respectively, and claimed that these numbers are the highest reported values for 
3.2 3.4 
3.3 
3.5 
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any commercially available resins. As expected, these resins are found to be highly 
selective for Fe
3+
 in the presence of Ca
2+
.  
 
 
 
Scheme 3.2 Crumbliss’ synthesis of hydroxamate chelating resins 
 
Inspired by the structure of naturally occurring trihydroxamic acids, Liu and 
coworkers
4
 synthesized chelating resins with varying spacing between the hydroxamate 
groups, i.e., resins 3.12, 3.16, and 3.17 (Scheme 3.3). A nitrile functionalized 
macroporous cross-linked co-polymer 3.10 was prepared by the reaction of acrylonitrile 
and divinylbenzene. The nitrile groups were hydrolyzed to carboxylic acids to obtain 
resin 3.11. The carboxylic acid resin 3.11 was then either converted to the hydroxamate 
resin 3.12 by treating with hydroxylamine or to the acid chloride resin 3.13 by treating 
with thionyl chloride. The resin 3.13 was reacted with two amine esters of varying chain 
lengths to obtain amide ester resins 3.14 and 3.15, which were converted to hydroxamate 
resins 3.16 and 3.17 by treating with hydroxylamine. They performed the Cu(II) binding 
studies on the chelating resins 3.12, 3.16, and 3.17 and found that the Cu(II) binding 
affinities were very similar for all three. 
 
R = H, 3.8 
R = CH3, 3.9 
3.7 3.6 
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Scheme 3.3 Liu’s synthesis of hydroxamate chelating resins 
 
Hutchinson and coworkers reported the synthesis of a macrocyclic 
tetrahydroxamate ligand based on calix[4]arene and silica immobilized calix[4]arene 
tetrahydoxamate.
5
 Such an immobilized tetrahydroxamate ligand was prepared by the 
reaction of activated silica with triethoxysilane calyx[4]arene tetrahydroxamate 3.18 
(Figure 3.2).  They prepared a cartridge packed with chelating silica and used the 
cartridge for on-line preconcentration of trace metal ions from aqueous samples. The 
resin removed divalent metal ions Cu(II), Mn(II), and Zn(II) almost quantitatively from 
such samples.  
 
Figure 3.2 Hutchinson’s triethoxysilane derivative of calix[4]arene 
tetrahydroxamate 
3.10 3.11 3.13 
n = 1, 3.14  
n = 3, 3.15 
 
 
n = 1, 3.16 
n = 3, 3.17 
 
 
3.12 
3.18 
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In most of the literature examples of hydroxamate based chelating resins, the solid 
supports are randomly functionalized with hydroxamate groups. We proposed the 
immobilization of rationally designed hydroxamate chelators containing a proper spacer 
for the formation of a stable octahedral complex with metal ions. Thus for optimal 
binding of trivalent metal ions, we proposed the immobilization of hydroxamate ligands 
such as 222-THA 2.27, 223-THA 2.28, and tetrahydroxamate-B 2.50 (Chapter 2).  
High affinity natural siderophores such as DFO would be a perfect ligand for such 
immobilization. DFO has a free amine which can be easily linked to various solid 
supports. There are previous examples of immobilization of DFO on solid support. 
Anthone and coworkers
6
 prepared a chelating device for the extracorporeal removal of 
aluminum from blood. The device is made up of high-flux polysulfone F-60 hollow fiber 
immobilized with DFO. DFO is prohibitively expensive for the preparation of large scale 
chelating resin, which prevents its use for the current application. Other commercially 
available chelating resins such as chelex are not strong enough to remove aluminum from 
calcium gluconate solutions, as indicated by a work performed by Prof. Wesley R. 
Harris.
7
 Thus, there is a need for a chelating resin that can be produced cost effectively 
and is also strong enough to significantly reduce aluminum contamination from 
commercial calcium gluconate solutions.  
The intermediates in the synthesis of solution phase chelating compounds such as 
2.33 and 2.40 described in Chapter 2 include a free primary amine group that allows 
these intermediates to be covalently linked to polymeric solid supports via various 
linkages. The ester groups present in these intermediates can be modified to 
hydroxamates in a single synthetic step. The solid supports of choice in the present study 
Dawadi, Surendra, 2013, UMSL, p.99 
 
 
 
are macroporous polystyrene divinylbenzene copolymer such as XAD-4 sold by Rohm 
and Haas and aminomethyl polystyrene resin sold by Sigma-Aldrich. Other solid supports 
that can be used for the immobilization of these chelating compounds are polymers such 
as polyacrylate, sepharose, and silica gel. 
 
3.3 Immobilization of 222-THA via sulfonamide linker and aluminum removal 
studies  
3.3.1 Synthesis 
Immobilization of trihydroxamate ligand 222-THA via a sulfonamide linkage on 
polystyrene resin was reported previously (Scheme 3.4).
8
 Synthesis of free amine 
trimethyl ester 2.33 is described in Chapter 2. The free amine 2.33 was treated with the 
sulfonyl chloride functionalized resin 3.18 in the presence of triethylamine to obtain the 
sulfonamide trimethyl ester functionalized resin 3.19. Resin 3.18 was prepared from 
commercially available macroporous polystyrene resin XAD-4 (from Rohm and Haas) in 
a single step by treating with chlorosulfonic acid. The ester functional groups in resin 
3.19 were converted to hydroxamic acid by treating with trimethylsilyl hydroxylamine 
and KOH in MeOH followed by aqueous acetic acid treatment to obtain the required 
resin 3.20. Complete conversion of ester to hydroxamic acid was confirmed by the 
disappearance of the ester peak at 1732 cm
-1
 and appearance of a hydroxamic acid peak 
at 1644 cm
-1
 in the IR spectrum. The loading of ligand on the resin surface was 0.3 mmol 
ligand per gram of resin as determined by S and N combustion analysis of the resin. 
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Scheme 3.4 Synthesis of solid supported 222-THA with sulfonamide linker  
 
3.3.2 Removal of aluminum from commercial calcium gluconate solution by resin 
3.20 
To determine the ability of resin 3.20 to remove aluminum from commercial 
calcium gluconate solutions, the following experiment was performed.
9
 Resin 3.20 (500 
mg, 0.15 mmol ligand) was added to 20 ml calcium gluconate solution (6500 ng Al per 
ml solution, pH 6.2, Abraxis Pharmaceutical Products, calcium gluconate Injection USP 
10% lot: 406253, exp 09/10), and the mixture was stirred with a magnetic overhead 
stirrer. Periodically, a 200 µl aliquot was removed from the mixture and 5 µl 
concentrated nitric acid was added to the aliquot to stabilize the aluminum ion in 
solution. Aluminum concentrations in each aliquot were determined by Inductively 
Coupled Plasma-Mass Spectrometry (ICP-MS). A blank sample was prepared by mixing 
200 µl 18 Mohm water and 5 µl concentrated nitric acid.  A plot of the fraction of the 
original aluminum concentration remaining in the extracted solution as a function of 
extraction time is shown in Figure 3.3. The pH of the extraction mixture at the end of 47 
hours of extraction was measured to be 4.5.  
2.33 3.19 
3.20 
3.18 
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Figure 3.3 Extraction of Al from Ca(glu)2 by resin 3.20  
 
The results shown in Figure 3.3 clearly indicated that resin 3.20 did not remove 
aluminum from calcium gluconate solution at all. The inability of resin 3.20 to remove 
aluminum could have been caused by the drastic decrease in the pH of calcium gluconate 
solution after the addition of resin. It could also be due to the nature of sulfonamide 
linker which might have interfered with the binding process. However, the resin 3.20 
easily removed Al
3+
 from buffered aqueous solutions.
1
 Thus, the need of utilizing various 
linker types and other modified hydroxamate ligand groups for the optimization of 
aluminum binding was realized.  
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3.4 Immobilization of 222-THA via urea linker and aluminum removal studies 
3.4.1 Synthesis 
Synthesis of urea linked 222-THA resin 3.25a and 3.25b started with the free 
amine trimethyl ester 2.33 (Scheme 3.5).
10
 The synthesis was accomplished by two 
slightly different methods. In method 1, the amine group of compound 2.33 was 
converted to isocyanate 3.21 by treating with triphosgene under Schotten and Baumann 
conditions. Commercially available macroporous aminomethyl polystyrene resin 3.20 
(from Sigma-Aldrich) was treated with the isocyanate 3.21 in the presence of 
diisopropylethylamine (DIPEA) for 15 h to obtain the urea triester resin 3.24a. In method 
2, the aminomethyl resin 3.22 was first converted to isocyanate resin 3.23 by treating 
with triphosgene. The isocyannate resin 3.23 was then treated with amine 2.33 to obtain 
the urea triester resin 3.24b. The only difference between resins 2.24a and 2.24b is the 
amount of loading of the triester group on the resin surface. Combustion analysis of 
resins 2.24a and 2.24b gave loading values of 1.23 meq/g and 1.22 meq/g respectively 
based on N analysis. The ester functional groups of resins 3.24a and 3.24b were 
converted to hydroxamic acids by treating with trimethylsilyl hydroxylamine and KOH in 
methanol followed by aqueous acetic acid treatment separately to obtain resins 3.25a and 
3.25b. Complete conversion of ester to hydroxamic acid was confirmed by disappearance 
of the ester peak at around 1735 cm
-1
 and appearance of a hydroxamic acid peak at 
around 1640 cm
-1
 in the IR spectrum. The loading of ligand on resins 3.25a and 3.25b 
were calculated by N combustion analysis of the resins to be 1.04 and 0.54 meq/g 
respectively. 
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Scheme 3.5 Synthesis of solid supported 222-THA with urea linker  
 
3.4.2 Removal of aluminum from commercial calcium gluconate solution by resin 
3.25a 
Resin 3.25a (237 mg, 1.04 meq/g, 0.25 mmol ligand) was added to 10 ml calcium 
gluconate solution (6500 ng Al per ml solution, pH 6.1, Abraxis Pharmaceutical 
Products, calcium gluconate Injection USP 10% lot: 406253, exp 09/10), and the mixture 
was stirred with a magnetic overhead stirrer.
9
 Periodically, a 100 µl aliquot was removed 
from the mixture and 5 µl concentrated nitric acid was added. Aluminum concentrations 
in each aliquot were determined by ICP-MS. A blank sample was prepared by mixing 
100 µl 18 Mohm water and 5 µl concentrated nitric acid.  A plot of fraction of original 
aluminum concentration remaining in the extracted solution as a function of extraction 
3.21 
2.33 3.23 
3.22 
3.24a, 3.24b 
3.25a, 3.25b 
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time is shown in Figure 3.2. After 47 hours, the final pH of the extracted solution was 
measured to be 5.0.  
 
Figure 3.4 Extraction of Al from Ca(glu)2 by resins 3.25a and 3.20  
 
The results provided in Figure 3.4 indicated that resin 3.25a removed about 60% 
of the aluminum present in the calcium gluconate solution over a period of 24 hours. This 
proves that the urea linked resin 3.25a is much better than the sulfonamide linked resin 
3.20 in removing aluminum from calcium gluconate solutions. At this stage, we started 
considering the immobilization of the slightly better solution phase ligand 223-THA and 
the much better ligand tetrahydroxamate-B through urea linkages, with the anticipation of 
improved binding of aluminum. 
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3.5 Immobilization of 223-THA via urea linker and aluminum removal studies 
3.5.1 Synthesis 
Synthesis of urea linked 223-THA resin 3.28 started with the free amine trimethyl 
ester 2.40 (Chapter 2). The free amine group of compound 2.40 was converted to the 
isocyanate 3.26 (Scheme 3.6) by treating with triphosgene under Schotten and Baumann 
conditions. Commercially available macroporous aminomethyl polystyrene resin 3.22 
(from Sigma-Aldrich) was treated with isocyanate 3.26 in the presence of 
diisopropylethylamine (DIPEA) for 15 h to obtain the urea triester resin 3.27. The ester 
functional groups of resin 3.27 were converted to hydroxamic acids by treating with 
trimethylsilyl hydroxylamine and KOH in methanol followed by aqueous acetic acid 
treatment to obtain resin 3.28. Complete conversion of ester to hydroxamic acid was 
confirmed by the disappearance of ester peak at 1736 cm
-1
 and appearance of a 
hydroxamic acid peak at 1641 cm
-1
 in the IR spectrum. The maximum possible loading of 
ligand on resin 3.28 was determined again by N combustion analysis of the resin to be 
0.66 meq/g. 
 
 
 
Scheme 3.6 Synthesis of solid supported 223-THA with urea linker 
3.28 3.27 
3.26 2.40 
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3.5.2 Removal of aluminum from commercial calcium gluconate solution by resin 
3.28
9
 
Resin 3.28 (242 mg, 0.66 meq/g, 0.16 mmol ligand) was added to 10 ml calcium 
gluconate solution (6136 ng Al per ml solution, pH 6.2, Abraxis Pharmaceutical 
Products, calcium gluconate Injection USP 10% lot: 6001317, exp 12/12) and the mixture 
was stirred with a magnetic overhead stirrer. Periodically, a 100 µl aliquot was removed 
from the mixture and 5 µl concentrated nitric acid was added. Aluminum concentrations 
in each aliquot were determined by ICP-MS. A blank sample was prepared by mixing 
100 µl 18 Mohm water and 5 µl concentrated nitric acid.  A plot of fraction of original 
aluminum concentration remaining in the extracted solution as a function of extraction 
time is shown in Figure 3.3. The final pH of the extraction mixture at the end of 28 hours 
of extraction was measured to be 5.3.  
 
Figure 3.5 Extraction of Al from Ca(glu)2 by resins 3.28, 3.25a and 3.20  
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The aluminum extraction studies shown in Figure 3.5 suggested that resins 3.25a 
and 3.28 were equally effective in removing aluminum from calcium gluconate solutions. 
These results are reasonable because the aluminum binding affinities of solution phase 
trihydroxamate ligands 222-THA and 223-THA were about the same. As a reminder, the 
slightly different 222-THA and 223-THA ligands are the functional groups of resins 
3.25a and 3.28 respectively. 
 
3.6 Immobilization of tetrahydroxamate-B ligand via urea linker 
3.6.1 Synthesis 
Tetrahydroxamate-B resin was prepared by immobilizing the appropriate 
isocyanate derivative on an aminomethyl polystyrene resin. This was accomplished via 
two different methods. The first method (Schemes 3.7, 3.8, and 3.10) involved the 
immobilization of di-ester on a polystyrene resin at the initial stage of the synthesis, 
followed by a large number of chemical transformations while on the solid support. The 
second route (Scheme 3.11) involved the preparation of fully protected tetrahydroxamate-
B, selective deprotection of the amine, and immobilization on the resin at the final stage 
of the synthesis. Both methods are examples of convergent synthesis because two 
coupling partners are prepared separately. 
Method 1: 
Amine 2.59 (Chapter 2) was treated with triphosgene in the presence of the 
aqueous base to produce the isocyanate 3.29 (Scheme 3.7). This reaction was quite 
vigorous with the evolution of gas. Isocyanate 3.29 was reacted with aminomethyl 
polystyrene resin beads in the presence of a base to produce the immobilized di-ester 
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3.30, the immobilization occurring via the formation of a urea linkage. The loading of 
diester group on resin 3.30 was calculated by N combustion analysis of the resin to be 
1.30 meq/g. The ester groups of resin 3.30 were converted to acid groups by alkaline 
hydrolysis, followed by protonation with a mineral acid to obtain resin immobilized 
dicarboxylic acid 3.31. Complete conversion of the ester to carboxylic acid was 
confirmed by the disappearance of the ester peak at 1736 cm
-1
 and appearance of a 
carboxylic acid peak at 1713 cm
-1
 in the IR spectrum. 
 
 
 
Scheme 3.7 Synthesis of solid supported dicarboxylic acid with urea linker 
 
The aldehyde 2.67 (Chapter 2) was reacted with hydroxylamine hydrochloride 
and pyridine in refluxing ethanol to produce the oxime 3.32 in 95% yields (Scheme 3.8). 
Sodium cyanoborohydride reduction of oxime 3.32 afforded unprotected hydroxylamine 
3.33 in 60-80% yield. This reduction should be carried out at pH lower than 3 to prevent 
the formation of the byproduct dialkylhydroxylamine 3.34. A mechanism for the 
3.29 
2.59 
3.31 3.30 
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formation of this byproduct is given in Scheme 3.9.
11
 In the absence of sufficient proton 
concentration, hydroxylamine 3.33 has the oppertunity to react with oxime 3.32 to give 
the addition product 3.35, which loses a molecule of hydroxylamine to form the 
positively charged species 3.36. Addition of a hydride to highly electrophilic iminium 
carbon of 3.36 leads to the formation of dialkylated hydroxylamine 3.34. Formation of 
this byproduct can be avoided if the pH is lowered quickly and sufficiently to cause rapid 
reduction of oxime to hydroxylamine. The formation of this byproduct was a more 
serious issue while scaling up this reaction. The ratio of product 3.33 to byproduct 3.34 
was found to be in the range of 4.4:1 to 1.5:1 solely depending upon the pH of the 
reaction mixture. 
 
 
 
Scheme 3.8 Synthesis hydroxylamine 
 
3.32 2.67 
3.34, 40-18 % 
3.33, 60-80% 
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Scheme 3.9 Mechanism for the formation of byproduct dialkylhydroxylamine 
 
Immobilized di-carboxylic acid 3.31 was then coupled with hydroxylamine 3.33 
using the coupling agent EDC to afford the product 3.37. EDC was preferentially used 
over DCC as a coupling agent because the byproduct of the reaction, EDC urea, was 
more soluble in common solvents than DCC urea. The ester groups of 3.37 were then 
converted to the hydroxamic acids by treating with O-trimethylsilyl hydroxylamine to 
afford the final product 3.38a. The maximum possible loading of ligand on resin 3.38a 
was calculated again by N combustion analysis of the resin to be 0.54 meq/g. 
 
 
3.32 
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Scheme 3.10 Coupling of resin immobilized dicarboxylic acid and hydroxylamine, 
and final synthesis of tetrahydroxamate immobilized chelating resin 3.38a (method 
1) 
 
Method 2: 
-Cbz and -THP were used as a set of orthogonal protecting groups for the amine 
and the hydoxamic acids, respectively. The -Cbz group can be selectively deprotected by 
hydrogenolysis in the presence of acid labile -THP group. The -THP protected 
hydroxamates can be easily deprotected at the last step of synthesis. 
 
3.31 
3.33 
3.37 
3.38a 
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Scheme 3.11 synthesis of tetrahydroxamate immobilized chelating resin 3.38b 
(method 2) 
2.67 
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2.64 
3.42 
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The -THP protected oxime 3.39 was prepared from aldehyde 2.67 by reacting 
with O-THP hydroxylamine hydrochloride and pyridine in refluxing ethanol in 84% yield 
(Scheme 3.11).
12
 Sodium cyanoborohydride reduction of oxime afforded O-THP 
protected hydroxylamine 3.40 in 78% yield, which was coupled with di-carboxylic acid 
2.64 to afford the compound 3.41 in 76% yield. The -Cbz group was selectively 
deprotected by hydrogenolysis with H2 over Pd/C to afford the free amine which was 
treated with triphosgene to form the isocyanate 3.42 in 78% yield over two steps. 
Isocyanate 3.42 was then treated with aminomethyl polystyrene resin to form the urea 
linked compound 3.43. The ester groups of compound 3.43 were converted to 
hydroxamic acids by reacting with O-trimethylsilyl hydroxylamine. Finally, -THP 
deprotection was carried out by treating the resin with TsOH.H2O to obtain the chelating 
resin 3.38b. The maximum possible loading of ligand on resin 3.38b was determined 
again by N combustion analysis of the resin to be 0.44 meq/g. 
 
3.6.2 Removal of aluminum from commercial calcium gluconate solution by resins 
3.38a and 3.38b  
To determine the ability of tetrahydroxamate functionalized resins 3.38a and 
3.38b to remove aluminum from commercial calcium gluconate solution, the following 
experiments were performed:
9
 
Resin 3.38a (213 mg, 0.54 meq/g, 0.11 mmol ligand) was added to 10 ml calcium 
gluconate solution (6770 ng Al per ml solution, pH 6.1, Abraxis Pharmaceutical 
Products, calcium gluconate Injection USP 10% lot: 406253, exp 09/10), and the mixture 
was stirred with a magnetic overhead stirrer. Periodically, a 100 µl aliquot was removed 
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from the mixture and 5 µl concentrated nitric acid was added. The aluminum 
concentration in each aliquot was determined by ICP-MS. A blank sample was prepared 
by mixing 100 µl 18 Mohm water and 5 µl concentrated nitric acid.  A plot of the fraction 
of original aluminum concentration remaining in the extracted solution as a function of 
extraction time is shown in Figure 3.6. The final pH of the extracted solution at the end of 
24 hours of extraction was measured to be 5.2.  
Similarly, resin 3.38b (410 mg, 0.44 meq/g, 0.18 mmol ligand) was added to 10 
ml calcium gluconate solution (4834 ng Al per ml solution, pH 6.1, Abraxis 
Pharmaceutical Products, calcium gluconate Injection USP 10% lot: 6001317, exp 
12/12), and the mixture was stirred with a magnetic overhead stirrer. Periodically, a 100 
µL aliquot was removed from the mixture and 5 µL concentrated nitric acid was added. 
The aluminum concentration in each aliquot was determined by ICP-MS. A blank sample 
was prepared by mixing 100 µl 18 Mohm water and 5 µl concentrated nitric acid.  A plot 
of the fraction of original aluminum concentration remaining in the extracted solution as 
a function of extraction time is shown in Figure 3.6. The final pH of the extracted 
solution at the end of 24 hours of extraction was measured to be 5.4. 
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Figure 3.6 Extraction of Al from Ca(glu)2 by resins 3.38a, 3.38b, 3.28, 3.25a and 3.20  
 
The result from above experiments (shown in Figure 3.6) indicated that the 
tetrahydroxamate functionalized resin 3.38b (prepared by method 2) was much better 
than resin 3.38a (prepared by method 1) in removing aluminum from calcium gluconate 
solution. Method 1 involved a large number of synthetic steps on solid support, and it 
was very difficult to monitor the reactions on the solid support. Therefore, the synthesis 
of resin 3.38a might not have proceeded as expected.  
It was also evident that three resins 3.25a, 3.28, and 3.38a, all containing urea as a 
linker group and each containing a different hydroxamate functional group, are almost 
equally effective for aluminum removal from calcium gluconate solution. All three resins 
removed about 60% aluminum from commercial calcium gluconate solution in a period 
of about 24 hours. At this stage, it was clear to us that the nature of linker is very 
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important for the efficiency of resins to bind metal ions. The nature of the linker seems to 
be much more important in metal binding kinetics than the ligand structure of the 
chelating resins.  
 
3.7 Effect of nature of linker on kinetics of binding 
Results from above experiments suggest that the linker plays a significant and 
dominating effect on the kinetics of binding metal ions by the chelating resins. To further 
evaluate the effectiveness of chelating resins to remove aluminum from calcium 
gluconate solutions, chelating resins were prepared that contain various types of linker 
groups between the solid support and the ligand.
13
 In some cases, the linker was 
elongated by adding polyethylene glycol units. Among these resins, the one with a 
secondary amine linker gave the best aluminum binding results and will be described in 
detail below. 
Immobilization of 222-THA on polystyrene resin via a secondary amine linker is 
presented in Scheme 3.12.
10
 The free amine 2.33 was treated with commercially available 
chloromethylated polystyrene resin 3.44 (Merrifield resin) in the presence of sodium 
iodide in N-methyl-2-pyrrolidone (NMP) to obtain the secondary amine trimethyl ester 
functionalized resin 3.45. The ester functional groups of resin 3.19 were converted to 
hydroxamic acids by treating with trimethylsilyl hydroxylamine and KOH in MeOH, 
followed by aqueous acetic acid treatment to obtain resin 3.46. Complete conversion of 
the ester to the hydroxamic acid group was confirmed by disappearance of the ester peak 
at 1739 cm
-1
 and appearance of a hydroxamic acid peak at 1652 cm
-1
 in the IR spectrum. 
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The loading of ligand on the resin surface was calculated by N combustion analysis of the 
resin to be 0.46 mmol ligand per gram of resin. 
 
 
 Scheme 3.12 Synthesis of solid supported 222-THA with a secondary amine linker  
 
To determine the ability of resin 3.46 to remove aluminum from commercial 
calcium gluconate solution, the following experiment was performed.
9
 Resin 3.46 (256 
mg, 0.46 meq/g, 0.12 mmol ligand) was washed in 100 ml milliQ water for 1 h by argon 
bubbling agitation, filtered, dried and added to a 10 ml calcium gluconate solution (5970 
ng Al per ml solution, pH 6.2, Abraxis Pharmaceutical Products, calcium gluconate 
Injection USP 10% lot: 6002512, exp 08/13), and the mixture was stirred with a magnetic 
overhead stirrer. Periodically, a 75 µl aliquot was removed from the mixture and 5 µl 
concentrated nitric acid was added. The aluminum concentration in each aliquot was 
determined by ICP-MS. A blank sample was prepared by mixing 75 µl 18 Mohm water 
and 5 µl concentrated nitric acid.  A plot of the fraction of original aluminum 
concentration remaining in the extracted solution as a function of extraction time is 
shown in Figure 3.7. An expanded graph for resin 3.46 is shown in Figure 3.8. The final 
pH of the extracted solution at the end of 4 hours of extraction was measured to be 6.0. 
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Figure 3.7 Extraction of Al from Ca(glu)2 by resins 3.46, 3.38a, 3.38b, 3.28, 3.25a 
and 3.20  
 
Figure 3.8 Expanded plot of extraction of Al from Ca(glu)2 by resin 3.46  
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The result provided in Figures 3.7 and 3.8 showed that resin 3.46 containing a 
secondary amine linker and the 222-THA ligand is the best chelating resin made in our 
group so far. It removed about 90% of the aluminum from the commercial calcium 
gluconate solution in about 1 hour. This resin removed 50% aluminum in about 2.5 
minutes, which demonstrates its superior kinetic efficiency. 
 
3.8 Summary 
A number of hydroxamate functionalized chelating resins were prepared. Various 
linker groups, which covalently attach ligands to the polymeric solid support, were 
analyzed. The resin 3.46 (222-THA ligand attached via a secondary amine linker to 
macroporous polystyrene resin) was found out to be the most efficient resin for the 
removal of aluminum from calcium gluconate solutions. The resin 3.46 was the best 
choice for the development of a resin packed cartridge for the in-line depletion of 
aluminum from commercial calcium gluconate solution. A significant reduction in the pH 
of calcium gluconate solution after the addition of resins was a serious issue which needs 
to be fixed before any commercialization of these aluminum binding resins. Multiple 
aqueous washes of the resin, prior to its use, seemed to address the problem as seen in the 
case of resin 3.46. 
The design and synthesis of the chelating resins were inspired by the analogy to 
the complexation behavior of solution phase model ligands described in Chapter 2. 
However, the analogy was not always perfect in the solid phase. The complexation 
behavior of ligands covalently bound to the solid support was often very different from 
those of solution phase ligands. The binding kinetics of chelating resins not only depends 
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upon the nature of the ligand, but also on the nature of linker and the solid support itself. 
The nature of linker was found to dictate the kinetics of binding. Changing the linker 
seemed to have a much more important effect on binding than changing the hydroxamate 
ligand. 
 
3.9 Experimental section 
Dimethyl-3,3'-((2-isocyanato-2-(2-(3-methoxy-3-oxopropoxy)ethyl)propane-1,3-
diyl)bis(oxy))dipropanoate (3.26). To a vigorously stirred solution of amine triester 2.40 
(12.0 g, 30.5 mmol) in CH2Cl2 (100 mL) and saturated NaHCO3 (100 mL) was added 
triphosgene (3.08 g, 36.0 mmol) in small portions. Once the addition was complete, the 
mixture was stirred for an additional 15 min., then the layers were separated and the 
aqueous layer was extracted with CH2Cl2 (2×100 mL). The combined organic extracts 
were dried over Na2SO4, evaporated under reduced pressure, and the residue was purified 
by column chromatography (SiO2, hexanes/EtOAc gradient) to give the isocyanate 3.26 
as a colorless oil (5.14 g, 41%): IR (neat) 2957, 2874, 2244, 1733 cm
-1
; 
1
H NMR (300 
MHz, CDCl3)  (ppm) 3.70 (t, J = 6.3 Hz, 4H), 3.64 (s, 9H), 3.63 (t, J = 6.3 Hz, 2H), 3.50 
(t, J = 6.3 Hz, 2H), 3.39 (s, 4H), 2.54 (t, J = 6.2 Hz, 4H), 2.52 (t, J = 6.2 Hz, 2H), 1.72 (t, 
J = 6.4 Hz, 2H); 
13
C NMR (300 MHz, CDCl3)  (ppm) 172.1, 171.9, 126.6, 73.4, 66.8, 
66.7, 66.2, 62.7, 51.8, 51.7, 34.9, 34.8, 33.8; HRMS (FAB) ) calcd for C18H30NO10 [M + 
H]
+
: 420.1870. Found 420.1885. 
 
Resin 3.27. To a suspension of aminomethyl polystyrene resin (Aldrich 564095, 
macroporous 30-60 mesh) (1.84 g, 2.2 meq/g, 4.05 mmol of –NH2), in CH2Cl2 (15 mL) 
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was added diisopropylethyl amine (2.12 ml, 12.2 mmol) followed by the isocyanate 3.26 
(5.10 g, 12.2 mmol).  The suspension was shaken using orbital shaker overnight at room 
temperature.  The resin was filtered and washed 3 times each with CH2Cl2, MeOH, H2O, 
saturated  NaHCO3, H2O, MeOH and Et2O. It was dried under reduced pressure to obtain 
a pale yellow resin (2.86 g): IR (ATR) 3393, 3026, 2912, 2869, 1736 (C=O), 1673 cm
-1
; 
Elemental Analysis C 75.50%, H 7.59%, N 3.35%, loading = 1.19 meq/g (based on %N); 
%C indicates 76% conversion of available NH2 groups of the resin. 
 
Resin 3.28. A suspension of the urea triester resin 3.27 (2.68 g, 1.14 meq/g maximum 
loading, 3.06 mmol) in MeOH (20 mL) was shaken for 15 minutes. A solution of KOH 
(1.54 g, 27.59 mmol) in MeOH (5 mL) was added followed by NH2OTMS (3.37 mL, 
27.6 mmol) and the mixture was shaken for 20 h using an orbital shaker. The resin was 
filtered and washed 3 times with MeOH, H2O.  The resin was then suspended in 10% 
aqueous AcOH (20 mL) and for shaken for 30 minutes. The resin was filtered and 
washed 3 times with 10 % aqueous AcOH, H2O, MeOH and Et2O and dried under 
reduced pressure to give a light yellow colored resin (2.7 g):  IR (ATR) 3221, 3025, 
2920, 1641 (C=O hydroxamate, sharp), 1551 cm
-1
; Elemental Analysis C 71.48%, H 
7.36%, N 4.65%, loading = 0.66 meq/g (based on %N). 
 
dimethyl 3,3'-((2-isocyanato-2-methylpropane-1,3-diyl)bis(oxy))dipropanoate (3.29).  
To a solution of amine 2.59 (30 g, 108.18 mmol) in CH2Cl2 (430 ml) was added saturated 
NaHCO3 (430 ml) and the mixture was stirred. Triphosgene (10.69 g, 36.02 mmol) was 
added in small portions. A lot of gas was produced during the reaction which stopped 20 
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min after the complete addition of triphosgene. Layers were separated and the aqueous 
layer was washed with CH2Cl2 (2 × 100 ml). The combined organics were dried over 
Na2SO4 and evaporated  to obtain the crude product which was purified by silica gel 
column chromatography (hexanes/ethyl acetate gradient) to give the product as a 
colorless oil (17.2 g, 53%): IR (neat) 2954, 2875, 2240 (sharp), 1735 (sharp), 1437, 1111 
cm
-1
; 
1
H NMR (300 MHz, CDCl3)  (ppm) 3.70 (t, J = 6.3 Hz, 4H), 3.63 (s, 6H), 3.33 (s, 
4H), 2.53 (t, J = 6.3 Hz, 4H), 1.14 (s, 3H); 
13
C NMR (300 MHz, CDCl3)  (ppm) 171.7, 
126.5, 74.7, 66.8, 60.6, 51.1, 34.7, 21.9; HRMS (FAB) C13H22NO7 [M+H]
+
 calc’d 
304.1396, found 304.1391. 
 
Resin 3.30. To a suspension of aminomethyl polystyrene resin (5.0 g, 2.2 meq/g, 11.0 
mmol of –NH2, Aldrich 564095, macroporous 30-60 mesh) in CH2Cl2 (20 ml) and 
diisopropylethyl amine (5.8 ml, 33.29 mmol) was added isocyanate 3.29 (10.08 g, 33.23 
mmol) and allowed to shake in an orbital shaker overnight at rt. The resin was filtered 
and washed 3 times each with CH2Cl2, MeOH, H2O, saturated NaHCO3, H2O, MeOH and 
Et2O. It was then dried under reduced pressure to obtain light colored resin (7.6 g): IR 
(ATR) 3379 (br), 3025, 2921, 2862, 1736 (C=O), 1681, 1540, 1451, 1196, 1108, 699 cm
-
1
; Elemental Analysis C 77.85%, H 7.88%, N 3.65%, Loading value = 1.30 meq/g (based 
on %N); %C indicates 75% conversion of available NH2 groups of the resin. 
 
Resin 3.31.  To a suspension of resin 3.30 (7.4 g, 0.98 meq/g) in 1:1 mixture of THF (22 
ml) and H2O (22 ml) was added LiOH (1.56 g, 65.1 mmol) in one portion and the mixture 
was shaken for 20 h at rt. The resin was isolated by filtration and washed 3 times each 
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with THF, H2O, MeOH and Et2O and dried under reduced pressure to give the 
carboxylate salt which was re-suspended in 1 N HCl (10 ml) and shaken for 30 minutes. 
The resin was filtered and washed again with H2O, MeOH and Et2O and dried under 
reduced pressure to obtain the product (7.1 g): IR (ATR) 3337, 3024, 2919, 2883, 1713 
(C=O), 1635, 1556, 1452, 1109, 698 cm
-1
. 
 
methyl 9-(hydroxyimino)nonanoate (3.32).  To a solution of aldehyde 2.67 (12.0 g, 
64.43 mmol) and hydroxylamine hydrochloride (6.3 g, 90.66 mmol) in EtOH (270 ml) 
was added pyridine (13.6 ml, 168.15 mmol) drop wise and refluxed at 79 
0
C for 3 h. The 
solvent was evaporated and the remaining residue was dissolved in CH2Cl2 (300 ml) and 
washed with water (300 ml). The aqueous layer was extracted with more CH2Cl2 (2× 100 
ml). Combined organics was dried over Na2SO4 and evaporated to obtain a solid crude 
product which was purified by SiO2 chromatography (hexanes/EtOAc gradient) to give a 
white solid (12.1 g, 95%) as the mixture of both geometric isomers of the product: IR 
(neat) 3205, 3094, 2927, 2854, 1732, 1436, 1172 cm
-1
; 
1
H NMR (300 MHz, CDCl3)  
(ppm) 8.43 (br s, 1.72H), 7.41 (t, J = 6.2 Hz, 1H), 6.72 (t, J = 5.4 Hz, 0.77H), 3.66 (s, 
5.55H), 2.37 (td, J = 7.5, 7.3 Hz, 1.72H), 2.29 (app t, J = 7.3 Hz, 3.70 H), 2.18 (app q, J = 
6.9 Hz, 2.05H), 1.61 (quintet, J = 6.5 Hz, 3.84H), 1.48 (quintet, J = 6.1 Hz, 3.79H), 1.31 
(br s, 11.42H); 
13
C NMR (300 MHz, CDCl3)  (ppm) 174.4, 152.8, 152.2,  51.5, 34.0, 
29.4, 29.1, 28.9 (× 2), 28.8, 26.4, 25.9; HRMS (FAB) C10H20NO3 [M+H]
+
 calc’d 
202.14430, found 202.14460.  
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methyl 9-(hydroxyamino)nonanoate (3.33).  To a solution of oxime 3.32 (0.67 g, 3.33 
mmol) and NaCNBH3 (0.23 g, 3.66 mmol) in MeOH (27 ml) was added 2N HCl in 
MeOH drop wise at room temperature until the pH (checked by universal indicator) was 
adjusted to 3. The pH should be reduced to 3 quickly to prevent the formation of the 
dialkylhydroxylamine byproduct. The mixture was stirred for 3 h at rt. Solvent was 
evaporated to obtain solid white residue which was dissolved in water (50 ml). A 6 N 
KOH solution was added drop wise to increase the pH to >9. This aqueous layer was 
extracted with CH2Cl2 (3 × 50 ml). The organic layers were combined and washed with 
brine and dried over Na2SO4 and evaporated under reduced pressure. The crude product 
was purified by column chromatography (SiO2, hexanes/ethyl acetate gradient) to give a 
white solid product (0.55 g, 80%): IR (neat) 3282, 3142, 2927, 2916, 2850, 1742, 1170 
cm
-1
; 
1
H NMR (300 MHz, CDCl3)  (ppm) 6.47 (br s, 2H), 3.56 (s, 3H), 2.81 (t, J = 7.1 
Hz, 2H), 2.20 (t, J = 7.4 Hz, 2H),  1.53-1.42 (m, 4H), 1.21 (br s, 8H); 
13
C NMR (300 
MHz, CDCl3)  (ppm) 174.2, 53.7, 51.4, 34.0, 29.2, 29.1, 29.0, 27.0, 26.8, 24.8; HRMS 
(FAB) C10H22NO3 [M+H]
+
 calc’d 204.1600, found 204.1602. 
 
dimethyl 9,9'-(hydroxyazanediyl)dinonanoate (3.34).  A white solid dialkylated 
hydroxylamine byproduct 3.34 (0.11 g, 18%) was also isolated from above experiment. 
IR (neat) 3183, 2930, 2912, 2848, 1733 cm
-1
; 
1
H NMR (300 MHz, CDCl3)  (ppm) 3.67 
(s, 6H), 2.70 (app t, J = 7.5 Hz, 4H), 2.30 (t, J = 7.7 Hz, 4H),  1.63-1.59 (m, 8H), 1.31 (br 
s, 16H); 
13
C NMR (300 MHz, CDCl3)  (ppm) 174.5, 60.6, 51.6, 34.2, 29.5, 29.3, 29.2, 
27.3, 26.8, 25.1; HRMS (FAB) C20H40NO5 [M+H]
+
 calc’d 374.2906, found 374.2900. 
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Resin 3.37. To a suspension of dicarboxylic acid resin 3.31 (7.1 g, 0.98 meq/g, if all 
esters have hydrolysed) in CH2Cl2 (150 ml) was added hydroxylamine 3.33 (7.4 g, 36.4 
mmol) and EDC (7.08 g, 36.9 mmol) and the mixture was shaken for 40 h in an orbital 
shaker at rt. The resin was isolated by filtration and washed 3 times each with CH2Cl2, 
MeOH, H2O, MeOH and Et2O and dried to obtain the product as light colored resin (8.1 
g): IR (ATR) 3347 (br), 3300-2500 (br), 3023, 2922, 2870, 1713 (C=O ester), 1642 (C=O 
hydroxamate), 1553, 1451, 1105, 699 cm
-1
; Elemental Analysis C 76.55%, H 7.82%, N 
4.81%; Loading value = 0.86 meq/g (based on %N). 
 
Resin 3.38a. To a suspension of resin 3.37 (8.0 g, 0.70 meq/g) in MeOH (90 ml) was 
added KOH (2.15 g, 38.4 mmol) and NH2OTMS (4.7 ml, 38.4 mmol) and the mixture 
was shaken for 20 h in an orbital shaker at rt. The resin was isolated by filtration and 
washed 3 times each with MeOH, H2O, 10% aqueous CH3CO2H, H2O, MeOH and Et2O 
and dried under reduced pressure to obtain the product as light yellow colored resin (7.6 
g): IR (ATR) 3350 (br), 3300-2500 (br), 3028, 2915, 2867, 1717 (some carboxylic acid), 
1637 (C=O hydroxamate), 1549, 1451, 1106, 699 cm
-1
; Elemental Analysis C 75.06%, H 
7.75%, N 4.55%; loading value = 0.54 meq/g (maximum loading based on %N). 
 
methyl 9-(((tetrahydro-2H-pyran-2-yl)oxy)imino)nonanoate (3.39).  To a solution of 
aldehyde 2.67  (2.89 g, 15.5 mmol) and O-(tetrahydro-2H- pyran-2-yl)hydroxylamine 
(2.0 g, 17.1 mmol) in EtOH (62 mL) at room temperature was added pyridine (1.88 mL, 
23.3 mmol) drop wise. The resulting solution was heated at reflux for 4 h. The solvent 
was evaporated under reduced pressure and the residue was dissolved in CH2Cl2 (100 
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mL) and washed with water (2×100 mL). The aqueous layer was re-extracted with 
CH2Cl2 (2×100 mL). The combined organic layers were dried over Na2SO4 and 
evaporated at reduced pressure. The crude product was purified by column 
chromatography (SiO2 hexanes) to give the oxime 3.39 as a colorless liquid (3.70 g, 84%) 
and as a mixture of geometric isomers: IR (neat) 2933, 2856, 1736 cm
-1
; 
1
H NMR 
(CDCl3)  (ppm) 7.42 (t, J = 6.3 Hz, 0.4H), 6.71 (t, J = 5.5 Hz, 0.6H), 5.19 (m, 1.2H), 
5.15 (m, 0.8H), 3.89-3.84 (m, 1H), 3.62 (s, 3H), 3.59-3.53 (m, 1H), 2.35 (m, 1.5H), 2.26 
(m, 2H), 2.18 (m, 0.5H), 1.90-1.40 (m, 10H), 1.29-1.26 (m, 6H); 
13
C NMR (CDCl3)  
(ppm) 174.2, 153.5, 152.9, 100.6, 100.5, 63.2, 63.1, 51.4, 34.0, 29.5, 29.1, 29.0, 28.9 (× 
3), 26.6, 26.1, 25.8, 25.2(× 2), 24.9, 20.1, 20.0; HRMS (FAB) C15H28NO4 [M+H]
+
 calcd 
286.20184, found 286.20110. 
 
methyl 9-(((tetrahydro-2H-pyran-2-yl)oxy)amino)nonanoate (3.40).  To a solution of 
oxime 3.39 (3.60 g, 12.31 mmol) and NaCNBH3 (0.95 g, 15.1 mmol) in MeOH (100 mL) 
was added 2N HCl in MeOH drop wise until the solution pH was adjusted to 4 (pH was 
never allowed to go below 4). The mixture was stirred for 3 h at rt. The solvent was 
evaporated under reduced pressure to give solid residue which was dissolved in water 
(100 mL) and then 6 N KOH solution was added drop wise to adjust the solution pH to 
>9. The aqueous mixture was extracted with CH2Cl2 (3×100 mL). The organic layers 
were combined and washed with brine, dried over Na2SO4 and evaporated under reduced 
pressure. The crude product was purified by column chromatography (SiO2 
hexanes/EtOAc gradient) to give a colorless liquid product (2.80 g, 78%): IR (ATR, neat) 
2931, 2854, 1736 cm
-1
; 
1
H NMR (CDCl3)  (ppm) 5.53 (s, 1H), 4.73-4.71 (m, 1H), 3.89-
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3.82 (m, 1H), 3.59 (s, 3H), 3.53-3.46 (m, 1H), 2.96-2.82 (m, 2H), 2.23 (t, J = 7.4 Hz, 
2H), 1.75-1.39 (m, 10H), 1.25 (m, 8H); 
13
C NMR (CDCl3)  (ppm) 174.2, 101.4, 63.1, 
52.2, 51.4, 34.0, 29.3, 29.2, 29.1, 29.0, 27.2, 27.1, 25.3, 24.9, 20.2; HRMS (FAB) 
C15H30NO4 [M+H]
+
 calcd 288.21747, found 288.21780. 
 
dimethyl 16-(((benzyloxy)carbonyl)amino)-16-methyl-11,21-dioxo-10,22-
bis((tetrahydro-2H-pyran-2-yl)oxy)-14,18-dioxa-10,22-diazahentriacontane-1,31-
dioate (3.41).  To a stirred solution of hydroxylamine 3.40 (2.30 g, 8.00 mmol) and 
DMAP (1.33 g, 10.9 mmol) in CH2Cl2 (70 mL) and pyridine (0.88 mL, 10.9 mmol) was 
added a solution of dicarboxylic acid 2.64 (1.39 g, 3.63 mmol) in CH2Cl2 and the mixture 
was cooled to 0 
0
C. DCC (1.65 g, 8.00 mmol) was added and the mixture was stirred for 
1 h at 0 
0
C. The mixture was then allowed to warm to room temperature and was stirred 
for an additional 15 h. The solvent was concentrated under reduced pressure, filtered and 
washed with CH2Cl2. The filtrate was evaporated under reduced pressure and the residue 
was purified by column chromatography (SiO2 hexanes/EtOAc gradient) to give the 
product as a colorless oil (2.50 g, 76%): IR (neat) 3329, 2930, 2856, 1732, 1655 cm
-1
; 
1
H 
NMR (CDCl3)  (ppm) 7.33-7.24 (m, 5H), 5.51 (s, 1H), 4.99 (s, 2H), 4.87 (s, 2H), 3.92-
3.87 (m, 2H), 3.78-3.68 (m, 6H), 3.61 (s, 6H), 3.58-3.37 (m, 8H), 2.65-2.60 (m, 4H), 2.25 
(t, J = 7.5 Hz, 4H), 1.76-1.54 (m, 20H), 1.29 (s, 3H), 1.24 (br s, 16H); 
13
C NMR (CDCl3) 
 (ppm) 174.1, 172.7, 155.1, 136.7, 136.6, 128.3 (× 2), 127.8, 127.7, 104.3, 77.4, 73.2, 
73.1, 67.9, 67.0, 65.8, 63.4, 55.7, 55.6, 51.3, 50.1, 48.6, 48.1, 35.5, 33.9, 32.9, 32.5, 30.6, 
29.0 (× 2), 28.9, 28.8 (× 2), 26.6, 26.5, 26.0, 25.6, 25.1, 19.8, 19.1; HRMS (FAB) 
C48H79N3O14Na [M+Na]
+
 calcd 944.5460, found 944.5488. 
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dimethyl 16-isocyanato-16-methyl-11,21-dioxo-10,22-bis((tetrahydro-2H-pyran-2-
yl)oxy)-14,18-dioxa-10,22-diazahentriacontane-1,31-dioate (3.42).  To a solution of 
compound 3.41 (2.50 g, 2.70 mmol) in MeOH (200 mL) under argon was added 10% 
Pd/C (0.275 g). The flask was evacuated then flushed with H2 (balloons) and the resulting 
mixture was stirred under H2 at room temperature until TLC analysis (75% EtOAc in 
hexanes) indicated that the starting material was consumed. The reaction flask was then 
purged with argon and filtered. The filtrate was evaporated under reduced pressure to 
give the amine as a thick oil (2.1 g, 100%) which was used directly in the next step. To a 
stirred biphasic mixture of the amine (2.1 g, 2.7 mmol) in CH2Cl2 (30 mL) and saturated 
NaHCO3 (30 mL) was added triphosgene (0.26 g, 0.89 mmol) in small portions. 20 min 
after the addition of triphosgene, the layers were separated and the aqueous layer was 
washed with CH2Cl2 (2×30 mL). The combined organic layers were dried over Na2SO4 
and evaporated under reduced pressure to give the isocyanate 3.42 as a thick colorless oil 
product (1.7 g, 78 %) which was found to be pure enough to use in the next step without 
further purification. IR (neat) 2932, 2856, 2241, 1736, 1655 cm
-1
; 
1
H NMR (CDCl3)  
(ppm) 4.89 (br s, 2H), 3.96-3.89 (m, 2H), 3.81-3.72 (m, 6H), 3.62 (s, 6H), 3.60-3.53 (m, 
4H), 3.41-3.32 (m, 4H), 2.68- 2.61 (m, 4H), 2.26 (t, J = 7.4 Hz, 4H), 1.78-1.57 (m, 20H), 
1.26 ( br s, 16H), 1.18 (s, 3H); 
13
C NMR (CDCl3)  (ppm) 174.3, 172.7, 126.8, 104.5, 
77.4, 75.3, 75.2, 75.1, 68.2, 67.3, 63.6, 61.2, 61.1, 61.0, 55.0, 51.5, 50.2, 48.3, 35.7, 34.1, 
33.1, 32.6, 30.8, 29.5, 29.2, 29.1, 26.9, 26.8, 26.2, 25.5, 25.4, 22.5, 19.8; HRMS (FAB) 
C41H71N3O13Na [M+Na]
+
 calcd 836.48846, found 836.48570. 
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Resin 3.43.  To a suspension of the aminomethyl resin (1.1 g, 2.2 meq/g, 2.42 mmol of –
NH2, Aldrich 564095, macroporous 30-60 mesh) in CH2Cl2 (17 mL) and diisopropyl 
ethyl amine (2.66 mL, 15.3 mmol) was added the isocyanate 3.42 (5.0 g, 6.10 mmol) and 
the resulting mixture was shaken on an orbital shaker for 24 h at room temperature. The 
resin was filtered and washed 3 times each with CH2CH2, MeOH, H2O, saturated 
NaHCO3, H2O, MeOH and Et2O. It was then dried under reduced pressure to obtain a 
light colored resin (1.5 g):  IR (ATR) 3377, 3022, 2924, 2848, 1734 (C=O ester), 1655 
(C=O hydroxamate) cm
-1
; Elemental analysis C 81.23%, H 7.96%, N 3.67%, loading = 
0.65 meq/g (based on %N); %C indicates 43% conversion of available NH2 groups of the 
resin. 
 
Resin 3.38b. To a suspension of the resin 3.43 (1.51 g, 0.30 meq/g, 0.45 mmol) in MeOH 
(10 mL) was added KOH (0.15 g, 2.7 mmol) and NH2OTMS (0.33 mL, 2.7 mmol) and 
the mixture was shaken for 20 h on an orbital shaker. The resin was isolated by filtration 
and washed 3 times with MeOH. The resin was re-suspended in a solution of TsOH.H2O 
(0.52 g, 2.7 mmol) in MeOH (10 mL) and shaken for 3 h. The resin was isolated by 
filtration and washed 3 times each with MeOH, H2O, MeOH and Et2O and dried under 
reduced pressure to give the product as a pale yellow colored resin (1.73 g):  IR (ATR) 
3382 (br), 3500-2500 (br), 3024, 2922, 2854, 1646 (C=O hydroxamate) cm
-1
; Elemental 
Analysis C 75.74%, H 7.51%, N 3.68%, Loading = 0.44 meq/g (maximum loading based 
on %N). 
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CHAPTER 4: Immobilization of citramide based chelators and application in the 
removal of trivalent metals from water at low pH 
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4.1 Specific objectives 
The objectives of this project were: 
(1) Immobilization of citric acid, a common carboxylate based chelating agent, on a solid 
support such as a polystyrene resin to obtain citramide functionalized chelating resins.  
(2) An application of such citramide resins for the removal of trivalent metal ion such as 
iron from aqueous solutions at low pH. The iron binding affinities of these resins will be 
determined by difference UV-Vis Spectroscopy. 
 
4.2 Background 
Several resins have been prepared in which chelating agents are covalently linked 
to polymer beads. Compared with simple ion exchange resins, the use of immobilized 
chelating agents allows one to achieve both higher binding affinity and greater selectivity 
among different metal ions.  This selectivity can be easily understood in terms of the 
well-known principles of hard-soft acid-base (HSAB) theory.
1
 Many of the known 
chelating resins simply immobilize a nonspecific generic ligand.  For some applications, 
immobilized ligands designed to target specific metals (or groups of metals) could yield 
superior results.
2
  
Citric acid 4.1 (Figure 4.1) has been extensively used as chelating agent for 
cleaning purposes.
3
 Trivalent metal ions such as iron and aluminum form strong 
complexes with citrates. Carboxylic acids are more acidic than hydroxamic acid, 
therefore, citrate binds metal ion more strongly than does hydroxamate at low pH. As a 
hard ligand, citrate coordinates metals via negatively charged oxygen atoms, and prefers 
to bind hard metal ions such as Fe
3+ 
and Al
3+
. Thus, a citrate immobilized chelating resin 
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is a good choice for applications that requires removal of such metal ions at low pH. 
After a thorough literature search, we realized that there are no previous reports of the 
immobilization of citric acid on a solid surface. 
Trivalent metal ions form relatively strong complexes with citrate by binding 
through its carboxyates and α-hydroxyl groups.3 Citrate is a tridentate chelator as seen in 
the structure 4.2 (Figure 4.1). The central carboxylate and α-hydroxyl group first form a 
perfect five membered chelate with the metal, then, one of the two equivalent terminal 
carboxylates binds. 
 
 
 
Figure 4.1 Citric acid and citric acid-trivalent metal complex 
 
Rhizoferrin 4.3 (Figure 4.2), a novel high affinity citrate based natural 
siderophore,
4
 forms a highly stable 1:1 complex with Fe(III). Structure determination of 
rhizoferrin revealed a diamine backbone symmetrically diacylated by citric acid at its 1-
carboxylate.
4
 It has two sets of tridentate hydroxy carboxylate chelating groups. The 
example of rhizoferrin is relevant here, as it further proves the very strong trivalent metal 
binding properties of the hydroxy carboxylate groups. 
 
 
 
4.1 4.2 
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Figure 4.2 Structure of a citrate based natural siderophore rhizoferrin 
 
4.3 Design of citramide functionalized chelating resins 
We recently developed a series of hydroxamate-based chelating resins for the 
removal of aluminum (and other trivalent metals) from aqueous solutions (Chapter 3).
5
  
However, the effective binding of trivalent metals to hydroxamates diminishes at low pH.  
Since waste water streams (and other aqueous solutions) can be acidic, a new system was 
needed which would operate at low pH.  We postulated that immobilized citramide 4.4 or 
4.5 (Figure 4.3) would show the desired characteristics. The binding unit of resin 4.4 is 
very similar to that of natural siderophore rhizofferin 4.3. The only difference between 
the resins 4.4 and 4.5 is the type of citrate carboxylate forming the amide linkage. In 4.4, 
one of the two equivalent 1-carboxylates of citrate is forming the amide linkage, whereas, 
in 4.5 the central carboxylate is doing so. Resin 4.4 chelates through an α-hydroxy 
carboxylate group, whereas, 4.5 binds through a β-hydroxy carboxylate. As mentioned 
earlier, the α-hydroxy carboxylate is the metal chelating group of citrate as shown in 
structure 4.2. Thus, resin 4.4 should be the better binding resin. However, in any 
synthetic route to resin 4.4, formation of resin 4.5 in some amount is inevitable. 
 
4.3 
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Figure 4.3 Two possible structures of mono-citramide functionalized resin 
 
To demonstrate the ability of citrate functionalized resin 4.4 to bind iron at low 
pH, the following speciation analysis was performed. An equilibrium model for the 
mixture of resin 4.4, Fe
3+
 and acetohydroxamic acid (AHA) was constructed within the 
speciation software HySS (Hyperquad Simulation and Speciation). The structure of AHA 
4.6 is given in Figure 4.4. AHA is a monohydoxamate Fe chelator used in these 
experiments as a competing ligand. The model included literature values for protonation 
and Fe binding constants for citrate
6
 (assuming the binding of a solution phase citrate is 
similar to that of a resin immobilized citrate) and AHA (β130 = 28.33)
7
 as fixed 
parameters. An effective concentration for the immobilized citrate was calculated by 
dividing the total mmoles of citrate on the resin by the total sample volume. The 
concentrations of AHA and citrate were manually varied until the speciation calculation 
matched about a 50% distribution of Fe
3+
 between the resin and AHA. Concentrations of 
10 mM AHA and 45.9 mM citrate gave about a 1:1 distribution of Fe
3+
 (0.1 mM) 
between these species at pH 6. The predicted speciation of the mixture of Fe
3+
, resin 4.4 
and AHA as a function of pH is shown in Figure 4.5. The result also indicates that the 
4.4 4.5 
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resin should bind essentially 100% of the Fe
3+
 below pH 5 at above mentioned 
concentrations. Above pH 5, AHA begins to compete for Fe with the resin, and 
Fe(AHA)3 is the only species above pH 7.  
 
 
 
Figure 4.4 Structure of a hydroxamate chelator Acetohydroxamic acid (AHA) 
 
 
 
Figure 4.5 Species distribution diagram of Fe
3+
 in a mixture of AHA and the resin 
4.4 at pH 3-9 
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To potentially increase the loading density and provide the opportunity for 
multiple carboxylates to bind to a single metal, branched polyamine linker scaffolds were 
studied. Thus, resin 4.7 (Figure 4.6) containing a bis- citramide system immobilized via a 
tetraamine linker was designed. The ligand on resin 4.7 is a regioisomeric mixture, where 
two non-eqivalent carboxylates of citric acid are forming amide bonds with the amine 
groups of resin giving structures 4.7’ and 4.7’’. The structure of resin 4.7 is very close to 
that of the earlier mentioned natural siderophore rhizoferrin 4.3. There are 4 carbon 
atoms between two the amide bonds of rhizoferrin, whereas, there are 4 carbon and 1 
nitrogen atoms (total 5 atoms) between two such groups in resin 4.7. Thus, the iron 
binding affinity of resin 4.7 was expected to be very close to that of rhizoferrin. 
 
 
 
Figure 4.6 Possible structures of bis-citramide functionalized resin 
 
An equilibrium model for the mixture of the bis-citramide resin 4.7, Fe
3+
 and 
acetohydroxamic acid (AHA) was constructed within the speciation software HySS. As 
resin 4.7 contains a bis-citramide system, the β120, β121 and β12-1 constants of citrate
8
 were 
4.7 
4.7’ 
4.7’’ 
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also included, in addition to the protonation and binding constants of the mono-citrate 
system. The concentration of AHA was manually varied keeping the concentration of the 
citrate resin constant until the speciation calculation matched about a 50% distribution of 
Fe
3+
 between the resin and AHA at pH 6. Concentrations of 30 mM AHA and 45.9 mM 
citrate gave about a 1:1 distribution of Fe
3+
 (0.1 mM) between these ligands at pH 6. The 
predicted speciation of the mixture of Fe
3+
, resin 4.7 and AHA as a function of pH is 
shown in Figure 4.7. The result also indicates that the resin should bind essentially 100% 
of the Fe
3+
 below pH 5 at above mentioned concentrations. Above pH 5, AHA begins to 
compete for Fe with the resin, and Fe(AHA)3 is the only species above pH 7.  
 
 
Figure 4.7 Species distribution diagram of Fe
3+
 in a mixture of AHA and the resin 
4.6 at pH 2-7 
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4.4 Synthesis of citric anhydride and solution phase model reactions 
Citric anhydride 4.8 was prepared from citric acid 4.1 in a single step following a 
literature procedure (Scheme 4.1).
9
 The spectral characterization data of citric anhydride 
4.8 was not provided in the procedure, which is included in the experimental section of 
this chapter. Before immobilizing citric anhydride 4.8 on an aminomethyl polystyrene 
resin or any other primary amine functionalized resins, the feasibility of the proposed 
chemistry was examined in solution. Reaction of benzylamine 4.9 with citric anhydride 
4.8 gave the benzyl citramides 4.10 and 4.11 (Scheme 4.1) in a 2:1 ratio, as determined 
by 
1
H NMR and reverse phase (C-18 column) HPLC.  The citramides were converted to 
the methyl esters 4.12 and 4.13. The methyl esters 4.12 and 4.13 were purified by silica 
gel column chromatography and fully characterized. The 2:1 ratio of ligands 4.10 and 
4.11 was further confirmed by the isolated yields of methyl esters 4.12 and 4.13. 
 
 
Scheme 4.1 Synthesis of citric acid anhydride and solution phase model reactions 
4.1 
4.12 
4.11 
4.10 
4.9 
4.8 
4.13 
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4.5 Immobilization of citric acid anhydride on polystyrene resin 
Following the procedures used for the solution phase ligands, aminomethyl 
polystyrene resin 4.14 (2.2 meq/g, of –NH2, Aldrich 564095, macroporous 30-60 mesh) 
was reacted with excess citric anhydride 4.8 in acetonitrile to obtain the citramide resins 
4.4 and 4.5 (Scheme 4.2).  From the solution studies, it is assumed that the resin is a 
mixture of two regioisomers 4.4 and 4.5, although the exact ratio of these two 
regioisomers is unknown in the solid phase. Based on the outcome of solution phase 
studies, we assumed the ratio of resins 4.4 and 4.5 to be 1:2. The presence of carboxylic 
acid and amide carbonyl stretching bands at 1720 and 1640 cm
-1
, respectively in the IR 
spectrum of the resin, suggested the formation of citamide species. The maximum 
possible loading of citamide group on the surface of resin was calculated to be 1.53 
meq/g based on N combustion analysis. But, some of the nitrogen in this calculation may 
be unreacted amines of the starting resin. As the resin was treated with HCl during the 
synthesis, the unreacted amine should be in the form of a hydrochloride salt. For the 
exact calculation of the loading of citamides, we calculated the ratio of reacted to 
unreacted amines by converting the hydrochloride salt to hydrobromide salt by treating 
the resin with 1 M NaBr solution followed by N and Br combustion analysis of the resin. 
The N to Br ratio of 2.8 suggested that 64% of the amines are acylated. Thus, the loading 
of citramide groups in resin 4.4 (or 4.5) was determined to be 0.98 meq/g (64% of 1.53 
meq/g). 
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Scheme 4.2 Synthesis of mono-citramide resin 
 
Two different resins with different surface properties were utilized for the 
synthesis of two different bis-citamide resins 4.7a and 4.7b (Scheme 4.3). Two 
chloromethyl polystyrene resins 4.15a (ChemPep G20J1233, 0.82 mmol/g Cl, 
macroporous 100-200 mesh) and 4.15b (chloromethylated XAD 4, 1.24 mmol/g of Cl) 
were reacted with tris(2-aminoethyl)amine  (TREN) 4.16 in DMF to give the tetra amino 
resins 4.17a (0.35 mmol/g tetramine based on N) and 4.17b (0.65 mmol/g tetramine 
based on N).
10
 Some cross-linking was expected, i.e., the reaction of multiple amine 
groups of the TREN with multiple chloromethyl groups of the resin. The amino resins 
were reacted with excess citric anhydride 4.8 in acetonitrile to give 4.7a and 4.7b.  Their 
formation was confirmed by the presence of carboxylic acid and amide carbonyl 
stretching bands in the IR spectrum. Due to the cross linking of TREN and the presence 
of multiple amines available for acylation, the calculation of exact loading values of 
citramide groups in the resins 4.7a,b is extremely problematic. The maximum possible 
loading of bis-citamide group on the surface of resin 4.7a and 4.7b were calculated to be 
0.31 and 0.53 meq/g based on N combustion analysis, respectively. These values 
represent the loading of tetraamine groups in these resins, which is equivalent to the 
loading of bis-citramide if both primary amines of tetraamine are acylated. As the 
speciation analysis of bis-citramide resins 4.7a,b included the species where two citrate 
4.8 
4.4 4.5 
4.14 
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units are bound to one metal, the bis-citramide group was taken as a single binding unit 
for the calculation of loading values. The resins 4.7a and 4.7b are also likely to contain 
mono-citramide (only one amine of TREN acylated), bis-citramide (as expected), and 
even tris-citramide (two primary amines and one secondary amine acylated) groups and 
both citramide regioisomers giving rise to multiple resin species.  The loading and the 
observed binding may be an average of the individual species. 
 
 
Scheme 4.3 Synthesis of bis-citramide resin 
 
4.6 Fe
3+
 extraction studies of citramide resins by difference UV-Vis Spectroscopy 
Mono-citramide resin 4.4 (and 4.5).   
A 2 ml mixture of Fe
3+
 (100 μM) and the chelating agent AHA (10 mM) in pH 
6.2 MES buffer was prepared, allowed to equilibrate, and the absorbance was recorded. 
Resin 4.4 (or 4.5) (60 mg, loading = 0.98 mmol/g, 29.4 mM) was added to the solution, 
4.8 
4.7a,b 
4.17a,b 4.16 4.15a,b 
Dawadi, Surendra, 2013, UMSL, p.144 
 
 
 
the mixture was agitated and the absorbance was recorded periodically. The removal of 
Fe
3+
 from the Fe-AHA complex by the resin was indicated by the decrease in the 
absorbance band of the Fe-AHA complex at 422 nm, as shown in Figure 4.8. The lowest 
absorbance in the figure represents an equilibrium distribution of the Fe
3+
 between AHA 
and the resin. The fraction of Fe
3+
 bound to the resin was calculated by comparing the 
absorbance at equlibrium to that of the initial Fe-AHA complex before the addition of 
resin. The results showed that 28% of the Fe
3+
 was bound to the resin 4.4 (and 4.5) and 
72% to AHA when the equilibrium was achieved. After 8 h 20 min, the final pH of the 
extracted solution was measured to be 5.9.  
 
 
Figure 4.8 Removal of Fe
3+
 from the Fe-AHA complex by mono-citramide resin 4.4 
(and 4.5)  
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Bis-citramide resin 4.7a.  
A 2 ml mixture of Fe
3+
 (100 μM) and the chelating agent AHA (40 mM) in pH 
6.2 MES buffer was prepared, allowed to equilibrate, and the absorbance was recorded. 
Resin 4.7a (65 mg, loading = 0.31 mmol/g, 10 mM) was added to the solution, the 
mixture was agitated and the absorbance was recorded periodically. The removal of Fe
3+
 
from the Fe-AHA complex by the resin was indicated by the decrease in the absorbance 
band of the Fe-AHA complex at 422 nm, as shown in Figure 4.9. The lowest absorbance 
in the figure represents an equilibrium distribution of the Fe
3+
 between AHA and the 
resin. The results showed that 36% of the Fe
3+
 was bound to the resin 4.7a and 64% to 
AHA when the equilibrium was achieved. After 3 h 30 min, the final pH of the extracted 
solution was measured to be 6.0.  
 
Figure 4.9 Removal of Fe
3+
 from Fe-AHA complex by the bis-citramide resin 4.7a 
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Bis-citramide resin 4.7b.  
A 2 ml mixture of Fe
3+
 (100 μM) and the chelating agent AHA (60 mM) in pH 
6.2 MES buffer was prepared, allowed to equilibrate, and the absorbance was recorded. 
Resin 4.7b (38 mg, loading = 0.53 mmol/g, 10 mM) was added to the solution, the 
mixture was agitated and the absorbance was recorded periodically. The removal of Fe
3+
 
from the Fe-AHA complex by the resin was again indicated by the decrease in the 
absorbance band of the Fe-AHA complex at 422 nm, as shown in Figure 4.10. The results 
showed that 44% of the Fe
3+
 was bound to the resin 4.7b and 56% to AHA when the 
equilibrium was achieved. After 3 h 15 min, the final pH of the extracted solution was 
measured to be 5.9.  
 
 
Figure 4.10 Removal of Fe
3+
 from Fe-AHA complex by the bis-citramide resin 4.6b 
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4.7 Calculation of iron binding affinities of citramide resins 
Iron binding constants of these citrate immobilized resins (KCitrR) are calculated 
using following equations: 
         Equation 4.1 
We don’t know how many protons are released in equation 4.1. At least the 
hydroxyl protons are released and maybe some other protons are released also. 
 
       
         
           
                                Equation 4.2 
 
As H
+
 is not included in equation 4.2, KCitrR becomes an effective binding 
constant, a constant which is valid at the pH at which it is measured. 
Equation 4.1 represents the equilibrium for the formation of Fe-citramide 
complex on the resin from free iron and the citramide resins. Charges are omitted for 
simplicity. The equilibrium constant KCitrR is represented in equation 4.2. 
 
      Equation 4.3 
     
          
          
                           Equation 4.4  
 
Similarly, KAHA (Equation 4.4) represents the equilibrium constant for the 
formation of the Fe-AHA complex from the free iron and acetohydroxamic acid (AHA), 
which is shown in equation 4.3. 
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   Equation 4.5 
    
               
                 
 
         
           
 
          
          
  
      
    
       Equation 4.6 
logKCitrR = LogKAHA + logKx                                 Equation 4.7 
 
In above discussed difference UV-Vis Spectroscopy experiments, the fully 
formed Fe(AHA)3 complex was treated with citramide resins, which led to the 
redistribution of Fe between the AHA and resin. This equilibrium is represented in 
equation 4.5. One can define an exchange constant, Kx, as shown in equation 4.6, which 
is equal to the ratio of KCitrR (equation 4.2) and KAHA (equation 4.4). Equation 4.7 is the 
logarithm form of equation 4.6. 
Values of Kx have been calculated from difference UV-Vis absorption 
experiments and using equations 4.8-4.12. The concentration of Fe bound to AHA at 
equilibrium was calculated from the experiment using equation 4.8. Total Fe used in the 
experiment was distributed between Fe-AHA and Fe-citramide resin (equation 4.9). As 
the total Fe concentation was known, and as the concentration of Fe-AHA complex was 
obtained from equation 4.8, the concentration of Fe bound citramide resin was calculated 
from equation 4.9. The total citramide used in the experiment (which is known) was 
equal to the sum of free citramide concentration and the concentration of Fe-citramide 
complex when the equilibrium has been reached (equation 4.10). Thus, the concentration 
of free citramide resin at equilibrium was calculated using equation 4.10. Also, as the 
total AHA concentration was known, the concentration of free AHA at equilibrium was 
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calculated using equation 4.11. The value α is defined by equation 4.12. When all the 
required concentrations were obtained, Kx was calculated using equation 4.13. 
 
            
   
 
                                     Equation 4.8  
                                        Equation 4.9 
                                           Equation 4.10 
                                        Equation 4.11 
                                
      
        
    Equation 4.12 
    
               
                 
                                   Equation 4.13 
 
Therefore, as logKAHA is known (28.33)
7
 and logKx was obtained from the 
experiment, logKCitrR has been calculated using equation 4.7. The logKCitrR values of 
mono-citramide resin 4.4 and bis-citramide resins 4.6a and 4.6b are listed in Table 4.1. 
 
Table 4.1 Fe binding constants of citrate immobilized resins 4.4, 4.7a and 4.7b 
Resin pH logKCitrR 
4.4 (and 4.5) 5.9 13.15 
4.7a 6.0 15.81 
4.7b 5.9 16.20 
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4.8 Summary 
The present study involved the design, synthesis and use of citramide 
functionalized chelating resins for the removal of trivalent metals such as iron at low pH. 
Citric anhydride was prepared in a single step from citric acid by a known procedure. 
Citric anhydride was then reacted with various amine functionalized polystyrene resins 
for the preparation of citramide resins. Three different citramide resins were prepared by 
this method, mono-citramide resin 4.4, and bis-citramide resins 4.7a and 4.7b. The iron 
binding affinities of these resins were determined by difference UV-Vis Spectroscopy. 
Binding studies suggested that the bis-citramide resins have about a 3 log unit higher iron 
binding affinities than mono-citramide resins. There are many directions this project 
could head in the future, including the study of differences in binding affinities of 
solution phase citramide chelators, 4.10 and 4.11. The result from such experiment may 
further establish a well-known concept that the strongest binding group of citric acid is 
the α-hydroxyl carboxylate.  
 
4.9 Experimental section 
Citric anhydride (4.8). IR (neat) 3454, 3186, 1856, 1772, 1731, 1692, 1179 cm
-1
; 
1
H 
NMR (acetone-d6)  (ppm) 3.26 (ABq,  = 119.4 Hz, J = 19.0 Hz, 2H), 3.17 (ABq,  
= 21.3 Hz, J =  17.6 Hz, 2H),; 
13
C NMR (acetone-d6)  (ppm) 174.6, 172.1, 169.7, 74.9, 
42.2, 41.3; HRMS (FAB) C6H5O6 [M-H]
+
 calcd 173.0086, found 173.0083. 
 
3-(benzylcarbamoyl)-3-hydroxypentanedioic acid (4.10) and 2-(2-(benzylamino)-2-
oxoethyl)-2-hydroxysuccinic acid (4.11). To a solution of the citric anhydride 4.8 (0.50 
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g, 2.9 mmol) in dry CH3CN (25 mL) was added benzylamine (0.47 mL, 4.3 mmol) drop 
wise and the resulting solution was stirred at room temperature. The reaction was fast and 
exothermic. The reaction mixture turned cloudy and finally oiled out at the bottom of the 
reaction flask. The reaction was allowed to stir for additional 2 h. After 2 h, 1N HCl (25 
mL) was added and the stirred mixture was extracted with EtOAc. The combined organic 
layers were dried over Na2SO4 and evaporated under reduced pressure to give the crude 
product as the regioisomeric mixture of 4.10 and 4.11 (0.71 g combined, 86%). The ratio 
of 4.10 and 4.11 was calculated to be 2:1 from 
1
H NMR and reversed phase (C-18 
column) HPLC experiments of the crude product. The carboxylic acids 4.10 and 4.11 
were converted to methyl esters without any further purification. 
 
dimethyl 3-(benzylcarbamoyl)-3-hydroxypentanedioate (4.12) and dimethyl 2-(2-
(benzylamino)-2-oxoethyl)-2-hydroxysuccinate (4.13). To a solution of the mixture of 
carboxylic acid regioisomers 4.10 and 4.11 (0.60 g, 2.13 mmol) in a 1:1 mixture of dry 
MeOH and Et2O (20 mL) was added TMSCHN2 (0.95 mL, 6.40 mmol) and the resulting 
solution was stirred at room temperature for 30 min. The solvent was evaporated under 
reduced pressure and the residue was purified by column chromatography (SiO2, 
hexane/EtOAc gradient) to give the products 4.12 (0.28 g, 43%) as the major and 4.13 
(0.13 g, 20%) as the minor regioisomers.  
Compound 4.12: IR (neat) 3393 (br), 2953, 1735, 1655, 1529, 1201 cm
-1
; 
1
H NMR 
(CDCl3)  (ppm) 7.26-7.15 (m, 5H), 4.87 (br s, 1H), 4.36 (d, J = 6.0 Hz, 2H), 3.57 (s, 
6H), 2.81 (ABq,  = 47.6 Hz, J = 15.7 Hz, 4H); 13C NMR (CDCl3)  (ppm) 173.0, 
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171.7, 138.0, 128.7, 127.8, 127.5, 74.5, 52.1, 43.5, 41.7; HRMS (FAB) C15H20NO6 
[M+H]
+
 calcd 310.1291, found 310.1286. 
Compound 4.13: IR (neat) 3359 (br), 2954, 1736, 1648, 1541, 1211 cm
-1
; 
1
H NMR 
(CDCl3)  (ppm) 7.26-7.15 (m, 5H), 6.39 (br s, 1H), 4.34 (d, J = 5.8 Hz, 2H), 3.69 (s, 
3H), 3.59 (s, 3H), 2.77 (ABq,  = 37.6 Hz, J = 15.8 Hz, 2H), 2.63 (ABq,  = 34.3 Hz, 
J = 14.7 Hz, 2H); 
13
C NMR (CDCl3)  (ppm) 174.1, 170.7, 169.2, 138.0, 128.8, 127.8, 
127.7, 73.9, 53.3, 52.2, 44.4, 43.7, 42.9; HRMS (FAB) C15H20NO6 [M+H]
+
 calcd 
310.1291, found 310.1282. The MS fragmentation pattern of compound 4.13 was 
different from that of compound 4.12. 
 
Polymer-supported mono citramide 4.4 (or 4.5). To a suspension of aminomethyl resin 
(2.0 g, 2.2 meq/g, 4.4 mmol of –NH2, Aldrich 564095, macroporous 30-60 mesh) in 
CH3CN (10 ml) was added anhydride 4.8 (2.3 g, 13.2 mmol) and the mixture was 
allowed to shake in an orbital shaker for 15 h at rt. The resin was filtered and washed 3 
times each with CH3CN, H2O, 1N HCl, H2O, MeOH and Et2O. It was then dried under 
reduced pressure to obtain a light colored resin (2.6 g). IR (ATR): 3420-2500 (br), 3380, 
3027, 2920, 1720 (C=O acid), 1640, 1597, 1180, 698 cm
-1
. Elemental Analysis: C 
78.21%, H 7.03%, N 2.62%. Maxium loading value = 1.53 meq/g (based on %N). 
Corrected loading = 0.98 meq/g. 
 
Polymer-supported tris(2-aminomethyl)amine (4.17a,b). 
Resin 4.17a. To a suspension of chloromethyl polystyrene resin (3.0 g, 0.82 mmol/g, 
2.46 mmol of Cl, ChemPep G20J1233, macroporous 100-200 mesh) in DMF (10 ml) and 
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was added tris(2-aminoethyl)amine (1.45 ml, 9.89 mmol) and the mixture was allowed to 
shake in an orbital shaker for 6 h at 65 
0
C. The resin was filtered and washed 3 times each 
with DMF, MeOH, Et3N, MeOH and Et2O. It was then dried under reduced pressure to 
obtain a white colored resin (3.0 g). IR (ATR) 3023, 2921, 1597, 1493, 1452, 697 cm
-1
. 
Elemental Analysis: C 87.96%, H 7.77%, N 1.97%, Cl 0.65%. Loading of tetraamine = 
0.35 mmol/g (based on %N).  
Resin 4.17b. To a suspension of chloromethyl polystyrene resin (3.0 g, 1.24 mmol/g, 
3.72 mmol of Cl, chloromethylated XAD 4) in DMF (10 ml) and was added tris(2-
aminoethyl)amine (2.17 ml, 14.88 mmol) and the mixture was allowed to shake in an 
orbital shaker for 6 h at 65 
0
C. The resin was filtered and washed 3 times each with DMF, 
MeOH, Et3N, MeOH and Et2O. It was then dried under reduced pressure to obtain a 
white colored resin (3.1 g). IR (ATR) 3370 (br), 3019, 2922, 1603, 1447, 708 cm
-1
. 
Elemental Analysis: C 77.48%, H 8.01%, N 3.64%, Cl 3.70%. Loading of tetraamine = 
0.65 mmol/g (based on %N).  
 
Polymer-supported bis-citramides 4.7a,b. 
Resin 4.7a: To a suspension of polymer-supported tris(2-aminomethyl)amine 4.17a (1.50 
g, 0.35 mmol/g, 0.52 mmol of –NH2) in CH3CN (8 ml) was added the citric anhydride 4.8 
(0.54 g, 3.12 mmol) and the mixture was allowed to shake in an orbital shaker for 15 h at 
rt. The resin was filtered and washed 3 times each with CH3CN, H2O, 1N HCl, H2O, 
MeOH and Et2O. It was then dried under reduced pressure to obtain off-white colored 
resin (1.65 g). IR (ATR): 3400-2500 (br), 3025, 2921, 1724 (C=O acid), 1650, 1601, 
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1452, 697 cm
-1
. Elemental Analysis: C 82.20%, H 7.48%, N 1.75%. Loading of 
tetraamine = 0.31 meq/g (based on %N). 
Resin 4.7b: To a suspension of Polymer-supported tris(2-aminomethyl)amine 4.17b 
(1.50 g, 0.65 mmol/g, 0.97 mmol of –NH2) in CH3CN (8 ml) was added the citric 
anhydride 4.8 (1.02 g, 5.85 mmol) and the mixture was allowed to shake in an orbital 
shaker for 15 h at rt. The resin was filtered and washed 3 times each with CH3CN, H2O, 
1N HCl, H2O, MeOH and Et2O. It was then dried under reduced pressure to obtain a light 
colored resin (1.86 g). IR (ATR): 3400-2500 (br), 2925, 1724 (C=O acid), 1653, 1604, 
1444, 1190, 708 cm
-1
. Elemental Analysis: C 70.02%, H 6.98%, N 2.97%. Loading of 
tetraamine = 0.53 meq/g (based on %N). 
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CHAPTER 5: Immobilization of dithio-succinamide based chelators and application in 
the removal of lead from water 
 
  
Dawadi, Surendra, 2013, UMSL, p.157 
 
 
 
5.1 Specific objectives 
The objectives of this project were: 
(1) Immobilization of dimercaptosuccinic acid (DMSA), a common heavy metal 
chelating agent in clinical practice, on a solid support such as polystyrene resin to obtain 
dithiolate functionalized chelating resins.  
(2) An application of such dithiolate resins for the removal of soft metals such as lead 
from aqueous solutions. The lead binding capacities of these resins will be determined by 
Atomic Absorption Spectroscopy (AAS). 
 
5.2 Background and Introduction 
Several soft metals (Pb, Hg, Cd, As) are high priority environmental 
contaminants.  Their presence in environmental waters is due to discharges from 
residential dwellings, groundwater infiltration and industrial discharges.
1
 The discharge 
of wastewater containing high concentrations of soft metals into ground water systems 
has serious adverse environmental effects. The 1997 Comprehensive Environmental 
Response, Compensation, and Liability Act (CERCLA) priority list of hazardous 
substances includes arsenic, lead, mercury, and cadmium within the first 10 positions.  
Arsenic, lead and mercury are ranked 1, 2, and 3 on the CERCLA list
2
 and are some of 
the most widely recognized environmental hazards. Unlike organic pollutants, heavy 
metals are not biodegradable and accumulate in the environment due to their 
recirculation. Thus, soft metal pollution of ground water has become a major problem 
worldwide. 
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Since the mid-seventies, the average blood lead level in the United States has 
fallen from 17 µg/dL to 6 µg/dL, due in large part to the reduction in the use of leaded 
gasoline.
3
 As the United States has reduced the exposure to environmental lead, the 
perceived “safe” level for blood lead has also dropped.  In 1991, the Centers for Disease 
Control reduced the recommended maximum blood lead level from 25 µg/dL to 10 
µg/dL.
3 
 One concern is that chronic exposure of children to even low lead levels has 
been associated with subtle reductions in cognitive abilities, and no clear threshold for 
these effects has been established.
4
 
To achieve unpolluted drinking water distribution and wastewater discharge, 
several technologies and processes for heavy metal remediation are currently in use. The 
most commonly used methods for heavy metal treatment of wastewater are 
physicochemical methods such as chemical precipitation, ion exchange, and reverse 
osmosis; and bioremediation such as phytoremediation, and microbial remediation.
1
 
Currently, all of the existing technologies for heavy metal remediation (chemical 
remediation, or bioremediation) have pros and cons.
1
 The precipitates of heavy metals 
formed during the chemical precipitation method are usually in the form of light, tiny 
flocks and occupy a large volume and require additional waste disposal costs. The 
membranes used in reverse osmosis methods are expensive to produce and operate and 
are very sensitive to rupture. Bioremediation is an extremely time consuming process and 
is limited to those compounds that are degradable. Not all compounds are susceptible to 
rapid and complete degradation. There are some concerns that the products of 
biodegradation may be more persistent or toxic than the parent compound.
1 
There have 
been recent developments in the ion exchange resins capable of removing soft metals, but 
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a significant drawback associated with ion exchange resins is the lack of selectivity 
towards soft metals in the presence of other metal ions. This lack of selectivity can lead 
to a rapid saturation of the resin. 
There are numerous applications for chelating resins capable of removing 
hazardous metal ions from water, including treatment of runoff and waste water and the 
purification of drinking water. An ideal chelating resin would also bind toxic soft metals 
selectively in the presence of harmless and beneficial metals. The binding should be very 
strong, and at the same time, metals should be easily released for the rejuvenation of the 
resin. An effective resin would allow one to produce large volumes of purified water, 
while concentrating the metals into a small volume for recycling or disposal.   
Several thiol based resins have been developed over the years for the selective 
chelation of soft metals. Sulfur containing soft ligands strongly coordinate soft acids such 
as Hg, and Pb. Mercury is especially thiophilic.  
Lezzi and coworkers
5
 reported the synthesis of a series of thiol functionalized 
chelating resins derived from a copolymer bead of styrene-divinylbenzene. Merifield 
resin 5.1 was reacted with various polyethylene glycols of 4, 9, and 13 methylene units in 
the presence of tetra n-butyl ammonium hydrogen sulfate to obtain a series of compounds 
shown in structure 5.2. The hydroxyl groups of 5.2 were substituted with bromides to 
obtain resins 5.3 which were reacted with thiourea followed by hydrolysis with piperidine 
to obtain thiol immobilized resins 5.4. The complexation behavior of these thiol resins 
with Hg(II), Cu(II), and Pb(II) ions was studied by batch equilibration techniques. The 
authors found that polyethylene units improved the hydrophilic behavior of resins, and 
binding was strongest for the resin with 13 polyethylene units. The binding affinity of 
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these resins with metals followed the order Hg(II) >> Cu(II) > Pb(II). The thiol resins can 
be regenerated by washing them with a solution of HCl (6N) and a 10% aqueous solution 
of thiourea. 
 
 
Scheme 5.1 Lezzi’s synthesis of thiol functionalized chelating resins  
 
5.3 Design of dithiolate functionalized chelating resins 
As mentioned earlier, thiol ligands form very stable metal complexes with soft 
metals,
6
 but their use can be limited by the tendency to air-oxidize to disulfide.
7
  The 
dithiolate ligand dimercaptosuccinic acid (DMSA or succimer) is unusually air-stable.  
DMSA is present in two stereoisomeric forms, meso DMSA 5.5, and dl pair DMSA 5.6 
(Figure 5.1). meso DMSA 5.5 has been studied extensively for use in chelation therapy 
for the treatment of lead and cadmium poisoning,
8
 and is approved as an oral drug for 
treating lead toxicity in children.
9
  At neutral pH, DMSA binds lead through its two thiol 
groups, and forms a very stable 1:1 complex as shown in structure 5.7 (Figure 5.2).  No 
2:1 complex forms even in the presence of a modest excess of ligand.
10
   
 
5.1 
5.4 
5.3 
5.2 
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Figure 5.1 Dimercaptosuccinic acid (DMSA) 
 
 
 
 
Figure 5.2 A DMSA Pb(II) complex 
 
DMSA has been chosen as the ligand for this study because it can easily be 
attached to the resin, it is an air-stable dithiolate, and it forms a stable 1:1 complex with 
Pb
2+
.  There have been previous examples of dithiol functionalized solid supports. Bruce 
and coworkers
11
 reported the immobilization of meso-DMSA 5.5 on silica gel via an 
amide bond linkage, and the evaluation of binding capacities of this material with Hg, 
Cd, and Pb. The attachment of DMSA to silica was accomplished in two steps (Scheme 
5.2). The silica 5.8 was first reacted with (3-aminopropyl)dimethylethoxysilane 
(APDMES) 5.9 to obtain primary amino group functionalized silica 5.10. The meso- 
DMSA 5.5 was then anchored to the surface via formation of amide linkages between the 
carboxylic acid groups of DMSA and surface amino groups of silica 5.10, forming 
DMSA-[silica] 5.11. This method of attachment of DMSA on silica provides a greater 
chance for two amine groups on the surface to react with one DMSA molecule to produce 
the silica with structure 5.12, thereby significantly increasing the ratio of thiolate to 
carboxylate in the final product compared to the ratio of such groups in solution phase 
meso-DMSA 5.5 dl pair-DMSA 5.6 
5.7 
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DMSA. When equal molar concentrations of the three metals are allowed to react 
simultaneously with DMSA-[silica] (as a mixture of 5.11 and 5.12) for 2 h, Hg(II) 
preferentially binds (99%) compared to Cd(II) (13%) or Pb(II) (0.4%). The increase in 
the thiol to carboxylic acid ratio over free DMSA appears to be the major factor in 
enhancing the preference of DMSA-[silica] for mercury. They concluded that the 
presence of a carboxylate group along with a dithiolate group is essential for strong lead 
binding. 
 
 
 
Scheme 5.2 Bruce’s method of immobilization of DMSA on silica  
 
Herein, we report the design and synthesis of chelating resins functionalized with 
the chelating groups present in DMSA, dithiolate and carboxylate, and the sequestration 
of lead from aqueous solutions. We propose the synthesis of mono-ditholate and bis-
dithiolate carboxylate resins 5.13 and 5.14 (Figure 5.3). To increase the loading density 
and provide the opportunity for multiple dithiols to bind to a single metal, the branched 
polyamine linker scaffold of resin 5.14 was designed. 
5.8 
5.10 
5.5 
5.12 
5.11 5.9 
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Figure 5.3 Structures of mono-dithiolate resin 5.13 and bis-dithiolate resin 5.14 
 
5.4 Synthesis of 2,3-diacetylthio-succinic anhydride  
To prevent the reaction of two amine groups of the resin with two carboxylic 
acids of a single DMSA molecule, we propose the synthesis of diacetylthio succinic 
anhydride. The benefit associated with the anhydride is that when an amine group opens 
the anhydride, no further reaction can occur. Dithioacetyl succinic anhydride 5.17 
(Scheme 5.3) was prepared by following a literature procedure.
12
  The potassium salt of 
acetylene dicarboxylic acid 5.15 was treated with HCl (5N in EtOAc) followed by 
thioacetic acid to obtain a diastereomeric mixture of meso and dl dithioacetyl succinic 
acid 5.16. The diastereomeric ratio of dithioacetyl succinic acid 5.16 was determined by 
1
H NMR to be 45:55 (meso:dl). The anhydride 5.17 was prepared by refluxing the 
dithioacetyl succinic acid 5.16 in acetyl chloride. The procedure provides a process for 
the enrichment of both the dl pair and the meso diastereomers of dithioacetyl succinic 
acid 5.16 and a process for the preparation of pure dl pair of anhydride 5.17. Spectral 
characterization data for both the dithioacetyl succinic acid 5.16 and the anhydride 5.17 
were not provided, so are included in the present study. 
 
5.13 
5.14 
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Scheme 5.3 Synthesis of dithioacetyl succinic anhydride  
 
5.5 Synthesis of solution phase dithiol ligands 
Before immobilizing dithiol succinic acid (via the anhydride 5.17) on 
aminomethyl polystyrene resin or any other primary amine functionalized resins, the 
feasibility of the proposed chemistry was examined in solution. Reaction of the 
benzylamine 5.18 with the dl pair dithioacetyl succinic anhydride 5.17 gave the acetyl 
protected hemisuccinamide 5.19 (Scheme 5.4), which was characterized as the methyl 
ester 5.20. The methyl ester 5.20 was prepared by reaction with TMSCHN2, purified by 
silica gel column chromatography and fully characterized. The IR spectrum of compound 
5.20 showed peaks at 3380, 1733, 1693, 1665 cm
-1
, confirming the presence of N-H, ester 
carbonyl, thioester carbonyl, and amide carbonyl groups, respectively. Deacetylation
13
 of 
the acetyl protected thiol groups of hemisuccinamide 5.19 with ammonium hydroxide in 
methanol gave the dithiol ligand 5.21. The deacetylation was confirmed by the loss of 
acetyl protons in the 
1
H NMR of the crude product. The reaction sequence work equally 
well with meso and dl enriched diastereomer mixtures. The solution phase ligand 5.22 
was obtained by the reaction of meso anhydride 5.17. 
 
5.15 
5.16 5.17 
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 Scheme 5.4 Synthesis of solution phase dithiol ligands  
 
5.6 Immobilization on polystyrene resin 
Following the procedures used for the solution phase ligand, aminomethyl 
polystyrene 5.23 (2.2 meq/g, 3.52 mmol of –NH2, Aldrich 564095, macroporous 30-60 
mesh) was reacted with pure dl pair dithioacetyl succinic anhydride 5.17 to give the 
hemisuccinamide resin 5.24. The IR spectrum of the powdered resin 5.24 showed peaks 
at 1715, 1681, 1660 cm
-1
, confirming the presence of acid carbonyl, thioester carbonyl, 
and amide carbonyl groups, respectively. The ligand loading was calculated to be 0.68 
meq/g (based on S combustion analysis, 4.39% S = 1.38 mmol/g S).  Deacetylation of the 
hemisuccinamide 5.24 with ammonium hydroxide in methanol gave the mono-dithiolate 
resin 5.13 with a ligand loading of 0.61 meq/g (based on S). Hydolysis of thioester 
groups is confirmed by the loss of the thioester carbonyl stretching band at 1681 cm
-1
. As 
5.18 5.19 
dl pair 5.17 
5.21 
5.20 
5.18 meso 5.17 
5.22 
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SH stretching bands are usually weak, they are not observed in the IR spectra of 
dithiolated resins. The S to N ratio was 1:1.5 (from elemental analysis of resin 5.13), 
indicating that approximately 33% of the available amines had reacted. If the reaction 
was complete, the expected S:N ratio would be 2:1. 
 
 
 
Scheme 5.5 Synthesis of mono-dithiolate resin 
 
The synthesis of bis-dithiolate resins 5.14 started with branched tetra-amine resins 
4.17a and 4.17b (Chapter 4). The two tetra-amine functionalized resins 4.17a and 4.17b 
differ in the nature of resin particles (ChemPep medium versus XAD-4). The resins 
4.17a, and 4.17b were each reacted with excess dl and meso enriched dithioacetyl 
succinic anhydride 5.17 in THF to give 5.25a-d (0.28 meq/g, 0.22 meq/g, 0.64 meq/g and 
0.50 meq/g of dithioacetyl based on %S) (Scheme 5.6).  Deacetylation of the 
hemisuccinamides 5.25a-d with ammonium hydroxide in methanol gave the dithiol resins 
5.14a-d (0.20 meq/g, 0.16 meq/g, 0.36 meq/g and 0.32 meq/g of dithiol based on %S).  
Both the anhydride opening and deacetylation reactions on solid phase were monitored 
by IR spectroscopy, and the results were analogous to the IR of solution phase 
compounds. 
 
5.23 5.24 
dl pair 5.17 
5.13 
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Scheme 5.6 Synthesis of bis-dithiolate resins 
 
Using 5.14a as an example, a comparsion of the % of S and N show that the 
tetraamines are 60% acylated (or 30% of the available primary amines have been 
acylated). Similar calculations were performed for all the resins and the loading values 
are listed in Table 5.1.  
 
 
 
 
 
 
 
 
4.17a,b 5.25a-d 
5.17  
meso or dl pair 
enriched 
5.14a-d 
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Table 5.1 Loading of various dithiolate resins 
Resin %S mmol S mmol dithiol % N mmol N mmol 
tetramine 
% NH2 
acylation 
5.13 3.89 1.22 0.61 2.56 1.83 N/A 33% 
5.14a 1.25 0.39 0.19 1.80 1.28 0.32 30% 
5.14b 0.99 0.31 0.16 1.81 1.28 0.32 24% 
5.14c 2.33 0.73 0.36 3.05 2.18 0.54 33% 
5.14d 2.04 0.64 0.32 3.10 2.21 0.55 29% 
 
5.7 Study of Pb
2+
 extraction by flame Atomic Absorption Spectroscopy (AAS) 
To determine the ability of resin 5.13 to remove lead from aqueous lead nitrate 
solutions, the following batch extraction experiment was performed. A 10 ml solution of 
Pb(NO3)2 (300 μM, 62.1 µg/ml Pb
2+
) in pH 6.7 MES buffer was prepared. Resin 5.13 (25 
mg) was added to the solution and allowed to equilibrate completely by shaking in an 
orbital shaker for about 22 h. The final pH of the mixture after 22 h was measured to be 
6.61. Resin beads were removed by filtration, and the amount of Pb remaining in the 
solution was measured by flame AAS. The instrument was calibrated with five Pb 
standard solutions (10, 20, 30, 40, and 50 ppm) each time before the Pb measurement was 
performed. The results showed that 68.1 μM (14.1 µg/ml) Pb2+ remained in the solution 
after 24 h. 77% of the Pb
2+
 was bound to the resin and 23% remained in the solution 
when the equilibrium was achieved. The experiment was performed at various pH values 
to understand the influence of pH on extraction capacity of resins, and the results are 
summarized in Table 5.2. 
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Table 5.2 Pb concentration before and after resin 5.13 (pure dl pair) treatment at 
various pH 
pH Weight 
of resin 
Pb concentration 
before resin 
treatment 
Pb concentration 
after 22 h resin 
treatment 
% Pb remaining 
in solution 
5.80 25.0 mg 480 μM 289 μM 60 
6.58 25.0 mg 300 μM 72 μM 24 
6.61 25.0 mg 300 μM 68 μM 23 
 
Similarly, Pb removal capacities of bis-dithiolate functionalized resins 5.14a-d 
are summarized in Tables 5.3-5.6. 
 
Table 5.3 Pb concentration before and after resin 5.14a (71% dl pair) treatment at 
various pH 
pH Wt. of 
resin 
Pb concentration 
before resin 
treatment 
Pb concentration 
after 22 h resin 
treatment 
% Pb remaining 
in solution 
5.84 45.0 mg 300 μM 127 μM 42 
6.56 45.0 mg 300 μM 5 μM 1.7 
6.61 33.0 mg 300 μM 26 μM 13 
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Table 5.4 Pb concentration before and after resin 5.14b (80% meso) treatment at 
various pH 
pH Wt. of 
resin 
Pb concentration 
before resin 
treatment 
Pb concentration 
after 22 h resin 
treatment 
% Pb remaining 
in solution 
5.85 56.0 mg 300 μM 122 μM 41 
6.56 56.0 mg 300 μM 3 μM 1 
6.61 41.0 mg 300 μM 17 μM 6 
 
Table 5.5 Pb concentration before and after resin 5.14c (71% dl pair) treatment at 
various pH 
pH Wt. of 
resin 
Pb concentration 
before resin 
treatment 
Pb concentration 
after 22 h resin 
treatment 
% Pb 
remaining in 
solution 
5.84 25.0 mg 300 μM 52 μM 17 
5.97 25.0 mg 300 μM 28 μM 9 
6.54 25.0 mg 300 μM 2 μM 0.7 
6.60 18.3 mg 300 μM 4 μM 1.3 
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Table 5.6 Pb concentration before and after resin 5.14d (80% meso) treatment at 
various pH 
pH Wt. of 
resin 
Pb concentration 
before resin 
treatment 
Pb concentration 
after 22 h resin 
treatment 
% Pb remaining 
in solution 
5.84 28.0 mg 300 μM 45 μM 15 
6.55 28.0 mg 300 μM 1 μM 0.3 
6.61 20.5 mg 300 μM 3 μM 1 
 
5.8 Summary 
The present study involving the design, synthesis and use of chelating resins 
functionalized with dithiolate ligands for soft metal remediation has shown great promise. 
Dithiol ligands such as dimercapto succinic acid (DMSA) are ideal soft metal chelators. 
The immobilization of DMSA on a polystyrene resin via an amide linkage presented a 
challenge. Diacetylthio succinic anhydride, in which thiols are protected with acetyl 
groups, was synthesized and reacted with aminomethylated polystyrene resins to obtain 
acetyl protected dithiol resins. Finally, the acetyl groups were deprotected to obtain the 
dithiolate resins. Lead binding studies of these resins showed that, depending on the pH 
of solution, they very efficiently remove lead from aqueous solutions. At pH 6.5, when 
excess resin was used, bis-dithiolate functionalized resin 5.14d removed more than 99% 
of lead from the lead nitrate solution. There are many directions this project could head in 
the future, including the study of the difference in binding affinities of pure meso versus 
pure dl pair solution phase dithiolate chelators 5.21 and 5.22, the study of binding 
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capacities of the resins with other soft metals, and the study of binding capacities of the 
resins with metals in the presence of competing ligands.  
 
5.9 Experimental section 
2,3-bis(acetylthio)succinic acid (5.16). It was obtained as a mixture of 55% dl pair and 
45% meso isomers. IR (neat) 3400-2500 (br.), 2908, 1698, 1654, 1412, 1125 cm
-1
; meso: 
1
H NMR (MeOD)  (ppm) 4.85 (s, 1H), 2.37 (s, 3H); 13C (MeOD)  (ppm) 194.8, 172.5, 
48.2, 29.8; dl pair: 
1
H NMR (MeOD)  (ppm) 4.61 (s, 1H), 2.38 (s, 3H); 13C (MeOD)  
(ppm) 194.1, 172.9, 47.7, 29.9; HRMS (FAB) C8H11O6S2 [M+H]
+
 calcd 266.9997, found 
267.0006. 
 
2,5-dioxotetrahydrofuran-3,4-diyl diethanethioate (5.17). IR (neat) 2993 (broad), 
2905, 1723, 1696, 1649, 1405, 1210 cm
-1
; meso: 
1
H NMR (CDCl3)  (ppm) 4.91 (s, 1H), 
2.43 (s, 3H); 
13
C (CDCl3)  (ppm) 194.5, 168.1, 45.4, 29.7; dl pair: 
1
H NMR (CDCl3)  
(ppm) 4.21 (s, 1H), 2.45 (s, 3H); 
13
C (CDCl3)  (ppm) 194.4, 166.9, 47.8, 30.0; HRMS 
(FAB) C8H9O5S2 [M+H]
+
 calcd 248.9891, found 248.9889. 
 
methyl 4-(benzylamino)-2,3-dimercapto-4-oxobutanoate (5.20). To a solution of 
anhydride 5.17 (pure dl pair, 0.31 g, 1.24 mmol) in THF was added benzylamine (0.15 
ml, 1.38 mmol) drop wise and the mixture was stirred at rt. Progress of the reaction was 
monitored by TLC (50% EtOAc in hexane). Reaction was complete in 45 minutes. To the 
reaction mixture was added 1N HCl (5 ml) and the mixture was stirred for about 5 
minutes. The mixture was extracted with CH2Cl2 and the combined organics was dried 
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over Na2SO4 and evaporated under reduced pressure to obtain the carboxylic acid 5.19 
(0.43 g, quant.) as a foamy solid.  To a solution of compound 5.19 (0.09 g, 0.25 mmol) in 
a 1:1 mixture of MeOH and Et2O (4 ml) was added trimethylsilyl diazomethane (2M in 
Et2O, 0.19 ml, 0.38 mmol) drop wise at rt. The reaction was vigorous with the evolution 
of gas and was completed immediately after the complete addition of trimethylsilyl 
diazomethane. The reaction mixture was stirred for a total of 30 min. The solvent was 
removed under reduced pressure and the crude product was purified by column 
chromatography (SiO2, hexane/EtOAc gradient) to give a colorless oil product 5.20 (0.09 
g, quant) as a mixture of geometrical isomers around the amide bond. IR (neat) 3380, 
2952, 1733, 1693, 1665, 1525 cm
-1
; 
1
H NMR (CDCl3)  (ppm) 7.28-7.14 (m, 5H), 6.47 
(app t, 1H), 4.80 (ABq,  = 42.2 Hz, J = 4.3 Hz, 0.7H) + 4.58 (ABq,  = 68.3 Hz, J = 
8.2 Hz, 1.3H), 4.34 (t, J = 5.9 Hz, 2H), 3.66 (s, 3H), 2.32 (s, 2.1H) + 2.31 (s, 3.9H); 
13
C 
(CDCl3)  (ppm) 195.86 + 195.81, 193.51 + 192.60, 170.40 +170.19, 169.05 + 168.99, 
137.88 + 137. 86, 128.87 + 128.86, 127.68 + 127.66, 127.65, 53.41 + 53.38, 47.39 + 
47.35, 45.87 + 45.40, 43.93, 30.42, 30.21 + 30.05 ; HRMS (FAB) C16H20NO5S2 [M+H]
+
 
calcd 370.0782, found 370.0786. 
 
General process I (reaction of anhydride 5.17 with amine functionalized resins). To a 
suspension of resin in THF (6 ml/g of resin) was added anhydride 5.17 (3 equiv. per –
NH2 of resin) and the mixture was allowed to shake in an orbital shaker for 15 h at rt. The 
resin was filtered and washed 3 times each with THF, MeOH, H2O, MeOH and Et2O. It 
was then treated with 1N HCl and the mixture was shaken for 20 min. The resin was 
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filtered and washed 3 times each with H2O, MeOH and Et2O. It was dried under reduced 
pressure to obtain the product resin. 
 
General process II (Conversion of thioacetate to thiol). To a thioacetate functionalized 
resin was added 2N NH4OH (7-35 ml per mmol of –SAc) and the mixture was allowed to 
shake in an orbital shaker for 15 h at rt. The resin was filtered and washed 3 times with 
H2O. It was then treated with 1 N HCl (~7 ml per mmol of –SAc) and the mixture was 
shaken for 1 h. The resin was filtered and washed 3 times each with H2O, MeOH and 
Et2O. It was dried under reduced pressure to obtain the thiol functionalized resin. 
 
Resin 5.24.  Following the general process I, aminomethyl resin (1.6 g, 2.2 meq/g, 3.52 
mmol of –NH2, Aldrich 564095, macroporous 30-60 mesh) was treated with anhydride 
5.17 (pure dl pair, 2.60 g, 10.47 mmol). Product was obtained as dark brown resin beads 
(2.27 g). IR (ATR): 3400-2500 (br), 3051, 2914, 1715 (C=O acid), 1681, 1660, 1602, 
1493, 698 cm
-1
. Elemental Analysis: C 76.47%, H 7.07%, N 2.32%, S 4.39%. Loading 
value = 0.68 meq/g (based on %S).  
 
Mono-dithiolated resin 5.13. Following the general process II, resin 5.24 (2.2 g, 0.68 
meq/g, 3.00 mmol of –SAc) was treated with 2N NH4OH (23 ml) to produce dark brown 
resin beads (1.9 g). IR (ATR): 3400-2500 (br), 3025, 2921, 1720 (C=O acid), 1655, 1602, 
1493, 698 cm
-1
. Elemental Analysis: C 77.95%, H 7.22%, N 2.56%, S 3.89%. Loading 
value = 0.61 meq/g (based on %S).  
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Resin 5.25a. Following the general process I, resin 4.16a (0.68 g, 0.35 mmol/g, 0.47 
mmol of –NH2) was treated with anhydride 5.17 (71% dl pair, 0.35 g, 1.43 mmol) to 
obtain light brown colored resin beads (0.74 g). IR (ATR): 3399 (br), 3023, 2922, 1695, 
1642 (br, acid carbonyl imbedded inside), 1602, 1493, 1452, 698 cm
-1
. Elemental 
Analysis: C 82.32%, H 7.47%, N 1.72%, S 1.80%. Loading value = 0.14 meq/g (based on 
%S). 
 
Resin 5.25b. Following the general process I, resin 4.16a (0.68 g, 0.35 mmol/g, 0.47 
mmol of –NH2) was treated with anhydride 5.17 (80% meso, 0.35 g, 1.43 mmol) to 
produce light brown colored resin beads (0.73 g).  IR (ATR): 3378 (br), 3027, 2922, 1650 
(br, acid carbonyl imbedded inside), 1602, 1493, 1451, 698 cm
-1
. Elemental Analysis: C 
83.24%, H 7.75%, N 1.82%, S 1.43%. Loading value = 0.11 meq/g (based on %S). 
 
Resin 5.25c. Following the general process I, resin 4.16b (0.78 g, 0.65 mmol/g, 1.01 
mmol of –NH2) was treated with anhydride 5.17 (71% dl pair, 0.76 g, 3.04 mmol) to 
produce dark brown colored resin beads (0.95 g).  IR (ATR): 3401 (br), 2923, 1695, 
1638, 1604, 1444, 1115, 707 cm
-1
. Elemental Analysis: C 70.21%, H 7.14%, N 2.91%, S 
4.05%. Loading value = 0.32 meq/g (based on %S). 
 
Resin 5.25d. Following the general process I, resin 4.16b (0.78 g, 0.65 mmol/g, 1.01 
mmol of –NH2) was treated with anhydride 5.17 (80% meso, 0.76 g, 3.04 mmol) to 
produce dark brown colored resin beads (0.94 g). IR (ATR): 3385 (br), 2924, 1695, 1633, 
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1605, 1444, 1115, 707 cm
-1
. Elemental Analysis: C 71.28%, H 7.26%, N 2.91%, S 
3.25%. Loading value = 0.25 meq/g (based on %S).  
 
Bis-dithiolated resin 5.14a. Following the general process II, resin 5.25a (0.70 g, 0.14 
meq/g, 0.39 mmol of –SAc) was treated with 2N NH4OH (14 ml) to produce beige 
colored resin beads (0.49 g). IR (ATR): 3403 (br), 3025, 2922, 1715 (C=O acid), 1650, 
1602, 1493, 1451, 698 cm
-1
. Elemental Analysis: C 83.50%, H 7.45%, N 1.80%, S 
1.25%. Loading value = 0.10 meq/g (based on %S).  
 
Bis-dithiolated resin 5.14b. Following the general process II, resin 5.25b (0.70 g, 0.11 
meq/g, 0.31 mmol of –SAc) was treated with 2N NH4OH (14 ml) to produce beige 
colored resin beads (0.52 g). IR (ATR): 3403 (br), 3025, 2922, 1715 (C=O acid), 1650, 
1602, 1493, 1452, 698 cm
-1
. Elemental Analysis: C 83.99%, H 7.47%, N 1.81%, S 
0.99%. Loading value = 0.08 meq/g (based on %S). 
 
Bis-dithiolated resin 5.14c. Following the general process II, resin 5.25c (0.91 g, 0.32 
meq/g, 1.16 mmol of –SAc) was treated with 2N NH4OH (18 ml) to produce brown resin 
beads (0.79 g). IR (ATR): 3384 (br), 3018, 2923, 1705 (C=O acid), 1634, 1445, 708 cm
-1
. 
Elemental Analysis: C 70.51%, H 7.21%, N 3.05%, S 2.33%. Loading value = 0.18 
meq/g (based on %S).  
 
Bis-dithiolated resin 5.14d. Following the general process II, resin 5.25d (0.90 g, 0.25 
meq/g, 0.90 mmol of –SAc) was treated with 2N NH4OH (18 ml) to produce brown resin 
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beads (0.78 g).  IR (ATR): 3396 (br), 3018, 2924, 1705 (C=O acid), 1636, 1445, 708 cm
-
1
. Elemental Analysis: C 70.74%, H 7.66%, N 3.10%, S 2.04%.  Loading value = 0.16 
meq/g (based on %S). 
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Structure determination summary 
 
 
 
333-THA 2.29 
2,2'-((4-(3-(2-(hydroxyamino)-2-oxoethoxy)propyl)-4-(4-methylphenylsulfonamido)heptane-1,7-
diyl)bis(oxy))bis(N-hydroxyacetamide) 
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Table A.  Crystal data and structure refinement for 2.29 
 
Identification code  s17309/lt/SD39 
Empirical formula  C23 H46 N4 O15 S 
Formula weight  650.70 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Triclinic 
Space group  P 1 
Unit cell dimensions a = 7.7871(7) Å  
 b = 11.0372(9) Å 950(5)°. 
 c = 18.3093(17) Å  
Volume 1520.1(2) Å3 
Z 2 
Density (calculated) 1.422 Mg/m3 
Absorption coefficient 0.183 mm-1 
F(000) 696 
Crystal size 0.439 x 0.195 x 0.068 mm3 
Theta range for data collection 1.875 to 26.574° 
Index ranges -9≤h≤9, -13≤k≤13, -22≤l≤22 
Reflections collected 39310 
Independent reflections 6260 [R(int) = 0.0339] 
Completeness to theta = 25.000° 99.8 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9877 and 0.9240 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6260 / 10 / 440 
Goodness-of-fit on F2 1.031 
Final R indices [I>2sigma(I)] R1 = 0.0350, wR2 = 0.0811 
R indices (all data) R1 = 0.0501, wR2 = 0.0895 
Extinction coefficient n/a 
Largest diff. peak and hole 0.401 and -0.338 e.Å-3 
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Table B.  Atomic coordinates (x 104) and equivalent isotropic displacement parameters 
(Å2x 103) for 2.29. U(eq) is defined as one third of  the trace of the orthogonalized Uij 
tensor. 
_______________________________________________________________________ 
 x y z U(eq) 
_______________________________________________________________________ 
S(1) 5080(1) 7838(1) 5029(1) 12(1) 
O(1) 3889(1) 8917(1) 4839(1) 17(1) 
O(2) 4367(2) 6862(1) 5501(1) 16(1) 
O(3) 6051(2) 5760(1) 8011(1) 20(1) 
O(4) 7746(2) 5590(1) 9687(1) 21(1) 
O(5) 6438(2) 3449(1) 9767(1) 23(1) 
O(6) 9894(2) 9747(1) 7365(1) 21(1) 
O(7) 12856(2) 9974(1) 7932(1) 21(1) 
O(8) 13660(2) 8720(1) 9170(1) 24(1) 
O(9) 12089(2) 7546(1) 3378(1) 16(1) 
O(10) 15098(2) 7140(1) 1667(1) 20(1) 
O(11) 14184(2) 9633(1) 1660(1) 21(1) 
N(1) 6472(2) 8356(1) 5419(1) 12(1) 
N(2) 6311(2) 4348(1) 9191(1) 17(1) 
N(3) 12028(2) 8723(1) 8944(1) 19(1) 
N(4) 13578(2) 8825(1) 2246(1) 17(1) 
C(1) 9025(3) 5562(2) 2178(1) 25(1) 
C(2) 8039(2) 6127(2) 2884(1) 17(1) 
C(3) 7470(2) 5392(1) 3515(1) 16(1) 
C(4) 6556(2) 5905(1) 4167(1) 14(1) 
C(5) 6181(2) 7182(1) 4188(1) 13(1) 
C(6) 6702(2) 7931(1) 3559(1) 16(1) 
C(7) 7639(2) 7404(2) 2918(1) 18(1) 
C(8) 7932(2) 7679(1) 5789(1) 11(1) 
C(9) 7196(2) 6824(1) 6445(1) 13(1) 
C(10) 5835(2) 7466(2) 7056(1) 18(1) 
C(11) 4895(2) 6568(2) 7602(1) 20(1) 
C(12) 6595(2) 6317(2) 8576(1) 19(1) 
C(13) 6934(2) 5376(2) 9202(1) 16(1) 
C(14) 8718(2) 8709(1) 6060(1) 13(1) 
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C(15) 10336(2) 8252(2) 6417(1) 16(1) 
C(16) 11024(2) 9283(2) 6708(1) 17(1) 
C(17) 10206(2) 9047(2) 8022(1) 23(1) 
C(18) 11842(2) 9300(1) 8288(1) 16(1) 
C(19) 9326(2) 6897(1) 5238(1) 12(1) 
C(20) 10230(2) 7629(1) 4570(1) 13(1) 
C(21) 11372(2) 6798(1) 3998(1) 15(1) 
C(22) 13176(2) 6829(2) 2819(1) 16(1) 
C(23) 14023(2) 7624(2) 2185(1) 15(1) 
O(1S) 1088(2) 6356(1) 9214(1) 25(1) 
O(2S) 7437(2) 7768(1) 427(1) 24(1) 
O(3S) 12715(2) 10036(1) 10358(1) 26(1) 
O(4S) 9310(2) 1918(1) 9190(1) 29(1) 
 
 
 Table C.   Bond lengths [Å] and angles [°] for 2.29 
_____________________________________________________  
S(1)-O(2)  1.4355(11) 
S(1)-O(1)  1.4417(11) 
S(1)-N(1)  1.6093(13) 
S(1)-C(5)  1.7667(16) 
O(3)-C(12)  1.413(2) 
O(3)-C(11)  1.427(2) 
O(4)-C(13)  1.244(2) 
O(5)-N(2)  1.3856(18) 
O(5)-H(5)  0.8400 
O(6)-C(17)  1.408(2) 
O(6)-C(16)  1.429(2) 
O(7)-C(18)  1.230(2) 
O(8)-N(3)  1.4093(19) 
O(8)-H(8)  0.8400 
O(9)-C(22)  1.4094(19) 
O(9)-C(21)  1.4213(19) 
O(10)-C(23)  1.2346(19) 
O(11)-N(4)  1.3927(17) 
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O(11)-H(11)  0.8400 
N(1)-C(8)  1.494(2) 
N(1)-H(1)  0.830(11) 
N(2)-C(13)  1.310(2) 
N(2)-H(2)  0.832(11) 
N(3)-C(18)  1.329(2) 
N(3)-H(3A)  0.832(11) 
N(4)-C(23)  1.323(2) 
N(4)-H(4A)  0.831(11) 
C(1)-C(2)  1.504(2) 
C(1)-H(1C)  0.9800 
C(1)-H(1D)  0.9800 
C(1)-H(1E)  0.9800 
C(2)-C(3)  1.393(2) 
C(2)-C(7)  1.396(2) 
C(3)-C(4)  1.384(2) 
C(3)-H(3)  0.9500 
C(4)-C(5)  1.393(2) 
C(4)-H(4)  0.9500 
C(5)-C(6)  1.390(2) 
C(6)-C(7)  1.381(2) 
C(6)-H(6)  0.9500 
C(7)-H(7)  0.9500 
C(8)-C(14)  1.537(2) 
C(8)-C(9)  1.539(2) 
C(8)-C(19)  1.540(2) 
C(9)-C(10)  1.522(2) 
C(9)-H(9A)  0.9900 
C(9)-H(9B)  0.9900 
C(10)-C(11)  1.515(2) 
C(10)-H(10A)  0.9900 
C(10)-H(10B)  0.9900 
C(11)-H(11A)  0.9900 
C(11)-H(11B)  0.9900 
C(12)-C(13)  1.506(2) 
C(12)-H(12A)  0.9900 
C(12)-H(12B)  0.9900 
C(14)-C(15)  1.522(2) 
C(14)-H(14A)  0.9900 
C(14)-H(14B)  0.9900 
C(15)-C(16)  1.512(2) 
C(15)-H(15A)  0.9900 
C(15)-H(15B)  0.9900 
C(16)-H(16A)  0.9900 
C(16)-H(16B)  0.9900 
C(17)-C(18)  1.523(2) 
C(17)-H(17A)  0.9900 
C(17)-H(17B)  0.9900 
C(19)-C(20)  1.524(2) 
C(19)-H(19A)  0.9900 
C(19)-H(19B)  0.9900 
C(20)-C(21)  1.508(2) 
C(20)-H(20A)  0.9900 
C(20)-H(20B)  0.9900 
C(21)-H(21A)  0.9900 
C(21)-H(21B)  0.9900 
C(22)-C(23)  1.505(2) 
C(22)-H(22A)  0.9900 
C(22)-H(22B)  0.9900 
O(1S)-H(1SA)  0.891(18) 
O(1S)-H(1SB)  0.890(18) 
O(2S)-H(2SA)  0.885(19) 
O(2S)-H(2SB)  0.886(19) 
O(3S)-H(3SA)  0.921(17) 
O(3S)-H(3SB)  0.920(17) 
O(4S)-H(4SA)  0.913(18) 
O(4S)-H(4SB)  0.912(18) 
 
O(2)-S(1)-O(1) 118.88(7) 
O(2)-S(1)-N(1) 109.42(7) 
O(1)-S(1)-N(1) 104.58(7) 
O(2)-S(1)-C(5) 106.31(7) 
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O(1)-S(1)-C(5) 107.65(7) 
N(1)-S(1)-C(5) 109.83(7) 
C(12)-O(3)-C(11) 114.46(13) 
N(2)-O(5)-H(5) 109.5 
C(17)-O(6)-C(16) 113.29(13) 
N(3)-O(8)-H(8) 109.5 
C(22)-O(9)-C(21) 111.54(12) 
N(4)-O(11)-H(11) 109.5 
C(8)-N(1)-S(1) 130.00(10) 
C(8)-N(1)-H(1) 117.9(13) 
S(1)-N(1)-H(1) 110.8(13) 
C(13)-N(2)-O(5) 120.16(14) 
C(13)-N(2)-H(2) 122.6(14) 
O(5)-N(2)-H(2) 117.1(14) 
C(18)-N(3)-O(8) 116.27(14) 
C(18)-N(3)-H(3A) 120.1(15) 
O(8)-N(3)-H(3A) 114.1(15) 
C(23)-N(4)-O(11) 119.62(14) 
C(23)-N(4)-H(4A) 122.2(13) 
O(11)-N(4)-H(4A) 113.6(13) 
C(2)-C(1)-H(1C) 109.5 
C(2)-C(1)-H(1D) 109.5 
H(1C)-C(1)-H(1D) 109.5 
C(2)-C(1)-H(1E) 109.5 
H(1C)-C(1)-H(1E) 109.5 
H(1D)-C(1)-H(1E) 109.5 
C(3)-C(2)-C(7) 118.42(15) 
C(3)-C(2)-C(1) 120.90(15) 
C(7)-C(2)-C(1) 120.67(15) 
C(4)-C(3)-C(2) 121.27(15) 
C(4)-C(3)-H(3) 119.4 
C(2)-C(3)-H(3) 119.4 
C(3)-C(4)-C(5) 119.25(15) 
C(3)-C(4)-H(4) 120.4 
C(5)-C(4)-H(4) 120.4 
C(6)-C(5)-C(4) 120.38(15) 
C(6)-C(5)-S(1) 120.33(12) 
C(4)-C(5)-S(1) 119.28(12) 
C(7)-C(6)-C(5) 119.58(15) 
C(7)-C(6)-H(6) 120.2 
C(5)-C(6)-H(6) 120.2 
C(6)-C(7)-C(2) 121.08(15) 
C(6)-C(7)-H(7) 119.5 
C(2)-C(7)-H(7) 119.5 
N(1)-C(8)-C(14) 103.71(12) 
N(1)-C(8)-C(9) 110.59(12) 
C(14)-C(8)-C(9) 111.44(13) 
N(1)-C(8)-C(19) 111.26(12) 
C(14)-C(8)-C(19) 111.28(12) 
C(9)-C(8)-C(19) 108.55(12) 
C(10)-C(9)-C(8) 115.10(13) 
C(10)-C(9)-H(9A) 108.5 
C(8)-C(9)-H(9A) 108.5 
C(10)-C(9)-H(9B) 108.5 
C(8)-C(9)-H(9B) 108.5 
H(9A)-C(9)-H(9B) 107.5 
C(11)-C(10)-C(9) 112.49(13) 
C(11)-C(10)-H(10A) 109.1 
C(9)-C(10)-H(10A) 109.1 
C(11)-C(10)-H(10B) 109.1 
C(9)-C(10)-H(10B) 109.1 
H(10A)-C(10)-H(10B) 107.8 
O(3)-C(11)-C(10) 113.14(14) 
O(3)-C(11)-H(11A) 109.0 
C(10)-C(11)-H(11A) 109.0 
O(3)-C(11)-H(11B) 109.0 
C(10)-C(11)-H(11B) 109.0 
H(11A)-C(11)-H(11B) 107.8 
O(3)-C(12)-C(13) 109.91(13) 
O(3)-C(12)-H(12A) 109.7 
C(13)-C(12)-H(12A) 109.7 
O(3)-C(12)-H(12B) 109.7 
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C(13)-C(12)-H(12B) 109.7 
H(12A)-C(12)-H(12B) 108.2 
O(4)-C(13)-N(2) 123.86(16) 
O(4)-C(13)-C(12) 121.03(15) 
N(2)-C(13)-C(12) 115.11(15) 
C(15)-C(14)-C(8) 113.93(13) 
C(15)-C(14)-H(14A) 108.8 
C(8)-C(14)-H(14A) 108.8 
C(15)-C(14)-H(14B) 108.8 
C(8)-C(14)-H(14B) 108.8 
H(14A)-C(14)-H(14B) 107.7 
C(16)-C(15)-C(14) 112.49(13) 
C(16)-C(15)-H(15A) 109.1 
C(14)-C(15)-H(15A) 109.1 
C(16)-C(15)-H(15B) 109.1 
C(14)-C(15)-H(15B) 109.1 
H(15A)-C(15)-H(15B) 107.8 
O(6)-C(16)-C(15) 112.19(13) 
O(6)-C(16)-H(16A) 109.2 
C(15)-C(16)-H(16A) 109.2 
O(6)-C(16)-H(16B) 109.2 
C(15)-C(16)-H(16B) 109.2 
H(16A)-C(16)-H(16B) 107.9 
O(6)-C(17)-C(18) 113.11(14) 
O(6)-C(17)-H(17A) 109.0 
C(18)-C(17)-H(17A) 109.0 
O(6)-C(17)-H(17B) 109.0 
C(18)-C(17)-H(17B) 109.0 
H(17A)-C(17)-H(17B) 107.8 
O(7)-C(18)-N(3) 124.43(16) 
O(7)-C(18)-C(17) 123.06(15) 
N(3)-C(18)-C(17) 112.51(14) 
C(20)-C(19)-C(8) 114.64(12) 
C(20)-C(19)-H(19A) 108.6 
C(8)-C(19)-H(19A) 108.6 
C(20)-C(19)-H(19B) 108.6 
C(8)-C(19)-H(19B) 108.6 
H(19A)-C(19)-H(19B) 107.6 
C(21)-C(20)-C(19) 111.82(13) 
C(21)-C(20)-H(20A) 109.3 
C(19)-C(20)-H(20A) 109.3 
C(21)-C(20)-H(20B) 109.3 
C(19)-C(20)-H(20B) 109.3 
H(20A)-C(20)-H(20B) 107.9 
O(9)-C(21)-C(20) 108.38(12) 
O(9)-C(21)-H(21A) 110.0 
C(20)-C(21)-H(21A) 110.0 
O(9)-C(21)-H(21B) 110.0 
C(20)-C(21)-H(21B) 110.0 
H(21A)-C(21)-H(21B) 108.4 
O(9)-C(22)-C(23) 111.39(13) 
O(9)-C(22)-H(22A) 109.4 
C(23)-C(22)-H(22A) 109.4 
O(9)-C(22)-H(22B) 109.4 
C(23)-C(22)-H(22B) 109.4 
H(22A)-C(22)-H(22B) 108.0 
O(10)-C(23)-N(4) 124.63(15) 
O(10)-C(23)-C(22) 119.79(14) 
N(4)-C(23)-C(22) 115.53(14) 
H(1SA)-O(1S)-H(1SB) 104(2) 
H(2SA)-O(2S)-H(2SB) 106(2) 
H(3SA)-O(3S)-H(3SB) 107(2) 
H(4SA)-O(4S)-H(4SB) 114(2) 
 
Dawadi, Surendra, 2013, UMSL, p.188 
 
 
 
Table D. The nisotropic displacement parameters (Å2x 103) for 2.29.  The anisotropic 
displacement factor exponent takes the form:  - 2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
_______________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
________________________________________________________________________  
S(1) 10(1)  9(1) 17(1)  0(1) -3(1)  -2(1) 
O(1) 13(1)  12(1) 26(1)  -1(1) -8(1)  0(1) 
O(2) 14(1)  13(1) 21(1)  -1(1) 1(1)  -4(1) 
O(3) 29(1)  17(1) 13(1)  1(1) -3(1)  -4(1) 
O(4) 21(1)  21(1) 22(1)  -4(1) -6(1)  -5(1) 
O(5) 29(1)  18(1) 19(1)  6(1) -6(1)  -2(1) 
O(6) 20(1)  22(1) 20(1)  -6(1) -7(1)  4(1) 
O(7) 24(1)  20(1) 21(1)  3(1) -7(1)  -8(1) 
O(8) 24(1)  27(1) 22(1)  -1(1) -7(1)  -5(1) 
O(9) 18(1)  16(1) 12(1)  -1(1) 4(1)  -4(1) 
O(10) 19(1)  24(1) 16(1)  -5(1) 3(1)  -6(1) 
O(11) 20(1)  25(1) 18(1)  8(1) -5(1)  -11(1) 
N(1) 12(1)  7(1) 15(1)  2(1) -4(1)  -2(1) 
N(2) 22(1)  17(1) 14(1)  3(1) -6(1)  -4(1) 
N(3) 20(1)  23(1) 18(1)  2(1) -6(1)  -10(1) 
N(4) 16(1)  18(1) 14(1)  1(1) 3(1)  -4(1) 
C(1) 25(1)  28(1) 19(1)  -2(1) -1(1)  -2(1) 
C(2) 13(1)  22(1) 17(1)  -1(1) -6(1)  -4(1) 
C(3) 14(1)  13(1) 21(1)  -2(1) -7(1)  -1(1) 
C(4) 13(1)  13(1) 16(1)  3(1) -4(1)  -4(1) 
C(5) 11(1)  13(1) 16(1)  -1(1) -6(1)  -3(1) 
C(6) 18(1)  12(1) 20(1)  2(1) -9(1)  -5(1) 
C(7) 18(1)  21(1) 16(1)  4(1) -7(1)  -6(1) 
C(8) 10(1)  12(1) 11(1)  1(1) -2(1)  -1(1) 
C(9) 14(1)  12(1) 13(1)  2(1) -1(1)  0(1) 
C(10) 19(1)  18(1) 14(1)  1(1) 0(1)  2(1) 
C(11) 17(1)  26(1) 16(1)  0(1) 1(1)  -2(1) 
C(12) 22(1)  16(1) 18(1)  -1(1) -1(1)  -5(1) 
C(13) 12(1)  19(1) 17(1)  -3(1) 1(1)  -2(1) 
C(14) 14(1)  11(1) 13(1)  -1(1) -3(1)  -1(1) 
C(15) 15(1)  17(1) 16(1)  -2(1) -4(1)  0(1) 
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C(16) 14(1)  20(1) 17(1)  0(1) -4(1)  -3(1) 
C(17) 20(1)  34(1) 16(1)  -4(1) -2(1)  -7(1) 
C(18) 18(1)  14(1) 16(1)  -4(1) -2(1)  -1(1) 
C(19) 12(1)  12(1) 12(1)  0(1) -3(1)  0(1) 
C(20) 12(1)  14(1) 13(1)  0(1) -3(1)  -3(1) 
C(21) 15(1)  16(1) 13(1)  1(1) -1(1)  -4(1) 
C(22) 16(1)  18(1) 15(1)  -3(1) 1(1)  -4(1) 
C(23) 12(1)  22(1) 12(1)  -3(1) -3(1)  -5(1) 
O(1S) 27(1)  26(1) 25(1)  2(1) -8(1)  -10(1) 
O(2S) 27(1)  22(1) 21(1)  -3(1) 4(1)  -8(1) 
O(3S) 30(1)  27(1) 22(1)  2(1) -9(1)  -10(1) 
O(4S) 27(1)  26(1) 34(1)  1(1) -3(1)  -7(1) 
 
Table E. Hydrogen coordinates (x 104) and isotropic displacement parameters (Å2 x 103) 
for 2.29. 
_______________________________________________________________________ 
 x  y  z  U(eq) 
_______________________________________________________________________ 
  
H(5) 7361 2940 9654 34 
H(8) 13490 9101 9561 36 
H(11) 15156 9810 1717 31 
H(1C) 8179 5340 1899 37 
H(1D) 9828 4821 2301 37 
H(1E) 9710 6155 1873 37 
H(3) 7713 4522 3498 19 
H(4) 6189 5393 4595 17 
H(6) 6416 8801 3571 19 
H(7) 8016 7918 2492 22 
H(9A) 6649 6205 6248 16 
H(9B) 8198 6376 6670 16 
H(10A) 6435 7951 7331 22 
H(10B) 4949 8045 6825 22 
H(11A) 3954 7036 7956 24 
H(11B) 4320 6070 7324 24 
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H(12A) 5663 6995 8768 22 
H(12B) 7688 6670 8367 22 
H(14A) 9048 9290 5630 15 
H(14B) 7796 9169 6426 15 
H(15A) 10026 7644 6835 19 
H(15B) 11285 7828 6045 19 
H(16A) 12220 8977 6820 20 
H(16B) 11128 9961 6316 20 
H(17A) 10349 8162 7932 27 
H(17B) 9161 9230 8420 27 
H(19A) 10243 6442 5510 14 
H(19B) 8747 6281 5054 14 
H(20A) 9317 8176 4335 16 
H(20B) 10970 8152 4742 16 
H(21A) 12339 6285 4217 18 
H(21B) 10656 6246 3837 18 
H(22A) 12456 6313 2627 20 
H(22B) 14110 6274 3036 20 
H(1) 6470(20) 9104(11) 5310(10) 20(5) 
H(2) 5770(20) 4221(18) 8863(9) 23(5) 
H(3A) 11580(30) 8090(14) 9084(11) 30(6) 
H(4A) 12664(18) 9127(16) 2525(9) 18(5) 
H(1SA) 30(30) 6100(20) 9344(14) 52(7) 
H(1SB) 1760(30) 5880(20) 9505(14) 67(9) 
H(2SA) 6620(30) 7700(30) 832(12) 69(9) 
H(2SB) 7470(40) 7110(20) 177(14) 72(9) 
H(3SA) 12790(30) 10813(18) 10135(13) 54(7) 
H(3SB) 13400(30) 9920(20) 10722(12) 61(8) 
H(4SA) 10350(30) 2020(20) 9317(13) 49(7) 
H(4SB) 9020(40) 1149(18) 9308(15) 68(9) 
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Table F.  Torsion angles [°] for 2.29 
________________________________________________________________  
O(2)-S(1)-N(1)-C(8) 46.05(15) 
O(1)-S(1)-N(1)-C(8) 174.43(13) 
C(5)-S(1)-N(1)-C(8) -70.29(15) 
C(7)-C(2)-C(3)-C(4) -1.2(2) 
C(1)-C(2)-C(3)-C(4) -179.75(15) 
C(2)-C(3)-C(4)-C(5) 0.8(2) 
C(3)-C(4)-C(5)-C(6) 0.7(2) 
C(3)-C(4)-C(5)-S(1) -177.91(12) 
O(2)-S(1)-C(5)-C(6) 166.74(13) 
O(1)-S(1)-C(5)-C(6) 38.33(15) 
N(1)-S(1)-C(5)-C(6) -74.98(14) 
O(2)-S(1)-C(5)-C(4) -14.65(15) 
O(1)-S(1)-C(5)-C(4) -143.06(12) 
N(1)-S(1)-C(5)-C(4) 103.63(13) 
C(4)-C(5)-C(6)-C(7) -1.8(2) 
S(1)-C(5)-C(6)-C(7) 176.81(12) 
C(5)-C(6)-C(7)-C(2) 1.4(2) 
C(3)-C(2)-C(7)-C(6) 0.1(2) 
C(1)-C(2)-C(7)-C(6) 178.65(16) 
S(1)-N(1)-C(8)-C(14) -178.59(11) 
S(1)-N(1)-C(8)-C(9) -59.02(18) 
S(1)-N(1)-C(8)-C(19) 61.70(17) 
N(1)-C(8)-C(9)-C(10) -59.55(17) 
C(14)-C(8)-C(9)-C(10) 55.24(18) 
C(19)-C(8)-C(9)-C(10) 178.13(13) 
C(8)-C(9)-C(10)-C(11) 168.39(14) 
C(12)-O(3)-C(11)-C(10) 74.43(18) 
C(9)-C(10)-C(11)-O(3) 63.84(19) 
C(11)-O(3)-C(12)-C(13) 150.15(14) 
O(5)-N(2)-C(13)-O(4) 4.1(2) 
O(5)-N(2)-C(13)-C(12) -175.61(14) 
O(3)-C(12)-C(13)-O(4) 165.87(14) 
O(3)-C(12)-C(13)-N(2) -14.4(2) 
N(1)-C(8)-C(14)-C(15) -176.10(13) 
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C(9)-C(8)-C(14)-C(15) 64.90(17) 
C(19)-C(8)-C(14)-C(15) -56.40(17) 
C(8)-C(14)-C(15)-C(16) -177.39(13) 
C(17)-O(6)-C(16)-C(15) 83.23(16) 
C(14)-C(15)-C(16)-O(6) 72.55(17) 
C(16)-O(6)-C(17)-C(18) 77.58(17) 
O(8)-N(3)-C(18)-O(7) -11.8(2) 
O(8)-N(3)-C(18)-C(17) 168.83(13) 
O(6)-C(17)-C(18)-O(7) -5.4(2) 
O(6)-C(17)-C(18)-N(3) 174.03(14) 
N(1)-C(8)-C(19)-C(20) 60.34(17) 
C(14)-C(8)-C(19)-C(20) -54.77(17) 
C(9)-C(8)-C(19)-C(20) -177.75(13) 
C(8)-C(19)-C(20)-C(21) -171.56(13) 
C(22)-O(9)-C(21)-C(20) -179.92(13) 
C(19)-C(20)-C(21)-O(9) 176.96(12) 
C(21)-O(9)-C(22)-C(23) -176.44(13) 
O(11)-N(4)-C(23)-O(10) 7.5(2) 
O(11)-N(4)-C(23)-C(22) -174.88(13) 
O(9)-C(22)-C(23)-O(10) 175.80(14) 
O(9)-C(22)-C(23)-N(4) -1.9(2) 
 
 
Table G.  Hydrogen bonds for 2.29  [Å and °] 
________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
________________________________________________________________________ 
 O(5)-H(5)...O(4S) 0.84 1.85 2.6726(19) 167.2 
 O(8)-H(8)...O(3S) 0.84 1.81 2.6440(18) 169.1 
 O(11)-H(11)...O(7)#1 0.84 1.84 2.6662(17) 166.2 
 O(11)-H(11)...O(8)#1 0.84 2.36 2.8218(17) 115.4 
 C(12)-H(12A)...O(8)#2 0.99 2.33 3.318(2) 174.5 
 C(16)-H(16A)...O(7) 0.99 2.57 3.090(2) 113.0 
 C(17)-H(17B)...O(3S)#3 0.99 2.55 3.493(2) 160.0 
 C(22)-H(22A)...O(3)#4 0.99 2.65 3.2731(19) 120.9 
 N(1)-H(1)...O(1)#5 0.830(11) 2.155(11) 2.9782(17) 171.4(18) 
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 N(2)-H(2)...O(10)#4 0.832(11) 2.124(15) 2.8470(19) 145.2(18) 
 N(3)-H(3A)...O(1S)#6 0.832(11) 1.997(12) 2.805(2) 164(2) 
 N(4)-H(4A)...O(6)#7 0.831(11) 2.150(14) 2.8907(19) 148.3(17) 
 O(1S)-H(1SA)...O(4)#2 0.891(18) 1.933(18) 2.8228(18) 177(2) 
 O(1S)-H(1SB)...O(4)#8 0.890(18) 2.13(2) 2.9575(18) 154(2) 
 O(1S)-H(1SB)...O(5)#8 0.890(18) 2.35(2) 2.9713(18) 126(2) 
 O(2S)-H(2SA)...O(10)#20.885(19) 1.87(2) 2.7381(17) 166(3) 
 O(2S)-H(2SB)...O(4)#9 0.886(19) 1.939(19) 2.8210(17) 174(3) 
 O(3S)-H(3SA)...O(2S)#70.921(17) 1.796(18) 2.6985(18) 166(2) 
 O(3S)-H(3SB)...O(11)#100.920(17) 1.912(18) 2.8054(18) 163(2) 
 O(4S)-H(4SA)...O(2S)#40.913(18) 1.923(18) 2.836(2) 179(2) 
 O(4S)-H(4SB)...O(3S)#110.912(18) 2.01(2) 2.8513(19) 153(2) 
